2018 Annual Meeting | P3 - Poster Session III

Date Tuesday 04/24/18

Time 11:30 AM - 07:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) Aging, Dementia, and Behavioral Neurology, Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Headache, Movement Disorders, Multiple Sclerosis, Neuromuscular and Clinical Neurophysiology (EMG), Practice, Policy, and Ethics, Research Methodology, ��ɫ��, and History

CME Available 0.00 credit

Event Timeline
11:30 AM - 07:00 PM	Abstract	001 - Effectiveness of Blended Learning for Resident ��ɫ�� in Neurology: Experience from Movement Disorder Course Danish Bhatti, MD, FAAN
11:30 AM - 07:00 PM	Abstract	002 - Predictors of Strong Performance during Neurology Residency and Beyond Deborah Y. Bradshaw, MD, FAAN
11:30 AM - 07:00 PM	Abstract	003 - Graduation competencies: What does a future Neurology resident need to know at medical school graduation to prepare for Neurology residency? Alexandra Gewirtz, MD
11:30 AM - 07:00 PM	Abstract	004 - Impact of a Novel Clinic Block Schedule on Resident Satisfaction and Continuity of Care in the adult neurology resident clinic at Columbia University Medical Center Andrew C. Taylor, MD
11:30 AM - 07:00 PM	Abstract	005 - Evaluation of Resident Physician Exposure and Patient Access in Outpatient Continuity Clinic Neeraj Singh, MD
11:30 AM - 07:00 PM	Abstract	006 - Implementing a Formal Faculty-Resident Feedback Protocol for NYU Neurology Residency Scott Grossman, MD
11:30 AM - 07:00 PM	Abstract	007 - The development of the National In-training examination for Canadian Pediatric Neurology Residents (NITECaP) Sunita Venkateswaran, MD
11:30 AM - 07:00 PM	Abstract	008 - Autonomy and Praise from Co-Residents May Protect Against Burnout in Neurology Residents Jeffrey B. Ratliff, MD, FAAN
11:30 AM - 07:00 PM	Abstract	009 - Residents' Perceptions of Inappropriate Consults: Expectations of Expertise Among Neurology and Medicine Residents as a Barrier to Interdisciplinary Collaboration Stephen Krieger, MD, FAAN
11:30 AM - 07:00 PM	Abstract	010 - Developing a Successful Wellness Program for Child Neurology Residents Aimee A. Sato, MD
11:30 AM - 07:00 PM	Abstract	011 - Assessing and Enhancing Neurology Resident ��ɫ�� on Interpersonal Communication and Professionalism Arielle M. Kurzweil, MD, FAAN
11:30 AM - 07:00 PM	Abstract	012 - Improving Resilience Among Neurology Residents Adrienne M. Keener, MD
11:30 AM - 07:00 PM	Abstract	013 - Burnout, resident satisfaction, and well-being among neurology residents with different service models Muhammad A. Iqbal, MD
11:30 AM - 07:00 PM	Abstract	014 - Neurologists in Trouble: Licensure Actions Involving ABPN Diplomates Larry R. Faulkner, MD
11:30 AM - 07:00 PM	Abstract	015 - Resident ��ɫ�� through Adult Learning: Two Years of Experience Hazem M. Shoirah, MD
11:30 AM - 07:00 PM	Abstract	016 - Code Stroke Simulation Training Benefits Junior Neurology Residents Linda C. Wendell, MD, FAAN
11:30 AM - 07:00 PM	Abstract	017 - Intensive Neuroanatomy Boot Camp Curriculum Demonstrates Improved Neurology Residency In-Service Training Examination (RITE) Scores
11:30 AM - 07:00 PM	Abstract	018 - Effectiveness of a Video-Based Lecture (VBL) EEG Curriculum for Incoming Neurology Residents Rachael Benson, MD
11:30 AM - 07:00 PM	Abstract	019 - Medical Simulation as the Standard for Acute Stroke ��ɫ��: Review of the Literature and Recommendations for Future Implementation Frances E. Chow, MD
11:30 AM - 07:00 PM	Abstract	020 - Flipped Classroom: Applications in Teaching EEG
11:30 AM - 07:00 PM	Abstract	021 - Increasing Knowledge and Comfortability in the Management of Pediatric Status Epilepticus Jeffrey M. Kornitzer, MD, FAAN
11:30 AM - 07:00 PM	Abstract	022 - Stroke Code Simulation Has Sustained Benefit on Neurology Resident ��ɫ�� and Preparedness for Stroke Call Catherine Legault, MD
11:30 AM - 07:00 PM	Abstract	023 - Feasibility of Online Resident ��ɫ�� in Pakistan with international collaborations: Implementing Blended learning Danish Bhatti, MD, FAAN
11:30 AM - 07:00 PM	Abstract	024 - NA
11:30 AM - 07:00 PM	Abstract	025 - NA
11:30 AM - 07:00 PM	Abstract	026 - NA
11:30 AM - 07:00 PM	Abstract	027 - Plasma Biomarkers in Early Neurodegenerative Disease Stages Fanny M. Elahi, MD, PhD
11:30 AM - 07:00 PM	Abstract	028 - Elevated CSF neurofilament levels are associated with risk of Mild Cognitive Impairment among individuals with and without low CSF amyloid-beta Michelle M. Mielke, PhD
11:30 AM - 07:00 PM	Abstract	029 - VEGF's Relationship to Brain Aging Biomarkers Meral Tubi
11:30 AM - 07:00 PM	Abstract	030 - Multisensory Impairment is Associated with Increased Risk of Dementia Willa D. Brenowitz, PhD, MPH
11:30 AM - 07:00 PM	Abstract	031 - Sense-encoded poly-GR dipeptide repeat proteins correlate to neurodegeneration and uniquely co-localize with TDP-43 in dendrites of repeat expanded C9orf72 amyotrophic lateral sclerosis
11:30 AM - 07:00 PM	Abstract	032 - Role of ABCA-1 Activity in Brain DHA Metabolism in Carriers of APOE4
11:30 AM - 07:00 PM	Abstract	033 - Changes in Functional and Structural Brain Connectome Along the Alzheimer's Disease Continuum Federica Agosta
11:30 AM - 07:00 PM	Abstract	034 - In Vivo [18F]-AV-1451 Tau-PET Imaging in Sporadic Creutzfeldt-Jakob Disease Gregory S. Day, MD, MSc, FAAN
11:30 AM - 07:00 PM	Abstract	035 - Transient Epileptic Amnesia: a Retrospective Analysis of Cases from the Mayo Clinic Vijay K. Ramanan, MD, PhD
11:30 AM - 07:00 PM	Abstract	036 - Characteristics and Progress on 312 Subjects in the Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects (LEFFTDS) Protocol Bradley F. Boeve, MD, FAAN
11:30 AM - 07:00 PM	Abstract	037 - Using Objective Measurement Via Wearable Sensors To Evaluate Real-world Effectiveness Of Carbidopa/Levodopa Enteral Suspension For Managing Motor Fluctuations: PROviDE Study Design And Baseline Characteristics Rajesh Pahwa, MD, FAAN
11:30 AM - 07:00 PM	Abstract	038 - Virtual research visits in individuals with Parkinson disease enrolled in a clinical trial: REACT-PD Study Christopher Tarolli, MD, FAAN
11:30 AM - 07:00 PM	Abstract	039 - Objective Data in Parkinson's Disease: A description of over 10,000 Parkinsons symptom scores across the world using the Personal KinetiGraph (PKG) Peter Lynch
11:30 AM - 07:00 PM	Abstract	040 - Using Wireless Wearable Sensors to Estimate the Severity of Rest Hand Tremor in PD
11:30 AM - 07:00 PM	Abstract	041 - Wearable Motion Quantification and Electronic Diaries for Long-Term Monitoring of Parkinson's Disease Aaron Hadley
11:30 AM - 07:00 PM	Abstract	042 - Machine learning algorithms applied to digital biomarker data (iMotor) discriminate Parkinson's motor status
11:30 AM - 07:00 PM	Abstract	043 - Developing a Self-Administered Instrumented Motor Exam for Home-based Parkinson's Disease Assessment Using Wearable Sensors
11:30 AM - 07:00 PM	Abstract	044 - Accelerometry-Based Quantitative Analysis of Mobility in Parkinson Disease Jia Zhen Cheng, MD
11:30 AM - 07:00 PM	Abstract	045 - Clinical Experience with Personal KinetiGraph Before and After Deep Brain Stimulation for Parkinson's Disease
11:30 AM - 07:00 PM	Abstract	046 - Remote patient testing with smartphones provides reliable, valid and sensitive measures of motor symptom severity in Parkinson's disease patients Florian Lipsmeier
11:30 AM - 07:00 PM	Abstract	047 - Hypomimia detection with a smartphone camera as a possible self-screening tool for Parkinson disease Yury Seliverstov, MD, PhD
11:30 AM - 07:00 PM	Abstract	048 - Clinician-Input Study (CIS-PD): how the Fox Wearable Companion Application can influence treatment and care in Parkinson's disease
11:30 AM - 07:00 PM	Abstract	049 - Rab8a protects against alpha-synuclein toxicity in a rat model of Parkinsonism Nikolaus McFarland, MD, PhD, FAAN
11:30 AM - 07:00 PM	Abstract	050 - Cytosolic glucocerebrosidase impairs alpha-synuclein degradation by blockade of chaperone-mediated autophagy Sheng-Han Kuo, MD, FAAN
11:30 AM - 07:00 PM	Abstract	051 - Evaluation of Glucosylceramide Synthase (GCS) Inhibition for GBA-Associated Parkinson's Disease Tanya Fischer, MD, PhD
11:30 AM - 07:00 PM	Abstract	052 - A comparative plasma alpha-synuclein concentration and metabolic profiling study in Parkinson´s disease and essential tremor Esther Cubo Delgado, MD, PhD, FAAN
11:30 AM - 07:00 PM	Abstract	053 - Dendritic cells, CD4+ T cells, and ? synuclein triangle fuels neuroinflammation in Parkinson's disease
11:30 AM - 07:00 PM	Abstract	054 - Patients with Alpha-synucleinopathies Display Distinct Chemokine Profiles Jessika Suescun, MD
11:30 AM - 07:00 PM	Abstract	055 - The Effect of NMDA Lesions in the Pedunculopontine Tegmental Nucleus as a Rat Model of Parkinson's Disease Anam Syed, DO
11:30 AM - 07:00 PM	Abstract	056 - Salivary Alpha-Synuclein a new tool for the diagnosis of Parkinson's disease? PARKSYN study
11:30 AM - 07:00 PM	Abstract	057 - Support for the Spreading Hypothesis: Pathologically Proven Alpha-synuclein Peripheral Neuropathy 20 years Before Development of Parkinsonism Olwen Murphy, MD
11:30 AM - 07:00 PM	Abstract	058 - Role of a-Synuclein in the GFAP.HMOX1 mouse model of PD Laurianne R. Garabed
11:30 AM - 07:00 PM	Abstract	059 - Alpha-synuclein Protein Homeostasis and Oligomerization in Iron-overloaded Cells Expressing Mutant HFE Yunsung Kim, PhD
11:30 AM - 07:00 PM	Abstract	060 - Pilot Assessment of Salivary Cortisol Levels as a Marker for Depression in Patients with Parkinson Disease Jared Sweeney
11:30 AM - 07:00 PM	Abstract	061 - Fundamental limit of alpha-synuclein pathology in gastrointestinal biopsy as a pathologic biomarker of Parkinson's disease: Comparison with surgical specimens Beomseok Jeon, MD
11:30 AM - 07:00 PM	Abstract	062 - Neuroprotective Effect of Parkin on Mitochondria in Central Dopaminergic Neurons Hae-young Hawong, DO, PhD
11:30 AM - 07:00 PM	Abstract	063 - Modulation of CaMKIIa-NR2B interaction in levodopa-induced dyskinesia in 6-OHDA-lesioned Parkinson's rats
11:30 AM - 07:00 PM	Abstract	064 - Progression of Parkinson's Disease: 2-Year Longitudinal Study of Clinical and MRI Changes in Patients at Different Stages of the Disease Massimo Filippi, MD, FAAN
11:30 AM - 07:00 PM	Abstract	065 - Functional Brain Connectome Architecture in a Large Cohort of Parkinson's Disease Patients Silvia Basaia
11:30 AM - 07:00 PM	Abstract	066 - Combining Metabolomics and Neuroimaging in mid-stage Parkinson's Disease. A Proof of Concept for Cross-Fertilization.
11:30 AM - 07:00 PM	Abstract	067 - Longitudinal Cortical Thickness Changes in GBA-Positive Relative to GBA-Negative Parkinson's Disease Patients with Hemiparkinsonism
11:30 AM - 07:00 PM	Abstract	068 - Domain-specific impact of cerebral white matter hyperintensities on Parkinson's disease cognitive functioning Patricia Linortner, PhD
11:30 AM - 07:00 PM	Abstract	069 - Microstructural Changes in the Thalamus and Putamen, as Measured by Diffusion Tensor Imaging, Correlate with Gait Abnormalities in Parkinson's Disease Jacob Surkont, MD
11:30 AM - 07:00 PM	Abstract	070 - Longitudinal Cortical Thickness Changes in Early Parkinson's Disease Patients with Impulsive Compulsive Behaviors
11:30 AM - 07:00 PM	Abstract	071 - Zonisamide Co-treatment Slows Reduction of Striatal Dopamine Transporter in Patients with Parkinson's Disease Ken Ikeda, MD, PhD
11:30 AM - 07:00 PM	Abstract	072 - Cortical Surface Analysis in Parkinson Disease Patients Rachel P. Guimaraes, PT
11:30 AM - 07:00 PM	Abstract	073 - Microstructural Changes in Balance Control Centers, as Measured by Diffusion Tensor Imaging, Correlate with the Ability to Use Somatosensory Information to Maintain Balance in Parkinson's Disease Jacob Surkont, MD
11:30 AM - 07:00 PM	Abstract	074 - DAT-SPECT Imaging in Cases of Drug-Induced Parkinsonism in a Specialty Movement Disorders Practice Jacob Yomtoob, MD
11:30 AM - 07:00 PM	Abstract	075 - Functional Magnetic Resonance Imaging-Based Neurofeedback Training in Patients with Parkinson's Disease Ayse S. Tinaz, MD, PhD
11:30 AM - 07:00 PM	Abstract	077 - Analysis of Tc-99m TRODAY study in patients with Parkinsonism Yu-Wei Lin, MD
11:30 AM - 07:00 PM	Abstract	078 - Transcranial sonography in real clinical practice: Differential diagnosis between idiopathic Parkinson´s disease, atypical parkinsonism and essential tremor Talyta Grippe, MD
11:30 AM - 07:00 PM	Abstract	079 - Substantia Nigra Hyperechogenicity in Parkinson´s Disease and Essential Tremor and Its Association with Premotor Symptoms of Parkinson´s Disease. Marcela Uribe Roca
11:30 AM - 07:00 PM	Abstract	080 - PATTERN ANALYSIS OF FDG PET IN ATYPICAL PARKINSONISM - AN INNOVATIVE APPROACH Balakrishnan Shankar, Jr., MD
11:30 AM - 07:00 PM	Abstract	081 - A CT-Based Diagnostic Index to differentiate between Progressive Supranuclear Palsy and Parkinson's disease: A potential application for DaT-SPECT/CT. Bhumika Balgobin, MD
11:30 AM - 07:00 PM	Abstract	082 - Hyperechogenicity of the substantia nigra in non-mutation-carrying family members of LRRK2 PD Mariel Pullman, MD
11:30 AM - 07:00 PM	Abstract	083 - White Matter Changes in Parkinson's Disease Mapped with a Novel Tract Mapping Algorithm Conor Corbin
11:30 AM - 07:00 PM	Abstract	084 - The Evaluation of the Ganglion Cell Layer-Inner Plexiform Layer Complex Thickness in Early Parkinson's Disease Durdane Aksoy, MD
11:30 AM - 07:00 PM	Abstract	085 - Ambulatory Computerized Physician Order Entry Associated with Greater Opioid Prescribing John Ney, MD, MPH, FAAN
11:30 AM - 07:00 PM	Abstract	086 - High resolution and high field diffusion MRI in the visual system of primates
11:30 AM - 07:00 PM	Abstract	087 - Effects of ��ɫ�� on Symptom Recognition and Management of Pseudobulbar Affect: A Mixed-Methods Evaluation of Knowledge and Behavior Changes of Clinicians and Patients Anne C. Roc, PhD
11:30 AM - 07:00 PM	Abstract	088 - Anterior horn cell (AHC) involvement in autosomal recessive hereditary spastic paraplegia with thin corpus callosum (ARHSPTCC) patients with SPG 11 mutations. Nouf S. Al-Faidi, MD
11:30 AM - 07:00 PM	Abstract	089 - "Doctor, I can't touch my cheek with my tongue" Vaibhav Goswami, MD
11:30 AM - 07:00 PM	Abstract	090 - Posterior Spinal Cord Infarction in a Patient with Moderate Degenerative Cervical Spondylosis Danielle M. Stember, MD
11:30 AM - 07:00 PM	Abstract	091 - DEWS (DEep White matter hyperintensity Segmentation framework): Fully automated pipeline for detecting small deep white matter hyperintensities in migraineurs Mi-Ji Lee, MD
11:30 AM - 07:00 PM	Abstract	093 - Vascular Wall Imaging in Reversible Cerebral Vasoconstriction Syndrome- a 3-tesla Contrast-Enhanced MRI study Chelsea S. Chen
11:30 AM - 07:00 PM	Abstract	094 - Is diffusion restriction of the optic disc head a new marker for Idiopathic Intracranial Hypertension? Elanagan Nagarajan, MD
11:30 AM - 07:00 PM	Abstract	095 - Neuroimaging Abnormalities in First-Visit Primary Headache Patients: A Prospective Multicenter Study
11:30 AM - 07:00 PM	Abstract	096 - Reversible Lesions of the Corpus Callosum in Migraine with Aura: a Case Study and Review of the Literature Richard A. Lewis, MD
11:30 AM - 07:00 PM	Abstract	097 - Is cortical dysexcitability is the basis of palinopsia in migraine? Jayantee Kalita, MD
11:30 AM - 07:00 PM	Abstract	098 - Clinical Characterization, Repetitive Pattern Reversal Visual Evoked Potentials (rVEP), Transcranial Magnetic Stimulation (TMS) and Brain Imaging in Visual Snow Fatma Gokcem Yildiz
11:30 AM - 07:00 PM	Abstract	099 - N=1 Statistical Approaches to examine Factors that Modify Headache Severity in Chronic versus Episodic patients
11:30 AM - 07:00 PM	Abstract	100 - Accelerating Headache Clinical Research Studies: The National Institute of Neurological Disorders and Stroke (NINDS) Headache Version 2.0 (V2.0) Common Data Elements (CDEs) Sarah Tanveer, PhD, MA
11:30 AM - 07:00 PM	Abstract	101 - Updated Results on Cerebrospinal Fluid (CSF) Volume Removal for Idiopathic Intracranial Hypertension (IIH): Removing Less CSF May Be Best Simy K. Parikh, MD
11:30 AM - 07:00 PM	Abstract	102 - Novel anti-neuronal antibodies in idiopathic intracranial hypertension patients Erdem Tuzun
11:30 AM - 07:00 PM	Abstract	103 - Correlation of Opening Pressure with Unilateral Versus Bilateral Venous Sinus Stenosis in Idiopathic Intracranial Hypertension (IIH) Roman M. Kassa, MD
11:30 AM - 07:00 PM	Abstract	104 - Intracranial hypertension and systemic lupus erythematosus
11:30 AM - 07:00 PM	Abstract	105 - Intra-dural fluid collections in spontaneous CSF leaks: The dural dissection theory Monique M. Montenegro, MD
11:30 AM - 07:00 PM	Abstract	106 - Sex-specific clinical features of spontaneous intracranial hypotension Yun Jik Park, MD
11:30 AM - 07:00 PM	Abstract	107 - Rare Cause of Explosive Headache: Iatrogenic Pneumocephalus Following Epidural Blood Patch Alison I. Thaler, MD
11:30 AM - 07:00 PM	Abstract	108 - Knocked Out: Concussion as a trigger for encephalopathic hemiplegic migraine. Maria Gaughan, MBBS
11:30 AM - 07:00 PM	Abstract	109 - Stroke-like image findings in sporadic hemiplegic migraine
11:30 AM - 07:00 PM	Abstract	110 - Familial Aphasic Migraine Scott Woolf, DO
11:30 AM - 07:00 PM	Abstract	111 - Chronic and Primary Daily Vestibular Migraine - Two New Subtypes of the Disorder Steffen Naegel, MD
11:30 AM - 07:00 PM	Abstract	112 - Headache in patients with isolated cortical vein thrombosis: report of 9 cases and review of the literature.
11:30 AM - 07:00 PM	Abstract	113 - Cerebral Venous Sinus Thrombosis Presenting With Headache And Papilledema Without Focal Neurological Deficits Sai Sripada R. Koneru, Sr., MD
11:30 AM - 07:00 PM	Abstract	114 - New Daily Persistent Headache (NDPH) & OnabotulinumtoxinA Therapy Ashhar Ali, DO, FAAN
11:30 AM - 07:00 PM	Abstract	115 - An Unusual Presentation of Hemicrania Continua Steven C. Yang, DO
11:30 AM - 07:00 PM	Abstract	116 - Unusual Presentation Of HaNDL Syndrome Musab Ali, MD
11:30 AM - 07:00 PM	Abstract	117 - Syndrome of transient headache with neurological deficits and CSF lymphocytosis (HaNDL) presenting with Diffusion Restriction in the Splenium of Corpus Callosum: Case report and review of literature Kunal Bhatia, MD
11:30 AM - 07:00 PM	Abstract	118 - Whole Body Cryotherapy Induced Reversible Cerebral Vasoconstriction Syndrome David S. Atkins, PA
11:30 AM - 07:00 PM	Abstract	119 - Cognitive and Hearing Complaints in Veterans: Is Central Auditory Processing Disorder an Overlooked Disability? Eliot A. Licht, MD
11:30 AM - 07:00 PM	Abstract	120 - Cardiac Cephalalgia: a Deadly Case Report Matheus K. Pedro, MD
11:30 AM - 07:00 PM	Abstract	121 - Third Cranial Nerve Palsy Associated with an Attack of Cluster Headache Jessica L. Coleman
11:30 AM - 07:00 PM	Abstract	122 - A Cluster Headache Phenotype (Never Smoker and No Parental Secondary Smoke Exposure as a Child): Results from the United States Cluster Headache Survey Todd D. Rozen, MD, FAAN
11:30 AM - 07:00 PM	Abstract	123 - Identifying Natural Subgroups of Migraine Based on Profiles of Comorbidities and Concomitant Conditions: Results of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study Richard B. Lipton, MD, FAAN
11:30 AM - 07:00 PM	Abstract	124 - The Relationship between Pain, Psychiatric, and Endocrine/Neurological Comorbidities of Migraine: Results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study Aubrey Adams, PhD
11:30 AM - 07:00 PM	Abstract	125 - Frequency of Recurrent Headaches in Children with Celiac Disease
11:30 AM - 07:00 PM	Abstract	126 - Migraine in Postural Orthostatic Tachycardia Syndrome (POTS) Juliana VanderPluym, MD
11:30 AM - 07:00 PM	Abstract	127 - Accuracy and safety of an artificial intelligent system for nonacute headache diagnosis
11:30 AM - 07:00 PM	Abstract	128 - Fibromyalgia and Myositis in Migraine: A Nationwide Study of Disability and Discharge outcome
11:30 AM - 07:00 PM	Abstract	129 - Productivity Loss and Indirect Costs of Chronic Migraine and Episodic Migraine in a Commercially-Insured Population
11:30 AM - 07:00 PM	Abstract	130 - Prevalence And Risk Factors Associated With Depression In Patients With Chronic Headache Cross Sectional Study, In Aseer Region, Saudi Arabia
11:30 AM - 07:00 PM	Abstract	131 - Vitamin D deficiency in migraine Cho Soo-Jin
11:30 AM - 07:00 PM	Abstract	132 - Development of a Claims-Based Algorithm for Use in Patients with Migraine to Identify Potentially Undiagnosed Chronic Migraine Patients Jelena M. Pavlovic, MD, PhD
11:30 AM - 07:00 PM	Abstract	133 - Medical Comorbidities of Migraine: Results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study Aubrey Adams, PhD
11:30 AM - 07:00 PM	Abstract	134 - The Cardiovascular Impact of Intravenous Dihydroergotamine for Pediatric Headache Patients Sara Molisani, MD
11:30 AM - 07:00 PM	Abstract	135 - Diagnostic Delay of Chronic Migraine and Medication-Overuse Headache in University-Based Headache Clinic
11:30 AM - 07:00 PM	Abstract	136 - Improving Patient-Centeredness of Headache Questionnaires Edlin Gonzales, MA
11:30 AM - 07:00 PM	Abstract	137 - Evaluation of Post-traumatic (PT) Chronic Migraine (CM) in Veterans of OEF/OIF Campaigns Using Serum Mass Profiling to Distinguish CM from other PT Headaches by Identification of Peptide Changes in Serum James R. Couch, Jr., MD, PhD, FAAN
11:30 AM - 07:00 PM	Abstract	138 - Post-Traumatic vs Non-Traumatic Headaches: A Phenotypic Analysis
11:30 AM - 07:00 PM	Abstract	139 - The Impact of Headache Free Days on Quality of Life and Costs Among People with Migraine with ?4 Headache Days in the Past Month
11:30 AM - 07:00 PM	Abstract	140 - Sleepy Brain in Pain; Prevalence of Sleep Problems in a University-Based Headache Clinic Natalia Murinova, MD, FAAN
11:30 AM - 07:00 PM	Abstract	141 - Symptom Bothersomeness in Migraine: Results from 2017 Migraine in America Symptoms and Treatment (MAST) Study Sagar Munjal, MD
11:30 AM - 07:00 PM	Abstract	142 - Prevalence and Burden of Primary Headache Disorders in Kuwaiti Children and Adolescents. Samar F. Ahmed, MD
11:30 AM - 07:00 PM	Abstract	143 - A Population Based Survey for Headaches in Greece to Estimate Prevalence and Treatment Preferences Dimos Dimitrios D. Mitsikostas, MD, PhD
11:30 AM - 07:00 PM	Abstract	144 - Burden of Illness Among Treated Migraine Patients with ?4 Headache Days in the Past Month
11:30 AM - 07:00 PM	Abstract	145 - 2017 Migraine in America Symptoms and Treatment (MAST) Study: Gender Differences in Treatment Patterns and Unmet Treatment Needs Aftab Alam
11:30 AM - 07:00 PM	Abstract	146 - Insufficient sleep in tension-type headache: a population study Jiyoung Kim
11:30 AM - 07:00 PM	Abstract	147 - Online Medical ��ɫ�� Improves Knowledge of Both Risk Factors for Chronification and Clinical Trial Data in Migraine
11:30 AM - 07:00 PM	Abstract	148 - What do Headache Patients Want? Patient Goals in Headache Medicine in a Tertiary Headache Center. Natalia Murinova, MD, FAAN
11:30 AM - 07:00 PM	Abstract	149 - Classification of cases with a diagnosis of acute headache, to emergency division in Regional Hospital Durres, Albania. Kledisa Shemsi
11:30 AM - 07:00 PM	Abstract	150 - Multimodal Communication Enhances Family Centered Care in the Neurocritical Care Unit (NCCU) Matthew N. Jaffa, DO
11:30 AM - 07:00 PM	Abstract	151 - Utilizing a Patient Contact Index to Determine Staffing of an Academic Neurology Department Benjamin M. Greenberg, MD, FAAN
11:30 AM - 07:00 PM	Abstract	152 - Improving Warfarin Management Through Pharmacy Lead Dose Capping for Patients ?85 Years Old Jonathan Falsetta, PharmD
11:30 AM - 07:00 PM	Abstract	153 - An Investigation of Tracking Technology in the Setting of an Established Exercise Program for Individuals with Parkinson's Disease Sarah Ingersoll, RN, PHN
11:30 AM - 07:00 PM	Abstract	154 - Trainee Responses to Hurricane Harvey: Correlating Volunteerism with Burnout Crystal J. Yeo, MD, PhD
11:30 AM - 07:00 PM	Abstract	155 - Improving access to sleep medicine clinic services through the implementation of an econsult program Asha Singh, MD
11:30 AM - 07:00 PM	Abstract	156 - Comprehensive Neurodevelopmental Care: Initiatives to empower health care professionals and care givers in resource constrained settings Shruthi N M, DM
11:30 AM - 07:00 PM	Abstract	157 - Improving Patient Satisfaction By Implementing Existing Tools in EHR Using Lean Methodology Anil Neelakantan, MD, FAAN
11:30 AM - 07:00 PM	Abstract	158 - Burnout and Vitality for Yale Neurology Paul Fu, MD
11:30 AM - 07:00 PM	Abstract	159 - Using Data Analytics to Increase Neurology Access With Existing Providers Neil R. Holland, MBBS, FAAN
11:30 AM - 07:00 PM	Abstract	160 - Barriers to Appropriate Inpatient Stroke Code Activation: A Quality Improvement Survey Chandler Gill, MD
11:30 AM - 07:00 PM	Abstract	161 - Trends in Coverage for Disease Modifying Therapies for Multiple Sclerosis in Medicare Part D Daniel Hartung, PharmD, MPH
11:30 AM - 07:00 PM	Abstract	162 - Factors Associated with Outpatient Follow-up in Stroke Clinic after Discharge from a Comprehensive Stroke Center Reema Choudhry, MD
11:30 AM - 07:00 PM	Abstract	163 - Stroke Stat: Notification System for In-Hospital Acute Strokes Jillian Alderson, MD
11:30 AM - 07:00 PM	Abstract	164 - Characteristics of General Neurology Readmissions Nina H. Kim, MD
11:30 AM - 07:00 PM	Abstract	165 - Optimization of Ambulatory Neurology Clinics at an Academic Medical Center Babar Khokhar, MD, FAAN
11:30 AM - 07:00 PM	Abstract	166 - Improving cost and laboratory utilization in Paraneoplastic Antibody Testing Dana L. Vanino, DO
11:30 AM - 07:00 PM	Abstract	167 - A Quality Improvement Project to Improve Trainee Compliance with Direct-to-Pharmacy Electronic Prescriptions Shivika Chandra, MD, FAAN
11:30 AM - 07:00 PM	Abstract	168 - Progress Note Quality Improvement Study: Results From a Resident and Faculty Survey Carolyn Zyloney, MD
11:30 AM - 07:00 PM	Abstract	170 - Transitioning Neurology Outpatients from a Tertiary Care Center to Primary Health Care Centers (PHCC). Edward J. Cupler, MD, FAAN
11:30 AM - 07:00 PM	Abstract	171 - NA
11:30 AM - 07:00 PM	Abstract	172 - NA
11:30 AM - 07:00 PM	Abstract	173 - Bilingualism and Age of Acquisition in Alzheimer Disease: a 18F-FDG PET Study Jean-Benoit Epiney, MD
11:30 AM - 07:00 PM	Abstract	174 - Amyloid and Hypertension Are Independently Associated with White Matter Injury Assessed by FLAIR and DTI MRI Omar M. Al-Janabi, MD, PhD, MSc
11:30 AM - 07:00 PM	Abstract	175 - Occipital and Cingulate Hypometabolism is Significantly Under-reported and Probably Missed on 18-Fluorodeoxyglucose Positron Emission Tomography Scans of Patients with Lewy Body Dementia Moath Hamed, MD
11:30 AM - 07:00 PM	Abstract	176 - Quantitative dopaminergic imaging identifies normal pressure hydrocephalus from its mimics Gilles Allali, MD, PhD
11:30 AM - 07:00 PM	Abstract	177 - Multimodal MRI Staging Improves Clinico-Imaging Correlations in sJCD.
11:30 AM - 07:00 PM	Abstract	178 - White matter microstructural damage and cerebral atrophy in middle age. The longitudinal CARDIA MRI sub-study. Justine Moonen
11:30 AM - 07:00 PM	Abstract	179 - Automatic classification of patients with Alzheimer's disease (AD) and mild cognitive impairment (MCI) who will convert to AD using deep neural networks Silvia Basaia
11:30 AM - 07:00 PM	Abstract	180 - Distinct Spatial Distribution of White Matter Hyperintensities Associated with Alzheimer's Disease Pathology and Hypertension. Omar M. Al-Janabi, MD, PhD, MSc
11:30 AM - 07:00 PM	Abstract	181 - MRI-derived markers of disease progression in early versus late PSP and CBS Kimiko Domoto-Reilly, MD
11:30 AM - 07:00 PM	Abstract	182 - Added Value of Multimodal Structural MRI to the Clinical Diagnosis of Primary Progressive Aphasia Variants Federica Agosta
11:30 AM - 07:00 PM	Abstract	183 - Assessing Test-Retest Reliability of Phase Contrast MRI for Measuring Cerebrospinal Fluid Flow Dynamics in Alzheimer’s Disease Ashwin Sakhare
11:30 AM - 07:00 PM	Abstract	184 - Neurodegeneration: Prion-like Behavior of Misfolded Proteins in the Syntactic Network Belen Pascual, PhD
11:30 AM - 07:00 PM	Abstract	185 - Volume and Functional Connectivity of the Ventral Tegmental Area as Early Markers of Alzheimer's Disease Matteo De Marco, PhD
11:30 AM - 07:00 PM	Abstract	186 - The impact of localized gray matter damage on connectivity: Posterior Cortical Atrophy study Haya Glick-Shames, PhD
11:30 AM - 07:00 PM	Abstract	187 - Longitudinal Changes in Metabolic Network Activity Associated with the Progression of Alzheimer's Disease Chris Tang, MD
11:30 AM - 07:00 PM	Abstract	188 - Longitudinal Cortical Thickness Analysis in Alzheimer Disease. ADNI-Arg Cohort Ismael Calandri, MD
11:30 AM - 07:00 PM	Abstract	189 - Diffusion MRI Measures from the Updated ADNI3 Protocol are Associated with Cognitive Impairment in the Elderly
11:30 AM - 07:00 PM	Abstract	190 - White matter connectivity differences between typical amnestic and variant non-amnestic individuals with early-onset Alzheimer's disease (EOAD) Paul M. Thompson, PhD
11:30 AM - 07:00 PM	Abstract	191 - Differential Susceptibility of Large-Scale Brain Networks to White Matter Alterations in Aging Christopher A. Brown, MD, PhD
11:30 AM - 07:00 PM	Abstract	192 - Longitudinal decline in the concreteness of speech in semantic variant primary progressive aphasia (svPPA)
11:30 AM - 07:00 PM	Abstract	194 - Dysprosody markers in PPA Naomi Nevler, MD
11:30 AM - 07:00 PM	Abstract	195 - Cerebrospinal Fluid Biomarkers of Likely Pathology in Primary Progressive Aphasia Catherine Norise, MD
11:30 AM - 07:00 PM	Abstract	196 - Investigating the use of high frequency repetitive transcranial magnetic stimulation for primary progressive apraxia of speech Danielle S. Shpiner, MD
11:30 AM - 07:00 PM	Abstract	197 - Clinicopathological Correlates of Verbal Fluency in Parkinson's Disease: A Pilot Study Rasheda El-Nazer, MD
11:30 AM - 07:00 PM	Abstract	198 - Unilateral Apraxic Agraphia without Ideomotor Apraxia in a patient with callosal and frontal lobe lesions Tigran Kesayan, MD
11:30 AM - 07:00 PM	Abstract	199 - Pure apraxia of speech associated with infarction in premotor cortex Riddhi Patira, MD
11:30 AM - 07:00 PM	Abstract	200 - NA
11:30 AM - 07:00 PM	Abstract	201 - Average Time from CT to CTP Completion is Long: What are we getting in return? Umar Shariff, MD
11:30 AM - 07:00 PM	Abstract	202 - Role of Thin-sliced Reformatted CT Imaging for acute Ischemic Stroke Patients, do we need CT angiography before deciding for acute neurointervention? Siddhart K. Mehta, MD
11:30 AM - 07:00 PM	Abstract	203 - Impact of Acute Interventions for Ischemic Strokes on Infarcted Tissue Volume: Comparison of MRI Profiles Michael M. Gezalian, MD
11:30 AM - 07:00 PM	Abstract	204 - Comparing Safety and Efficacy of Biplane versus Monoplane Angiography in Hyperacute Neuroendovascular Therapy
11:30 AM - 07:00 PM	Abstract	205 - Choice of Pretreatment Neuroimaging Impacts Clinical Outcomes Following Mechanical Thrombectomy Sitara Koneru, MD
11:30 AM - 07:00 PM	Abstract	206 - Pitfalls of CT Perfusion Imaging in Acute Ischemic Stroke: A Case Series Rae E. Bacharach, DO
11:30 AM - 07:00 PM	Abstract	207 - Inter-User Scoring Discrepancies Amongst Residents using The Alberta Stroke Program Early CT Score (ASPECTS) Shows Limited Use of this Scoring Tool without Formal Training. Saman Zafar, MD
11:30 AM - 07:00 PM	Abstract	208 - Impact of Ultra-Rapid-Sequential IV/Contrast on Renal Function and incidence of CIN in a Comprehensive Stroke Center Phillip Ye
11:30 AM - 07:00 PM	Abstract	209 - Flat- Panel Cone Beam Computed Tomography is a NOT a Reliable Predictor for Early Changes in Ischemic Stroke Patients with Large Vessel Occlusions (LVO) Amrinder Singh, MD
11:30 AM - 07:00 PM	Abstract	210 - CTP Mismatch Imaging Underestimates Tissue Viability in Ultra-Early Large Artery Occlusion James L. Frey, MD, FAAN
11:30 AM - 07:00 PM	Abstract	211 - Diffusion And Perfusion Mismatch Is Associated with Early Neurologic Deterioration in Single Small Subcortical Infarction Si Baek Lee
11:30 AM - 07:00 PM	Abstract	212 - The Prediction of The Hemorrhagic Transformation Locations After Reperfusion Therapy in Acute Stroke Patients: A Perfusion Study using Deep Learning Eva-Laudon Meyer
11:30 AM - 07:00 PM	Abstract	213 - Magnetic Resonance Angiography with Black Blood as Routine for Evaluate Cerebrovascular Disease Hennan S. Teixeira, MD
11:30 AM - 07:00 PM	Abstract	214 - Is Contrast Staining on Post-thrombectomy CT Predictive of Final Stroke Volume? Kristie Chu, MD
11:30 AM - 07:00 PM	Abstract	215 - Diffuse Abnormal Cerebral Activation may Underlie Post-Stroke Cognitive Dysfunction, or the "Minor Stroke Syndrome" Elisabeth B. Marsh, MD, FAAN
11:30 AM - 07:00 PM	Abstract	216 - MIND Diet Slows Cognitive Decline in Stroke Survivors Laurel J. Cherian, MD, FAAN
11:30 AM - 07:00 PM	Abstract	217 - Motor Impairment and Lack of Functional Independence as Predictors of Depression in Post-Stroke Patients
11:30 AM - 07:00 PM	Abstract	218 - Prevalence and Factors Associated with Depression in Young Argentinian Patients with Ischemic Stroke Anibal Chertcoff
11:30 AM - 07:00 PM	Abstract	219 - The Influence of Sleep Derangement, Low Energy and Fatigue on Depression after Stroke Pratik D. Bhattacharya, MD, MPH
11:30 AM - 07:00 PM	Abstract	220 - Anxiety and Depression in Patients Who Undergo a Cerebrovascular Procedure
11:30 AM - 07:00 PM	Abstract	221 - Beta Blockers do not Increase the Risk of Post-stroke Depression in a Predominantly Afro-Caribbean Population Elizabeth McCuaig
11:30 AM - 07:00 PM	Abstract	222 - Post-Traumatic Stress Disorder in functionally independent patients following a first-ever Ischemic Stroke/TIA Marcos C. Lange, MD
11:30 AM - 07:00 PM	Abstract	223 - A Depression Screening Protocol for Patients With Acute Stroke: A Quality Improvement Project Celia McIntosh, NP
11:30 AM - 07:00 PM	Abstract	224 - Do Selected Stroke Risk Factors Predict Post-Stroke Fatigue in an Afro-Carribean Population? Cindy Tsui
11:30 AM - 07:00 PM	Abstract	225 - Thalamic Atrophy Mediates the Effects of Cerebral Small Vessel Disease on Gait Impairment Ning Su, MD
11:30 AM - 07:00 PM	Abstract	226 - Consciousness disorders in thalamic vascular lesions
11:30 AM - 07:00 PM	Abstract	227 - Early tablet-assisted cognitive rehabilitation for aneurysmal subarachnoid hemorrhage: feasibility of a single-center randomized controlled trial Bing Yu Chen, MD
11:30 AM - 07:00 PM	Abstract	228 - Anterior Striatal Lesions are Associated with Aiming Neglect After Right Brain Stroke Jonathan D. Thomas, MD
11:30 AM - 07:00 PM	Abstract	229 - Late Functional Recovery After Lacunar Stroke: Implications For Rehabilitation Studies Aravind Ganesh, MD
11:30 AM - 07:00 PM	Abstract	230 - Aphasia Rapid Test - Quantification and assessment of Aphasia in Stroke Harish Jayakumar, MD MRCP DM DNB FRCP FEBN PDF, FAAN
11:30 AM - 07:00 PM	Abstract	231 - Prevalence of Cognitive Impairment and Effects on Survival in the Mayo Clinic Florida Familial Cerebrovascular Diseases Registry Kevin M. Barrett, MD, FAAN
11:30 AM - 07:00 PM	Abstract	232 - Help-seeking delay in stroke increases mortality and hospital stay: results from a developing country. Alejandro Gonzalez Aquines, Sr.
11:30 AM - 07:00 PM	Abstract	233 - Factors Affecting Time Between Symptom Onset and Emergency Department Arrival in Stroke Patients Scott M. Le, DO
11:30 AM - 07:00 PM	Abstract	234 - Reasons for Delayed Arrival among Veterans with Acute Ischemic Stroke Carolina Temple
11:30 AM - 07:00 PM	Abstract	235 - Health Literacy and Length of Stay in Stroke
11:30 AM - 07:00 PM	Abstract	236 - Hmong Stroke Knowledge Survey
11:30 AM - 07:00 PM	Abstract	237 - Language Barrier Does Not Affect Acute Stroke Management and Treatment Noriko T. Anderson, MD
11:30 AM - 07:00 PM	Abstract	238 - Primary Language Predicts Outcomes in Acute Ischemic Stroke Afra Janarious, MD
11:30 AM - 07:00 PM	Abstract	239 - Evaluation Times and Outcomes in English versus Non-English Speaking Patients Undergoing Telestroke Evaluation Alejandro Vargas, MD, MS, FAAN
11:30 AM - 07:00 PM	Abstract	240 - A 31-year old Postpartum Woman with Thunderclap Headache: A Case of Segmental Cerebral Vasoconstriction Secondary to Pheochromocytoma Stephen W. English, MD
11:30 AM - 07:00 PM	Abstract	241 - A Case of Fulminant Unilateral Perioperative RCVS Lin Zhang, FRACP
11:30 AM - 07:00 PM	Abstract	242 - Catastrophic Reversible Cerebral Vasoconstriction Syndrome with Bilateral Intraocular Hemorrhage Hae Young Baang, MD
11:30 AM - 07:00 PM	Abstract	243 - Stroke-like Symptoms following a Lumbar Epidural Block: A Rare Case Report of Pneumocephalus Nicholas Lannen, MD
11:30 AM - 07:00 PM	Abstract	244 - Painless Labor: A Case of Progressive Myelopathy during Pregnancy Andrea C. Wasilewski, MD
11:30 AM - 07:00 PM	Abstract	245 - Ruptured Anterior Spinal Artery of the Craniocervical Junction: Case Report and Review Lakshmi Leishangthem, MD, MBBS
11:30 AM - 07:00 PM	Abstract	246 - Spinal Cord Infarction: Clinical and Imaging Insights from the Periprocedural Setting Nicholas L. Zalewski, MD
11:30 AM - 07:00 PM	Abstract	247 - Pathological Crying Prior to the Onset of Pontine Ischemic Stroke Eric S. Lee
11:30 AM - 07:00 PM	Abstract	248 - First-order Horner’s Syndrome and Cognitive Impairments from Thalamic-Hypothalamic Stroke Jessica P. Ng, MD
11:30 AM - 07:00 PM	Abstract	249 - Atypical ipsilateral Dejerine Roussy syndrome following a left thalamic ischemic stroke Faddi G. Saleh Velez, MD
11:30 AM - 07:00 PM	Abstract	250 - Acute Bilateral Apraxia of Eyelid Closure (AEC) Following Bilateral Subcortical Frontal Infarctions-Case Report Eyad Almallouhi, MD
11:30 AM - 07:00 PM	Abstract	251 - Frontal eye field ischemic stroke presenting with internuclear opthalmoplegia: case report and review of anatomy Hussam Shaker, MD
11:30 AM - 07:00 PM	Abstract	252 - Rapid Revascularization of Simultaneous Bilateral ICA Occlusions causing Coma
11:30 AM - 07:00 PM	Abstract	253 - Typical Stroke Symptoms with Atypical Imaging: a case series of cortical ribboning on MRI representing acute ischemic stroke Muhammad Niazi, MD
11:30 AM - 07:00 PM	Abstract	254 - Unilateral Vocal Cord Paralysis associated with Ipsilateral Acute Cortical Stroke: A Rare Case Presentation
11:30 AM - 07:00 PM	Abstract	255 - An Unexpected Imitator: HLH Presenting as CNS Infarction
11:30 AM - 07:00 PM	Abstract	256 - Reversal of Fortune: Congenital PCA Laterality is Detrimental to Infarct Volume Kalea L. Colletta, DO
11:30 AM - 07:00 PM	Abstract	257 - NA
11:30 AM - 07:00 PM	Abstract	258 - NA
11:30 AM - 07:00 PM	Abstract	259 - Resident Competency and Interrater Agreements Using the ACNS Critical Care EEG Terminology Joy Z. Ding, MD
11:30 AM - 07:00 PM	Abstract	260 - Improving Diagnostic Accuracy in Epilepsy: Effect of Online Medical ��ɫ�� on EEG Interpretation Among Neurologists Stacey L. Hughes
11:30 AM - 07:00 PM	Abstract	261 - Utility of Inpatient EEG and Role of Neurologic Input in Tertiary Care Hospital Bakhtier Nurmukhamedov, MD
11:30 AM - 07:00 PM	Abstract	262 - Testing and Turnaround Time for Stat EEGs: How do we get faster? Brian J. Hanrahan, MD
11:30 AM - 07:00 PM	Abstract	263 - Analysis of EEG Use Utilizing the National Inpatient Sample Rebecca Bernheimer
11:30 AM - 07:00 PM	Abstract	264 - Survey of Neurologists Regarding the Use of Continuous EEG (cEEG) Monitoring in Children Presenting With Encephalopathy Following Status Epilepticus (SE) Asri Yuliati, MD
11:30 AM - 07:00 PM	Abstract	265 - Time to Detection of Seizures with Continuous EEG (cEEG) Monitoring: The Correlation with Seizure Etiologies, Neurologic Status and EEG Findings Ifrah Zawar, MD
11:30 AM - 07:00 PM	Abstract	266 - Quantitative EEG Spectrograms: Diagnostic efficacy in Intensive care and Epilepsy Monitoring units and the common seizure mimickers. Ajay Goenka, MD
11:30 AM - 07:00 PM	Abstract	267 - Efficacy of Simultaneous Scalp and Intracranial EEG in Detecting Seizure Onset Zone Ying Sun, MD
11:30 AM - 07:00 PM	Abstract	268 - Electroencephalogram Characteristics in Critical Ill Patients before Cardiac Arrest: A Small Case Series Jian Xu, MD, PhD
11:30 AM - 07:00 PM	Abstract	270 - Concordance of Focal Electrographic Slowing with Structural Lesions on MRI Syed H. Shabbir, MD
11:30 AM - 07:00 PM	Abstract	271 - Heart Rate Variability as a Prognostic Marker Following Cardiac Arrest Rahul Guha, MD
11:30 AM - 07:00 PM	Abstract	272 - Retrospective Analysis of the Etiology and Prognostic Value of Bilateral Independent Periodic Discharges James J. Gugger, Jr., MD, PharmD
11:30 AM - 07:00 PM	Abstract	273 - Electroencephalography in West Nile virus Neuroinvasive Disease Angela Parsons, DO
11:30 AM - 07:00 PM	Abstract	274 - EEG Predictors of Post-Stroke Seizure Lesley Kaye, MD
11:30 AM - 07:00 PM	Abstract	275 - Mapping the dynamics of heart rate variability and complexity changes with progressive focal status epilepticus. Manmeet Kaur, MBBS
11:30 AM - 07:00 PM	Abstract	276 - Bilateral independent periodic discharges are associated with electrographic seizures and poor outcome: a case-control study Gamaleldin M. Osman, MD
11:30 AM - 07:00 PM	Abstract	277 - Comparison of Ambulatory and Inpatient 24 hour EEG: A Value Analysis Sotiris G. Mitropanopoulos, MD
11:30 AM - 07:00 PM	Abstract	278 - A Case of Focal REM-Sleep Epilepsy Originating from the Occipital Lobe Umar A. Shuaib, MBBS
11:30 AM - 07:00 PM	Abstract	279 - Functional Connectivity Analysis on Scalp EEG for Identification of Deep Parenchymal Lesions Jalyoung Joe, MD
11:30 AM - 07:00 PM	Abstract	280 - Mapping Cortical Connectivity Using Cortico-Cortical Evoked Potentials
11:30 AM - 07:00 PM	Abstract	281 - Spectral analysis of dynamic functional connectivity between resting-state networks reveals information beyond static connectivity Sharon Chiang, MD, PhD
11:30 AM - 07:00 PM	Abstract	282 - Involvement of Different Networks in Mesial Temporal Lobe Epilepsy Subtypes Identified by Interictal EEG Source Analysis and Structural Neuroimaging Luiz E. Betting
11:30 AM - 07:00 PM	Abstract	283 - Reduced Resting State Functional Connectivity of the Hippocampi as a Biomarker of Temporal Lobe Epilepsy Thomas R. Henry, MD, FAAN
11:30 AM - 07:00 PM	Abstract	284 - The Role of Generalized Tonic-Clonic Seizures and Partial Onset Seizures and the Effects of Antiepileptic Drugs on Retinal Architecture. Samuel Lichtman-Mikol, BA
11:30 AM - 07:00 PM	Abstract	285 - Using Surface Electromyography to Differentiate between Generalized Tonic-Clonic Seizures and Psychogenic Non-Epileptic Spells Damon P. Cardenas, PhD
11:30 AM - 07:00 PM	Abstract	286 - Anxiety and Depression Symptoms Disrupts Resting State Networks in Patients with Generalized Epilepsies
11:30 AM - 07:00 PM	Abstract	287 - Frontal Lobe Functions in Children with Newly Diagnosed Temporal Lobe Epilepsy: Functional Magnetic Resonance Imaging Temitayo Oyegbile-Chidi, MD, PhD, FAAN
11:30 AM - 07:00 PM	Abstract	288 - Status epilepticus: what do peri-ictal changes in brain images mean? Alejandro Thomson, MD
11:30 AM - 07:00 PM	Abstract	289 - Yield of Emergent Computed Tomography in Epilepsy Patients Presenting with a Seizure Kathryn Kvam, MD
11:30 AM - 07:00 PM	Abstract	290 - Arterial spin labeling (ASL) MRI in a patient with non-convulsive status epilepticus (NCSE) Jae Eun Lee, MD
11:30 AM - 07:00 PM	Abstract	291 - NA
11:30 AM - 07:00 PM	Abstract	292 - NA
11:30 AM - 07:00 PM	Abstract	293 - NA
11:30 AM - 07:00 PM	Abstract	294 - NA
11:30 AM - 07:00 PM	Abstract	295 - The Influence of Presenting Characteristics on Outcomes in Moderate to Severe Pediatric Traumatic Brain Injury: Penetrating versus Blunt Mechanisms Ryan Chae
11:30 AM - 07:00 PM	Abstract	296 - Characterization of Features of PHACE Syndrome on Fetal MRI and Natural History of Postnatal Management Ana G. Cristancho, MD, PhD
11:30 AM - 07:00 PM	Abstract	297 - Sensory-Motor Network Functional Connectivity in Hemiparetic Children With Perinatal Stroke Kristine Woodward, MD
11:30 AM - 07:00 PM	Abstract	298 - Inaccuracies In Coding In Neonatal Stroke Ana C. Albuja, MD
11:30 AM - 07:00 PM	Abstract	299 - Predicting Perinatal Stroke Outcomes with Neonatal EEG Activity Bridget V. MacDonald
11:30 AM - 07:00 PM	Abstract	300 - Reversible Cerebral Vasoconstriction Syndrome: A novel mechanism for neurologic complications in Schimke Immuno-osseus Dysplasia. Darrah Haffner, MD
11:30 AM - 07:00 PM	Abstract	301 - Role of Arterial Spin Labelling Perfusion weighted MRI in evaluation of children with hemiplegic migraine. Rachit Patil, MD
11:30 AM - 07:00 PM	Abstract	302 - STARS: A Phase 2 Adult Angelman Syndrome Clinical Trial: Randomized, Double-blind, Safety and Efficacy Study of Gaboxadol Cesar Ochoa-Lubinoff
11:30 AM - 07:00 PM	Abstract	303 - Comparison of Functional Connectivity Abnormalities in Autism and Williams Syndrome
11:30 AM - 07:00 PM	Abstract	304 - Processing Speed as a marker to stimulants effect in Autism Spectrum Disorder Itai Berger, MD
11:30 AM - 07:00 PM	Abstract	305 - 49,XXXXY, a rare genetic disorder: The Relationship with Autism Spectrum Disorders (ASD), Developmental delay, and Testosterone Andrea L. Gropman, MD, FAAN
11:30 AM - 07:00 PM	Abstract	306 - MicroRNAs and Gene-Environment Interactions in Autism: Prenatal Maternal Stress and the SERT Gene David Q. Beversdorf, MD, FAAN
11:30 AM - 07:00 PM	Abstract	307 - Healthcare and Medical Service Utilization Among Patients With Angelman Syndrome By Molecular Subtype: Results From The AS-NHS Study
11:30 AM - 07:00 PM	Abstract	308 - A Portrait of Cerebral Palsy in Quebec Over a Decade : Birth years 1999-2010 Aristides Hadjinicolaou, MD
11:30 AM - 07:00 PM	Abstract	309 - Head circumference in preterm neonates: Size at birth and postnatal growth predict neurodevelopmental outcomes Thiviya Selvanathan, MD
11:30 AM - 07:00 PM	Abstract	310 - Profile of Children with Cerebral Palsy and Congenital Malformations in Canada Marcel Severe, MD
11:30 AM - 07:00 PM	Abstract	311 - Chandigarh Autism Spectrum Disorder Study: Prevalence in India Elif Bayraktar
11:30 AM - 07:00 PM	Abstract	312 - Social Functioning Mediates ADHD Symptomatology and Mental Health Functioning in Neurotypical Children versus Children with Autism Spectrum Disorder or Williams Syndrome Rowena Ng
11:30 AM - 07:00 PM	Abstract	313 - Effect of a Combination of Carnitine, Coenzyme Q10 and Alpha-Lipoic Acid (MitoCocktail) on Mitochondrial Function and Neurobehavioral Performance in Children with Autism Spectrum Disorder Agustin Legido, MD, PhD, MBA
11:30 AM - 07:00 PM	Abstract	314 - Clinical Unmet Needs and Burden in Fragile X Syndrome: Results of a Targeted Literature Review
11:30 AM - 07:00 PM	Abstract	315 - Micronutrient Levels in Patients With ADHD Siddharth Gupta, MD
11:30 AM - 07:00 PM	Abstract	316 - Anatomic and Functional Connectivity Relationship in Autistic Children Jeffrey Bakal
11:30 AM - 07:00 PM	Abstract	317 - Tourette Syndrome: Childhood Predictors of Adult Outcomes
11:30 AM - 07:00 PM	Abstract	318 - Cannabidiol Based Medical Cannabis in Children with Autism- a Retrospective Feasibility Study
11:30 AM - 07:00 PM	Abstract	319 - A Literature Review of the Economic Burden of Fragile X Syndrome Patricia Sacco, MPH
11:30 AM - 07:00 PM	Abstract	320 - EEG Endophenotypes in Autism Spectrum Disorder Jamie K. Capal, MD
11:30 AM - 07:00 PM	Abstract	321 - Prospective validation of molecular subtype diagnostics for autism spectrum and neurodevelopmental disorders Elizabeth Donley, JD, MBA, MS
11:30 AM - 07:00 PM	Abstract	322 - LeukoSeq Whole Genome Sequencing Clinical Trial: An Interim Analysis Guy T. Helman
11:30 AM - 07:00 PM	Abstract	323 - Pilot study of the use of Janus Kinase Inhibitor, Baricitinib, in the treatment of heritable interferonopathy Aicardi Goutières Syndrome Adeline Vanderver, MD, FAAN
11:30 AM - 07:00 PM	Abstract	324 - Pridopidine Treatment Recovers Gait Abnormalities and Rescues Impaired BDNF Expression in a Rett Syndrome Mouse Model
11:30 AM - 07:00 PM	Abstract	326 - A case of Alexander disease with peripheral neuropathy associated with a novel mutation Sireesha Chinthaparthi, MD
11:30 AM - 07:00 PM	Abstract	327 - Case Report: Expanded Access Treatment of an Infantile Neuroaxonal Dystrophy Patient with a Novel Stabilized Polyunsaturated Fatty Acid Drug
11:30 AM - 07:00 PM	Abstract	328 - Expanded Phenotypes of Vanishing White Matter disease Hitha Amin, MD, MBBS
11:30 AM - 07:00 PM	Abstract	329 - A Novel RMND1 knock-in Mouse Recapitulates Clinical and Biochemical Abnormalities Observed in Patients Maria J SANCHEZ-QUINTERO, PhD
11:30 AM - 07:00 PM	Abstract	330 - Retinal Nerve Fiber Layer (RNFL) and Ganglion Cell Inner Plexiform Layer (GCIPL) in Persistently Myelin Oligodendrocyte Glycoprotein Antibody Positive Youth Stephanie Grover, MSc, CCRP
11:30 AM - 07:00 PM	Abstract	331 - Nervus Intermedius Neuralgia Caused By Craniofacial Fibrous Dysplasia In A Pediatric Patient: A Case Report And Literature Review Philip G. Eye, MD
11:30 AM - 07:00 PM	Abstract	332 - Chemotherapy Exposure Disrupts the Gliogenic Microenvironment
11:30 AM - 07:00 PM	Abstract	333 - Isolated ophthalmoplegia as presenting sign of pediatric Wernicke encephalopathy Danielle Takacs, MD
11:30 AM - 07:00 PM	Abstract	334 - Neonatal Dexamethasone Treatment Attenuates Hippocampal and Amygdaloid GPR30 Gene Expression in Adult Female Rats Keiko Lo
11:30 AM - 07:00 PM	Abstract	335 - A Patient with 4H Syndrome Who Presents in Adulthood
11:30 AM - 07:00 PM	Abstract	336 - PURA Syndrome and Myotonia: A Case Report and Review of the Literature Steven Trau, MD
11:30 AM - 07:00 PM	Abstract	337 - Neurological manifestations of X-linked ichthyosis: case report and review of the literature William S. Baek, MD, FAAN
11:30 AM - 07:00 PM	Abstract	338 - NA
11:30 AM - 07:00 PM	Abstract	339 - Autoimmune Cerebellitis as a paraneoplastic syndrome in Ovarian Teratoma Ashley M. Roque, MD
11:30 AM - 07:00 PM	Abstract	340 - Amateur Fundus Photography with Various New Devices- Our Experience as Neurology Residents Saman Zafar, MD
11:30 AM - 07:00 PM	Abstract	341 - Developing a First-of-its-Kind Telemedicine Rotation for Neurology Residents Mitra Afshari, MD
11:30 AM - 07:00 PM	Abstract	342 - Massive Right-sided Ovarian Tumor as a Probable Cause of Left-sided Meralgia Paresthetica Nikesh Bajaj, DO
11:30 AM - 07:00 PM	Abstract	343 - Online education for interprofessional competency in opioid-sparing acute pain management Joseph G. Nugent, MHS, CRT-I
11:30 AM - 07:00 PM	Abstract	344 - A Mobile Electroencephalogram (EEG) Tutorial Atlas as a Learning Tool for Neurology Residents Rachael Benson, MD
11:30 AM - 07:00 PM	Abstract	345 - Magnetic Resonance Imaging in Multiple Sclerosis associated Seizures Kalyan Yarraguntla, MD
11:30 AM - 07:00 PM	Abstract	346 - Atrophied lesion volume: A novel and robust imaging biomarker in multiple sclerosis for predicting disability progression Robert Zivadinov, MD, PhD, FAAN
11:30 AM - 07:00 PM	Abstract	347 - Disability-Specific Atlases of Gray Matter Loss in Relapsing-Remitting Multiple Sclerosis Allan J. MacKenzie-Graham, PhD, BS
11:30 AM - 07:00 PM	Abstract	348 - Regional brain atrophy and its clinical correlations in single MS patients at first visit Alaleh Raji, MD
11:30 AM - 07:00 PM	Abstract	349 - Great reduction of correlation between global and regional brain volume and spinal cord volume in multiple sclerosis patients with severe disability Manuela Vaneckova
11:30 AM - 07:00 PM	Abstract	350 - Accelerated subcortical atrophy following new lesion accrual in directly connected tracts is significant and appears limited to the first year Keith Carolus
11:30 AM - 07:00 PM	Abstract	351 - Brain lesion segmentation and atrophy measurement in MS patients: comparison between manual and automated methods Alexandria E. Matic, MD
11:30 AM - 07:00 PM	Abstract	352 - Gray Matter Atrophy and Microstructural White Matter Abnormalities Underlying Cognitive Impairment in Benign MS Maria A. Rocca
11:30 AM - 07:00 PM	Abstract	353 - Disappearing Brainstem MRI Lesions in Multiple Sclerosis Svetlana Eckert, MD
11:30 AM - 07:00 PM	Abstract	354 - Comparison of Techniques for Measurement of Brain Volume in Multiple Sclerosis Patients
11:30 AM - 07:00 PM	Abstract	355 - MRI predictors of improvement during specific rehabilitation of information processing speed and attention in MS: a randomized trial against non-specific training with semi-ecological evaluation.
11:30 AM - 07:00 PM	Abstract	356 - Whole Brain and Lateral Ventricular Volume Changes are associated with Development of Disability Progression in Multiple Sclerosis: Results from a Large-Scale Clinical Routine 5-Year Observational Study Emanuele Ghione, MD
11:30 AM - 07:00 PM	Abstract	357 - Accelerated central atrophy in multiple sclerosis patients may be sex-specific Dejan Jakimovski, MD, PhD
11:30 AM - 07:00 PM	Abstract	358 - Micro and Macrostructural Limbic System Correlates of Comprehensive Cognitive Symptomatology in Multiple Sclerosis using Quantitative MRI and DTI Zafer Keser, MD
11:30 AM - 07:00 PM	Abstract	359 - Multiple sclerosis patients who improve in their disability over time develop less brain atrophy compared to those who remain stable or progress Emanuele Ghione, MD
11:30 AM - 07:00 PM	Abstract	360 - Cerebellar cortical lesions selectively contribute to cognitive dysfunction in early Multiple Sclerosis Valentina Poretto, MD
11:30 AM - 07:00 PM	Abstract	361 - Thalamic Atrophy and Disability in Progressive Multiple Sclerosis Subgroups
11:30 AM - 07:00 PM	Abstract	362 - Brain Volume Increase in Multiple Sclerosis Patients
11:30 AM - 07:00 PM	Abstract	363 - Brain Activity Induced by Psychological Stress Predicts Future Gray Matter Atrophy Accumulated in a Two-Year Period in MS Patients Martin Weygandt, PhD
11:30 AM - 07:00 PM	Abstract	364 - INSPIRATION: An approach to brain volume and quantitative lesion load assessments from standardized MRI acquisition in daily clinical routine of MS patients Achim Gass, MD
11:30 AM - 07:00 PM	Abstract	365 - Cognitive impairment in Multiple Sclerosis: the contribution of cognitive reserve and regional gray matter volumes Alvino Bisecco
11:30 AM - 07:00 PM	Abstract	366 - Prospective multi-modal MRI study to examine the effect of Fingolimod on tissue injury and repair in the brain in patients with relapsing remitting multiple sclerosis Sara Razmjou-Schwarz, MD
11:30 AM - 07:00 PM	Abstract	367 - Optic Neuritis Neuroimaging Characteristics Are Affected By Etiology Casey F. Jeffreys, MD
11:30 AM - 07:00 PM	Abstract	368 - Plasma levels of hemostasis inhibitors and MRI outcomes in multiple sclerosis Nicole Ziliotto
11:30 AM - 07:00 PM	Abstract	369 - The functional brain network remains stable in natalizumab-treated multiple sclerosis patients: a one year study
11:30 AM - 07:00 PM	Abstract	370 - Evolution of New Lesions and its Temporal Patterns in Patients with Clinically Isolated Syndrome (CIS) Treated with Subcutaneous Interferon beta-1a (scIFN?-1a)
11:30 AM - 07:00 PM	Abstract	371 - Brain Volume Loss in RRMS is Associated to Clinical Scores Irrespective of Quantification Method Jozef Magdic, MD
11:30 AM - 07:00 PM	Abstract	372 - Use of LesionQuant® to Measure Cerebral White Matter Lesion Distribution in Neuromyelitis Optica and Relapsing Multiple Sclerosis
11:30 AM - 07:00 PM	Abstract	373 - Brain atrophy staging of single MS patients with MRI at first visit Alaleh Raji, MD
11:30 AM - 07:00 PM	Abstract	374 - INSPIRATION: Towards individual determination of NEDA 4 - Qualitative visual determination of short term stable brain volumes from standardized MRI acquisition in daily clinical routine of MS patients Achim Gass, MD
11:30 AM - 07:00 PM	Abstract	375 - Relationship between clinical manifestation of MS relapse and Gadolinium enhancing lesions in brain MRI
11:30 AM - 07:00 PM	Abstract	376 - Ocrelizumab May Reduce Tissue Damage in Chronic Active Lesions as Measured by Change in T1 Hypo-Intensity of Slowly Evolving Lesions in Patients With Primary Progressive Multiple Sclerosis Colm Elliott
11:30 AM - 07:00 PM	Abstract	377 - Longitudinal change of myelin water fraction (MWF) within chronic multiple sclerosis (MS) lesions Sneha Pandya
11:30 AM - 07:00 PM	Abstract	378 - Double Inversion Recovery Imaging MRI: A Good Tool to Identify Optic Neuritis Lesions in Multiple Sclerosis and Neuromyelitis Optica Izumi Kawachi, MD, PhD
11:30 AM - 07:00 PM	Abstract	379 - Reduced Dynamism of Functional Connectivity Is Associated with Cognitive Impairment in Multiple Sclerosis Patients: A Dynamic Functional Connectivity Study in a Multi-Center Setting Alessandro D'Ambrosio
11:30 AM - 07:00 PM	Abstract	380 - One Size Does Not Fit All: Large-scale neuronal network Functional Connectivity differs across Cognitive Phenotype groups in Multiple Sclerosis Korhan Buyukturkoglu, PhD
11:30 AM - 07:00 PM	Abstract	381 - Quantitative Magnetization Transfer Imaging in Multiple Sclerosis: A 3.0 Tesla Clinical Study Francesca Bagnato, MD
11:30 AM - 07:00 PM	Abstract	382 - Column-specific demyelination in Spinal Cord Normal Appearing White Matter occurring in Multiple Sclerosis: A preliminary study using inhomogeneous Magnetization Transfer and DTI
11:30 AM - 07:00 PM	Abstract	383 - Multi-compartment Spherical Microscopic Diffusion Imaging Using Spherical Mean Techniques to Probe Axonal Injury in Multiple Sclerosis Francesca Bagnato, MD
11:30 AM - 07:00 PM	Abstract	384 - Modulation of Cortico-Subcortical Functional Connectivity Occurs After Symptomatic Treatment of Fatigue in Patients with Multiple Sclerosis Maria A. Rocca
11:30 AM - 07:00 PM	Abstract	385 - Dynamic Functional Network Connectivity in CIS Patients: A Longitudinal Study Milagros Hidalgo de la Cruz
11:30 AM - 07:00 PM	Abstract	386 - [F-18]PBR06 PET to assess TSPO binding and its association with brain atrophy and disability in multiple sclerosis Tarun Singhal, MD
11:30 AM - 07:00 PM	Abstract	388 - Diagnostic Utility of FDG-PET in Neuro-sarcoidosis: A Case Report and Review of the Literature Yujie Wang, MD
11:30 AM - 07:00 PM	Abstract	389 - Ultra-Small Superparamagnetic Iron Oxide (USPIO) Nanoparticle Enhanced High-Field Imaging of Neuro-inflammation Michelle L. Sudyn
11:30 AM - 07:00 PM	Abstract	390 - Natalizumab Treatment of Multiple Sclerosis Leads to Diminished Microglial Activation in the Normal Appearing White Matter Laura Airas, MD, PhD
11:30 AM - 07:00 PM	Abstract	391 - Effect of teriflunomide on gray and white matter brain pathology in multiple sclerosis using volumetric and diffusion-tensor imaging MRI measures Niels Bergsland
11:30 AM - 07:00 PM	Abstract	392 - The role of Right Anterior White Matter area in Multiple Sclerosis-related fatigue: A Magnetic Resonance Spectroscopy (MRS) Study Shitiz K. Sriwastava, MBBS
11:30 AM - 07:00 PM	Abstract	393 - Phase 1 Trial of Intrathecal Rituximab in Progressive MS Patients with Evidence of Leptomeningeal Contrast Enhancement Pavan Bhargava, MD, FAAN
11:30 AM - 07:00 PM	Abstract	395 - Ozanimod (RPC1063) Reduces Plasma Levels of Neurofilament Light Chain (NfL) in Patients With Relapsing Multiple Sclerosis (RMS): Results From RADIANCE Part A, a Randomized, Placebo-Controlled, Phase 2 Study
11:30 AM - 07:00 PM	Abstract	396 - Ozanimod Demonstrates Efficacy and Safety in a Multicenter, Randomized, Double-Blind, Double-Dummy, Active-Controlled Phase 3 Trial of Relapsing Multiple Sclerosis (SUNBEAM)
11:30 AM - 07:00 PM	Abstract	397 - Efficacy and Safety of Tabalumab in Patients with Relapsing-Remitting Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study
11:30 AM - 07:00 PM	Abstract	398 - Efficacy and Safety of 2 Doses of Ponesimod (10 and 20 mg o.d.): Interim Analysis of a Phase II Extension Trial in Relapsing-remitting Multiple Sclerosis
11:30 AM - 07:00 PM	Abstract	399 - Safety, Tolerability and Pharmacodynamics of Intravenous Siponimod in Healthy Subjects
11:30 AM - 07:00 PM	Abstract	400 - Personalised dosing of cladribine for people with multiple sclerosis Jinesh M. Shah, MBBS
11:30 AM - 07:00 PM	Abstract	401 - Biotin - the forgotten Vitamin in MS ? Gerhard D. Roth, MD
11:30 AM - 07:00 PM	Abstract	402 - Absolute Bioavailability of Single, Oral Dose of Siponimod in Healthy Subjects
11:30 AM - 07:00 PM	Abstract	403 - Treatment Optimization Using a Multidimensional Decision Model (TIME Study): A Proof-of concept Study to Assess a Multidimensional Standardized Documentation Model to Optimize Management of Patients with Multiple Sclerosis in Germany
11:30 AM - 07:00 PM	Abstract	404 - Siponimod is a Functional Agonist for the S1P5 Receptor Marc Bigaud
11:30 AM - 07:00 PM	Abstract	405 - Rapid Improvement of Symptoms after Fibrinolysis in a Patient with Multiple Sclerosis Exacerbation Konstantin E. Balashov, MD, PhD, FAAN
11:30 AM - 07:00 PM	Abstract	406 - Comparison of Biodistribution Following Subcutaneous and Intravenous Administration of a Novel Zirconium-89 Labeled Anti-CD20 Antibody Using Imaging
11:30 AM - 07:00 PM	Abstract	407 - Integrated Safety Analysis of Infections during Periods of Grade 3 or 4 Lymphopenia in Patients Taking Cladribine Tablets 3.5mg/kg Stuart D. Cook, MD, FAAN
11:30 AM - 07:00 PM	Abstract	408 - Predictors of an Opicinumab Treatment Effect and Identification of an Efficacy Subpopulation: A Post hoc Analysis of the SYNERGY Study Sarah I. Sheikh, BM Bch, MSc, MRCP, FAAN
11:30 AM - 07:00 PM	Abstract	409 - Final MRI Results At 6 Months From A Phase 2 Multicenter Study Of Ublituximab, A Novel Glycoengineered Anti-CD20 Monoclonal Antibody (mAb), In Patients With Relapsing Forms Of Multiple Sclerosis (RMS), Demonstrates Complete Elimination Of Gd-Enhancing Lesions Matilde Inglese, MD, PhD
11:30 AM - 07:00 PM	Abstract	410 - Clinical and Magnetic Resonance Imaging Results From RADIANCE Part B, a Multicenter, Randomized, Double-Blind, Phase 3 Trial of Ozanimod Versus Intramuscular Interferon ?-1a in Relapsing Multiple Sclerosis (RMS) Jeffrey A. Cohen, MD
11:30 AM - 07:00 PM	Abstract	411 - Clinical Features and 7T MRI Findings of Progressive Multifocal Leukoencephalopathy in the Setting of Extended Natalizumab Dosing: A Case Report Laura E. Baldassari, MD, MHS
11:30 AM - 07:00 PM	Abstract	413 - Prospective Observational Study in a Cohort of Patients Affected by Relapsing-Remitting Multiple Sclerosis Treated with Dimethyl Fumarate
11:30 AM - 07:00 PM	Abstract	414 - Efficacy and Safety of Mitoxantrone Use in Aggressive Multiple Sclerosis Marzena Pedrini, PhD
11:30 AM - 07:00 PM	Abstract	415 - Defining Glatiramer Acetate: The USA Definition of Sameness and the EU Definition of Similarity Sigal Melamed-Gal
11:30 AM - 07:00 PM	Abstract	416 - Bayesian analysis of glatiramer acetate 40 mg/mL TIW treatment effect in reducing relapse rate
11:30 AM - 07:00 PM	Abstract	417 - Longitudinal Assessment of Retinal Structure of Patients with Relapsing-Remitting Multiple Sclerosis on Glatiramer Acetate 40mg Samuel Lichtman-Mikol, BA
11:30 AM - 07:00 PM	Abstract	418 - Checkpoint Inhibitor-Induced Central Nervous System Autoimmunity: A Case Series Suma Shah, MD
11:30 AM - 07:00 PM	Abstract	419 - A Distinct Case of CLIPPERS with predominant Spinal Cord Involvement Maha Daimee, MD
11:30 AM - 07:00 PM	Abstract	420 - Evaluating the Positive Predictive Value of Onconeural Antibody Testing in Patients with Suspected Paraneoplastic Neurologic Syndromes Adrian Budhram, MD
11:30 AM - 07:00 PM	Abstract	421 - Polyneuritis Cranialis Associated With Franciscella Tularemia Infection Benzion Blech, MD
11:30 AM - 07:00 PM	Abstract	422 - Amyloid Beta-Related Angiitis: A Rare Cause of CNS Vasculitis Zachery Rohm, MD
11:30 AM - 07:00 PM	Abstract	423 - Multiple Autoantibody-Related Paraneoplastic Limbic Encephalitis with Complete Neurologic Recovery Thomas J. Shoemaker, MD
11:30 AM - 07:00 PM	Abstract	424 - NA
11:30 AM - 07:00 PM	Abstract	425 - NA
11:30 AM - 07:00 PM	Abstract	426 - NA
11:30 AM - 07:00 PM	Abstract	427 - NA
11:30 AM - 07:00 PM	Abstract	428 - NA
11:30 AM - 07:00 PM	Abstract	429 - Utility of Intrathecal Baclofen Pump in Primary Lateral Sclerosis Adeel Zubair, MD
11:30 AM - 07:00 PM	Abstract	430 - Successful Percutaneous Gastrostomy Tube Placement with Fluoroscopy in ALS Patient Requiring 24/7 Ventilation Senda Ajroud-Driss, MD, FAAN
11:30 AM - 07:00 PM	Abstract	431 - A Systematic Review of the Blood-central Nervous System Barrier Pathology in ALS
11:30 AM - 07:00 PM	Abstract	432 - Unreported Gene Mutation of Episodic Ataxia Abdallah M. Hamdallah, MD
11:30 AM - 07:00 PM	Abstract	433 - Patient with MT-ATP 6 gene mutation and NARP like disease Yasushi Kisanuki, MD, FAAN
11:30 AM - 07:00 PM	Abstract	434 - Spastic Dysarthria as a presenting sign of Stiff Person Syndrome Samuel Giles, MD
11:30 AM - 07:00 PM	Abstract	435 - Efficacy and safety of dichlorphenamide in adolescent patients with primary periodic paralysis Emma Ciafaloni, MD, FAAN
11:30 AM - 07:00 PM	Abstract	436 - Open Label Trial of Ranolazine for the Treatment of Paramyotonia Congenita Samantha J. LoRusso, MD
11:30 AM - 07:00 PM	Abstract	437 - Circulatory Kv1.3+ cells in patients with sIBM
11:30 AM - 07:00 PM	Abstract	439 - Myopathies Presenting with "dropped-head syndrome" Reem M. Alhammad, MD
11:30 AM - 07:00 PM	Abstract	440 - A series of aggregated randomized-controlled N-of-1 trials with mexiletine in non-dystrophic myotonia: clinical trial results and validation of rare disease design
11:30 AM - 07:00 PM	Abstract	441 - Sensitivity of IBM Criteria in a Large Multicenter Cross-Sectional IBM Cohort Sumiko Weir
11:30 AM - 07:00 PM	Abstract	442 - Muscle Biopsy and Electromyography Correlation Elie Naddaf, MD
11:30 AM - 07:00 PM	Abstract	443 - Willingness to Participate in Natural History Studies amongst Sporadic Inclusion Body Myositis Patients Veena Mathew
11:30 AM - 07:00 PM	Abstract	444 - A pilot trial of Canakinumab (Ilaris), an IL-1? Receptor antagonist, in the treatment of patients with sporadic Inclusion Body Myositis (sIBM) MICHAIL KOSMIDIS
11:30 AM - 07:00 PM	Abstract	445 - Correlation of Electromyography Findings to Muscle Biopsy Findings in Patients with Suspected Myopathy Ugur Sener, MD
11:30 AM - 07:00 PM	Abstract	446 - Feasibility and Validation of Modified Oculobulbar Facial Respiratory Score (mOBFRS) in Sporadic Inclusion Body Myositis Marie Wencel, CCRP
11:30 AM - 07:00 PM	Abstract	448 - Diagnostic Spectrum and Treatment Outcomes of Granulomatous Myopathy Reem M. Alhammad, MD
11:30 AM - 07:00 PM	Abstract	449 - RNA-sequencing analysis of muscle biopsy samples from patients with inclusion body myositis and those with polymyositis Chiseko Ikenaga, MD, PhD
11:30 AM - 07:00 PM	Abstract	450 - Variable penetrance of Andersen-Tawil Syndrome in a Caucasian family with a rare missense KCJN2 mutation Reem Deeb, MD
11:30 AM - 07:00 PM	Abstract	451 - Follow-up of clinical and MRI changes in juvenile adult onset DM1
11:30 AM - 07:00 PM	Abstract	452 - Response to Liver Transplant and Riboflavin in MADD Myopathy Elisabeth Golden, MD
11:30 AM - 07:00 PM	Abstract	453 - Necrotizing Inflammatory Myopathy Following Immune Checkpoint Inhibitor Therapy Presenting With Progressive Upper Extremity Weakness Pariwat Thaisetthawatkul, MD, FAAN
11:30 AM - 07:00 PM	Abstract	454 - Subacute paresis in a 28-year-old man with HIV Yohei Harada, MD
11:30 AM - 07:00 PM	Abstract	455 - Individual N-of-1 Trial Salbutamol Versus Placebo as Attack Treatment in a Patient with Hyperkalemic Periodic Paralysis Robyn Weijma, MD
11:30 AM - 07:00 PM	Abstract	456 - Severe Necrotizing Myopathy Associated with Pembrolizumab for Urothelial Carcinoma Chandler Gill, MD
11:30 AM - 07:00 PM	Abstract	457 - Diminished Distal Finger Creases in Patients with Inclusion Body Myositis Benjamin J. Koo, MD
11:30 AM - 07:00 PM	Abstract	458 - Role of microRNAs in lipid storage myopathies.
11:30 AM - 07:00 PM	Abstract	459 - Correlation of MRI with Muscle Biopsy Findings in Critical Illness Myopathy Edward Labin, MD
11:30 AM - 07:00 PM	Abstract	460 - Pulmonary-Sparing Anti-MDA5-Positive Dermatomyositis with Scleroderma Overlap, Glomerulonephritis and Cardiomyopathy Cina Sasannejad, MD
11:30 AM - 07:00 PM	Abstract	461 - Anti-dopaminergic medication related myopathy causing respiratory muscle weakness without neuroleptic malignant syndrome Yohei Harada, MD
11:30 AM - 07:00 PM	Abstract	462 - Acute necrotizing myopathy associated with bronchiolitis obliterans with organizing pneumonia (BOOP) responding to treatment with rituximab and steroids. Guru Ramaiah, MD
11:30 AM - 07:00 PM	Abstract	463 - Neuromuscular Ultrasound to Identify Deep Muscle Fasciculations in a Suspected Case of Amyotrophic Lateral Sclerosis (ALS) Arjumond Khan
11:30 AM - 07:00 PM	Abstract	464 - The Portrayal of Amyotrophic Lateral Sclerosis in Cinema and Television J. David Avila, MD, FAAN
11:30 AM - 07:00 PM	Abstract	465 - Hypersensitivity and Edaravone - Summary of Case Reports
11:45 AM - 11:50 AM	Discussion	P3.027
11:50 AM - 11:55 AM	Discussion	P3.028
11:55 AM - 12:00 PM	Discussion	P3.029
12:00 PM - 12:05 PM	Discussion	P3.030
12:05 PM - 12:10 PM	Discussion	P3.031
12:10 PM - 12:15 PM	Discussion	P3.032
12:15 PM - 12:20 PM	Discussion	P3.033
12:20 PM - 12:25 PM	Discussion	P3.034
12:25 PM - 12:30 PM	Discussion	P3.035
12:30 PM - 12:35 PM	Discussion	P3.036
05:30 PM - 07:00 PM	Discussion	Poster Author Standby Time

Faculty Disclosures
David Irwin, MD	The institution of Dr. Irwin has received research support from NIH. The institution of Dr. Irwin has received research support from Prevail. The institution of Dr. Irwin has received research support from Passage Bio. The institution of Dr. Irwin has received research support from Alector. The institution of Dr. Irwin has received research support from Transposon. The institution of Dr. Irwin has received research support from Denali. The institution of Dr. Irwin has received research support from Cervo Med.
Scott D. Newsome, DO, FAAN	Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Newsome has received research support from Biogen. The institution of Dr. Newsome has received research support from Genentech/Roche. The institution of Dr. Newsome has received research support from Department of Defense. The institution of Dr. Newsome has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Newsome has received research support from National MS Society. The institution of Dr. Newsome has received research support from Lundbeck. The institution of Dr. Newsome has received research support from Sanofi. The institution of Dr. Newsome has received research support from Kyverna Therapeutics. Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving as a Lead PI for Clinical Trial with Roche.
Jennifer A. Frontera, MD	Dr. Frontera has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FirstKindMedical. Dr. Frontera has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Physician ��ɫ�� Resource. The institution of Dr. Frontera has received research support from NIH. The institution of Dr. Frontera has received research support from Alexion. Dr. Frontera has received publishing royalties from a publication relating to health care.
Gavin Giovannoni, MD	Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck KGaA. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche-Genentech. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Astoria Biologica. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medscape.
Benjamin M. Greenberg, MD, FAAN	Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Clene. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Greenberg has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Siegel Rare Neuroimmune Association. Dr. Greenberg has or had stock in GenrAb.Dr. Greenberg has or had stock in Clene.Dr. Greenberg has received intellectual property interests from a discovery or technology relating to health care. Dr. Greenberg has received publishing royalties from a publication relating to health care.
Hans-Peter Hartung, MD, FAAN	Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS Celgene. Dr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Geneuro. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Neurology.
Eva Havrdova, MD	Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Walter Maier-Janson, MD	Dr. Maier-Janson has nothing to disclose.
Steven C. Yang, DO	Dr. Yang has nothing to disclose.
Amy Z. Crepeau, MD	Dr. Crepeau has nothing to disclose.
Danish Bhatti, MD, FAAN	Dr. Bhatti has nothing to disclose.
Andrea Falini	No disclosure on file
Erich Scholz, MD	No disclosure on file
Gerhard D. Roth, MD	No disclosure on file
Hazem M. Shoirah, MD	Dr. Shoirah has nothing to disclose.
Navpreet K. Bains, DO	Dr. Bains has nothing to disclose.
Bob Bucelli, MD, PhD	Dr. Bucelli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen . Dr. Bucelli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Bucelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron. Dr. Bucelli has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Hamilton Weber. Dr. Bucelli has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for O'Bryan Brown and Toner. Dr. Bucelli has stock in Neuroquestions.com. An immediate family member of Dr. Bucelli has stock in Neuroquestions.com. The institution of Dr. Bucelli has received research support from Biogen. The institution of Dr. Bucelli has received research support from Ionis.
Bryan K. Ho, MD	No disclosure on file
Sara Molisani, MD	Dr. Fridinger has nothing to disclose.
Paul Wacnik	No disclosure on file
Amanda Persaud, MD	Dr. Persaud has nothing to disclose.
Matthew W. Luedke, MD	Dr. Luedke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aucta Pharmaceuticals. Dr. Luedke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. Dr. Luedke has received personal compensation in the range of $0-$499 for serving as a Consultant for Alphasights . Dr. Luedke has received personal compensation in the range of $0-$499 for serving as a Consultant for Clarivate. Dr. Luedke has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Starnes Davis Florie LLP. Dr. Luedke has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Huff Powell Bailey. The institution of Dr. Luedke has received research support from US NAVY. The institution of Dr. Luedke has received research support from Neurona. The institution of Dr. Luedke has received research support from Xenon.
Gustavo C. Roman, MD, FAAN	The institution of Dr. Roman has received research support from Brain Chamistry Labs.
Richard J. Barohn, MD, FAAN	Dr. Barohn has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for NuFactor. The institution of Dr. Barohn has received research support from FDA OPD R01. Dr. Barohn has received intellectual property interests from a discovery or technology relating to health care.
Yi Tong	No disclosure on file
Hemal Patel, MD	Dr. Patel has nothing to disclose.
Charles C. Windon, MD	Dr. Windon has received personal compensation in the range of $0-$499 for serving as a Consultant for LCN Consulting. Dr. Windon has received research support from Alzheimer's Association. Dr. Windon has received personal compensation in the range of $0-$499 for serving as a ��ɫ��al Material Collaborator with ��ɫ��.
Keiko Lo	No disclosure on file
Carolina Temple	No disclosure on file
	No disclosure on file
Rafia P. Jawed, MD	Dr. Jawed has nothing to disclose.
Devon I. Rubin, MD, FAAN	Dr. Rubin has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neurophysiology. Dr. Rubin has received intellectual property interests from a discovery or technology relating to health care. Dr. Rubin has received intellectual property interests from a discovery or technology relating to health care. Dr. Rubin has received publishing royalties from a publication relating to health care. Dr. Rubin has received publishing royalties from a publication relating to health care.
Ariane Lewis, MD, FAAN	Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Seminars in Neurology. Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neuroscience.
John L. Goudreau, DO, PhD	Dr. Goudreau has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for National Board of Osteopathic Medical Examiners. Dr. Goudreau has received research support from AskBIO. Dr. Goudreau has received research support from UCB. Dr. Goudreau has received research support from Cerevel. Dr. Goudreau has received research support from Motric Bioscience.
Irene Cortese, MD	Dr. Cortese has stock in Keires, AG. Dr. Cortese has stock in Nouscom, AG. Dr. Cortese has stock in PDC*line Pharma.
Susan B. Bressman, MD, FAAN	The institution of Dr. Bressman has received research support from Michael J Fox Foundation . The institution of Dr. Bressman has received research support from NIH .
John M. Bertoni, MD, PhD, FAAN	Dr. Bertoni has nothing to disclose.
A. D. Rothner, MD	No disclosure on file
Richard M. Camicioli, MD, FAAN	An immediate family member of Dr. Camicioli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi_Tenabi Canada. The institution of Dr. Camicioli has received research support from Canadian Institutes for Health Research. The institution of Dr. Camicioli has received research support from Western Foundation. The institution of Dr. Camicioli has received research support from NIH. The institution of an immediate family member of Dr. Camicioli has received research support from Brain Canada. The institution of an immediate family member of Dr. Camicioli has received research support from Pharmaceutical Sponsored Studies in ALS.
Anna Pace, MD	Dr. Pace has received personal compensation in the range of $0-$499 for serving as a Conference speaker with ��ɫ��.
Jian Xu, MD, PhD	Dr. Xu has nothing to disclose.
Steven Trau, MD	Dr. Trau has nothing to disclose.
Michael D. Geschwind, MD, PhD, FAAN	Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainstorm Cell Therapeutics, Inc.. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Walter Grubb. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reata Pharmaceuticals, Inc..
Ralph H. Benedict, PhD	Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic Therapeutics. Dr. Benedict has received intellectual property interests from a discovery or technology relating to health care.
Nikolaos Fakas, MD	No disclosure on file
Tachira Tavarez, MD	Dr. Tavarez has nothing to disclose.
Moath Hamed, MD	Dr. Hamed has nothing to disclose.
Joela T. Mathews, MRPSGB	Miss Mathews has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Miss Mathews has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Miss Mathews has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Celegene.
Darrah Haffner, MD	Dr. Haffner has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Naiser Law Office.
Rachael Benson, MD	No disclosure on file
Tom Fuchs	Mr. Fuchs has nothing to disclose.
Carsten Eggers	No disclosure on file
Ruple S. Laughlin, MD, FAAN	Dr. Laughlin has nothing to disclose.
Sandeep Kumar, MD	Dr. Kumar has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for CRICO.
Irene Litvan, MD, FAAN	Dr. Litvan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aprinoia. Dr. Litvan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Litvan has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology. Dr. Litvan has received personal compensation in the range of $50,000-$99,999 for serving as a Chief Editor with Frontiers in Neurology.
Michelle Monje, MD, PhD, FAAN	An immediate family member of Dr. Monje has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for MapLight Therapeutics . An immediate family member of Dr. Monje has stock in MapLight Therapeutics .
Anat Achiron, MD, PhD, FAAN	Dr. Achiron has nothing to disclose.
Jeffrey Statland, MD	Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ML Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epic Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Armatus . Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kate Therapeutics. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vita Therapeutics. Dr. Statland has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne Therapeutics. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity . Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum Therapeutics. Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex . The institution of Dr. Statland has received research support from NIH. The institution of Dr. Statland has received research support from FSHD Society. The institution of Dr. Statland has received research support from Friends of FSH Research. The institution of Dr. Statland has received research support from FSHD Canada. The institution of Dr. Statland has received research support from MDA.
Roberto P. Ortega, MD	No disclosure on file
Karen L. Campbell, PharmD	No disclosure on file
Carolyn Zyloney, MD	No disclosure on file
Jacob Surkont, MD	No disclosure on file
Yohei Harada, MD	Dr. Harada has nothing to disclose.
Thiviya Selvanathan, MD	Dr. Selvanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mallinckrodt. Dr. Selvanathan has received research support from Canadian Institutes of Health Research. Dr. Selvanathan has received research support from SickKids Research Institute. The institution of Dr. Selvanathan has received research support from Canadian Institutes of Health Research. The institution of Dr. Selvanathan has received research support from Heart & Stroke Foundation of Canada. The institution of Dr. Selvanathan has received research support from Newborn Brain Society.
Rachel J. Saunders-Pullman, MD	The institution of Dr. Saunders-Pullman has received research support from NIH, Bigglesworth Family Foundation, Empire Clinical Research Investigatory Program.
Gregory S. Day, MD, MSc, FAAN	Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for DynaMed (EBSCO Health). Dr. Day has or had stock in ANI Pharmaceuticals. The institution of Dr. Day has received research support from National Institutes of Health / NIA. The institution of Dr. Day has received research support from National Institutes of Health / NINDS. The institution of Dr. Day has received research support from Amgen Pharmaceuticals. The institution of Dr. Day has received research support from AVID Radiopharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Presenter at Annual Meeting (CME) with ��ɫ��. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development (CME) with PeerView, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Continuing ��ɫ��, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Ionis Pharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a ��ɫ��al Case Development + Presentation (video) with PeerDirect (P\S\L Group). Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development / Presentation (non-CME) with MJH Life Sciences (NeurologyLive). Dr. Day has a non-compensated relationship as a Clinical Director with Anti-NMDA Receptor Encephalitis Foundation that is relevant to AAN interests or activities.
Thomas H. Massey, MD	No disclosure on file
Adolfo C. Cordero	No disclosure on file
Okkes Kuybu, MD	No disclosure on file
Hema Viswanathan	Ms. Viswanathan has received personal compensation for serving as an employee of Allergan plc. Ms. Viswanathan has received personal compensation for serving as an employee of Precision Medicine Group. Ms. Viswanathan has received stock or an ownership interest from Allergan plc. Ms. Viswanathan has received stock or an ownership interest from Precision Medicine Group.
Anand R. Shewale	Anand R. Shewale has received personal compensation for serving as an employee of AbbVie. Anand R. Shewale has stock in AbbVie.
Brian G. Weinshenker, MD, FAAN	Dr. Weinshenker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CANbridge Pharmaceuticals. Dr. Weinshenker has received personal compensation in the range of $0-$499 for serving as a Consultant for CALIBR. Dr. Weinshenker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Group (Chugai, Genentech, Roche). Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharmaceuticals. Dr. Weinshenker has received research support from Guthy Jackson Charitable Foundation. Dr. Weinshenker has received intellectual property interests from a discovery or technology relating to health care.
Michelle M. Mielke, PhD	Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LabCorp. Dr. Mielke has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens Healthineers. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunbird Bio. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Mielke has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novo Nordisk.
David S. Liebeskind, MD, FAAN	Dr. Liebeskind has received research support from Cerenovus. Dr. Liebeskind has received research support from Genentech . Dr. Liebeskind has received research support from Medtronic. Dr. Liebeskind has received research support from Stryker.
M. M. Mesulam, MD, FAAN	Dr. Mesulam has received publishing royalties from a publication relating to health care.
Marwan N. Sabbagh, MD, FAAN	Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech=Roche. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaptogenix. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant Health. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Anavex. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognito Therapeutics. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for CervoMed. Dr. Sabbagh has stock in Neurotau. Dr. Sabbagh has stock in Seq Biomarque. Dr. Sabbagh has stock in uMethod Health. Dr. Sabbagh has stock in Athira. Dr. Sabbagh has stock in Lighthouse Pharmaceuticals. Dr. Sabbagh has stock in Alzheon. The institution of Dr. Sabbagh has received research support from NIH. The institution of Dr. Sabbagh has received research support from ADDF.
Bachir Estephan, MD	No disclosure on file
Jonathan Cahill, MD, FAAN	The institution of Dr. Cahill has received research support from Roche / Genentech. Dr. Cahill has received publishing royalties from a publication relating to health care.
Joy Z. Ding, MD	No disclosure on file
Samuel Giles, MD	The institution of Dr. Giles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai . Dr. Giles has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai . Dr. Giles has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli lilly .
Tahseen Mozaffar, MD, FAAN	Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amicus. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astellas Gene Therapy. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bayer. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Therapeutics. The institution of Dr. Mozaffar has received research support from NIH. The institution of Dr. Mozaffar has received research support from Muscular Dystrophy Association. The institution of Dr. Mozaffar has received research support from Sanofi. The institution of Dr. Mozaffar has received research support from Argenx. The institution of Dr. Mozaffar has received research support from Amicus Therapeutics. The institution of Dr. Mozaffar has received research support from Astellas Gene Therpay. The institution of Dr. Mozaffar has received research support from Cartesian. The institution of Dr. Mozaffar has received research support from Cabaletta. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH.
Niels Bergsland	Prof. Bergsland has nothing to disclose.
Muhammad A. Javed, MD	No disclosure on file
Aaron Desai, MD, MBBS	Dr. Desai has nothing to disclose.
Jonathan Falsetta, PharmD	No disclosure on file
Charles H. Adler, MD, PhD, FAAN	Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Adler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CND Life Sci. Dr. Adler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precon. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. The institution of Dr. Adler has received research support from NIH. The institution of Dr. Adler has received research support from Michael J. Fox Foundation. The institution of Dr. Adler has received research support from Arizona Biomedical Research Commission. Dr. Adler has received publishing royalties from a publication relating to health care.
Kejal Kantarci, MD	The institution of Dr. Kantarci has received research support from Eli Lilly. The institution of Dr. Kantarci has received research support from NIH. The institution of Dr. Kantarci has received research support from ADDF. The institution of Dr. Kantarci has received research support from Eisai. The institution of Dr. Kantarci has received research support from BioArctic.
Usha K. Misra, MD, FAAN	No disclosure on file
John M. Ravits, MD, FAAN	Dr. Ravits has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Iris, Inc. Dr. Ravits has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Maze, Inc. Dr. Ravits has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Transposon, Inc. Dr. Ravits has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Libra, Inc. The institution of Dr. Ravits has received research support from NIH R21 Research Grant. The institution of Dr. Ravits has received research support from NIH R01 Research Grant. The institution of Dr. Ravits has received research support from FightMND Foundation Research Grant. The institution of Dr. Ravits has received research support from DOD Research Grant. Dr. Ravits has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH Office of Scientific Review.
Nicola De Stefano, MD	Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Healthcare KGaA. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunic AG. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis Pharma AG. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Serono S.p.A. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche S.p.A.. The institution of Dr. De Stefano has received research support from Italian MS Society. The institution of Dr. De Stefano has received research support from Merck Healthcare KGaA.
Rodolfo R. Llinas, MD	No disclosure on file
Namita Goyal, MD, FAAN	Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Souffle. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CSL Behring. Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Goyal has received research support from Fulcrum. The institution of Dr. Goyal has received research support from Healey Platform. The institution of Dr. Goyal has received research support from Medicinova. The institution of Dr. Goyal has received research support from Transposon. The institution of Dr. Goyal has received research support from Abcuro. The institution of Dr. Goyal has received research support from Calico. The institution of Dr. Goyal has received research support from Clene. The institution of Dr. Goyal has received research support from Janssen. The institution of Dr. Goyal has received research support from PepGen. The institution of Dr. Goyal has received research support from PTC. The institution of Dr. Goyal has received research support from Roche. The institution of Dr. Goyal has received research support from Sanofi. The institution of Dr. Goyal has received research support from Prilenia. The institution of Dr. Goyal has received research support from RAPA. The institution of Dr. Goyal has received research support from Avidity. Dr. Goyal has received publishing royalties from a publication relating to health care.
Ronald Postuma, MD	Dr. Postuma has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche, Biogen, Takeda, Theranexus, GE, Jazz, Curasen, Paladin, Inception Sciences, Phytopharmics, Vaxxinity, Merck. Dr. Postuma has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen/Partners. The institution of Dr. Postuma has received research support from CIHR, Weston Foundation, Webster Foundation, Roche, MJFF, Parkinson Canada, FRSQ, NIH.
Jeffrey A. Cohen, MD	Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Convelo. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria. Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSI. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celltrion.
William B. Young, MD, FAAN	Dr. Young has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Young has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Dr. Young has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven Pharmaceuticals. Dr. Young has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly and Company. Dr. Young has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Young has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven Pharmaceuticals Inc. Dr. Young has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly and Company. Dr. Young has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Young has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Coalition for Headache and Migraine Patients. Dr. Young has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Miles for Migraine. The institution of Dr. Young has received research support from Amgen. The institution of Dr. Young has received research support from Cumberland. The institution of Dr. Young has received research support from Eli Lilly. The institution of Dr. Young has received research support from Novartis. The institution of Dr. Young has received research support from PCORI. The institution of Dr. Young has received research support from Satsuma. The institution of Dr. Young has received research support from Scion. The institution of Dr. Young has received research support from Teva. The institution of Dr. Young has received research support from Zosano.
Xavier Montalban, MD, PhD, FAAN	The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck/ EMD Serono. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS/ Celgene. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/ Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIAL PD. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerVoice. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung Biosys. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas BioPharma. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion/ Janssen Pharmaceuticals. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS/ Celgene. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/ EMD Serono. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic Therapeutics. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris/ Mylan. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. The institution of Dr. Montalban has received research support from Biogen. The institution of Dr. Montalban has received research support from Hoffmann-La Roche. The institution of Dr. Montalban has received research support from Sanofi/ Genzyme. The institution of Dr. Montalban has received research support from Merck/ EMD Serono. The institution of Dr. Montalban has received research support from Novartis. The institution of Dr. Montalban has received research support from Teva Pharmaceuticals. The institution of Dr. Montalban has received research support from Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received research support from BMS/ Celgene.
Robert Zivadinov, MD, PhD, FAAN	The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Omnicuris. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrobalan. Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Neishay Ayub, MD	The institution of Dr. Ayub has received research support from Brown Physicians Incorporated. The institution of Dr. Ayub has received research support from Pappitto Opportunity Connection.
Kathie Lin, MD	Dr. Lin has nothing to disclose.
Natalia S. Cunha, MD	Dr. Cunha has nothing to disclose.
Itai Berger, MD	Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Berger has received personal compensation in the range of $0-$499 for serving as a Consultant for Medison. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medison.
Jaya Trivedi, MD, FAAN	The institution of Dr. Trivedi has received research support from Avidity.
Vanja C. Douglas, MD, FAAN	Dr. Douglas has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Various legal firms. Dr. Douglas has received publishing royalties from a publication relating to health care. Dr. Douglas has received publishing royalties from a publication relating to health care.
Benzion Blech, MD	Dr. Blech has nothing to disclose.
Jae Eun Lee, MD	Dr. Lee has nothing to disclose.
Gisbert Weckbecker	No disclosure on file
Ruth-Ann Marrie, MD, PhD	The institution of Dr. Marrie has received research support from CIHR. The institution of Dr. Marrie has received research support from MS Canada. The institution of Dr. Marrie has received research support from National MS Society. The institution of Dr. Marrie has received research support from Crohn's and Colitis Canada. The institution of Dr. Marrie has received research support from US Department of Defense. The institution of Dr. Marrie has received research support from The Arthritis Society. The institution of Dr. Marrie has received research support from CMSC.
Lisa M. Shulman, MD, FAAN	The institution of Dr. Shulman has received research support from NIH. Dr. Shulman has received publishing royalties from a publication relating to health care. Dr. Shulman has received publishing royalties from a publication relating to health care.
Paul M. Thompson, PhD	No disclosure on file
Gregory A. Jicha, MD, PhD	Dr. Jicha has nothing to disclose.
Brenda L. Banwell, MD, FAAN	Dr. Banwell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Banwell has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Banwell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Banwell has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Banwell has received research support from National MS Society. The institution of Dr. Banwell has received research support from NIH.
Eoin P. Flanagan, MBBCh, FAAN	The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Merck. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology that is relevant to AAN interests or activities.
Richard B. Lipton, MD, FAAN	Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has or had stock in Biohaven.Dr. Lipton has or had stock in Manistee.Dr. Lipton has or had stock in Axon.Dr. Lipton has or had stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
James K. Sheffield, MD	Dr. Sheffield has received personal compensation for serving as an employee of BMS.
Maria-Jesus Arevalo	Maria-Jesus Arevalo has nothing to disclose.
Stephanie L. Paolini, MD	Dr. Paolini has nothing to disclose.
Sagar Munjal, MD	No disclosure on file
Robert C. Griggs, MD, FAAN	Dr. Griggs has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Strongbridge Pharmaceuticals. Dr. Griggs has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idera Pharmaceuticals. Dr. Griggs has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Solid Biopharma. Dr. Griggs has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Santhera Pharmaceuticals. Dr. Griggs has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Griggs has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Lippincott. The institution of Dr. Griggs has received research support from PTC Pharmaceuticals. The institution of Dr. Griggs has received research support from Sarepta Pharmaceuticals. The institution of Dr. Griggs has received research support from National Institutes of Health. The institution of Dr. Griggs has received research support from Santhere Pharmaceuticals. Dr. Griggs has received personal compensation in the range of $500-$4,999 for serving as a Study section member with National Institutes of Health. Dr. Griggs has a non-compensated relationship as a Board of Directors;Chair Research Advisory Committee with American Brain Foundation that is relevant to AAN interests or activities.
Zbigniew K. Wszolek, MD, FAAN	Dr. Wszolek has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Polish Neurological Society/Via Medica. Dr. Wszolek has received intellectual property interests from a discovery or technology relating to health care.
Peter Goadsby, MD, PhD, FRS	Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CoolTech LLC. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health LLC. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kallyope. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Seaport Therapeutics. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dr Reddy's. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orion Pharma. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Massachusetts Medical Society. The institution of Dr. Goadsby has received research support from NIHR. Dr. Goadsby has received publishing royalties from a publication relating to health care. Dr. Goadsby has received publishing royalties from a publication relating to health care. Dr. Goadsby has a non-compensated relationship as a Trustee with Migraine Trust that is relevant to AAN interests or activities. Dr. Goadsby has a non-compensated relationship as a Trustee with Organisation for Understanding Cluster Headache (UK) that is relevant to AAN interests or activities.
Walter A. Kukull, PhD, FAAN	The institution of Dr. Kukull has received research support from NIH/NIA. Dr. Kukull has a non-compensated relationship as a Associate editor with Alzheimer's and Dementia TRCI (journal) that is relevant to AAN interests or activities. Dr. Kukull has a non-compensated relationship as a Editorial board with Journal of American Geriatrics Soc that is relevant to AAN interests or activities.
Kimberly L. Panizzon	No disclosure on file
Mary E. Phelan, BS, C-TAGME	No disclosure on file
Laura J. Balcer, MD, MSCE, FAAN	An immediate family member of Dr. Balcer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Children's Hospital of Philadelphia.
Maria C. Rodriquez	No disclosure on file
Ronald C. Petersen, MD, PhD, FAAN	Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
Todd J. Schwedt, MD, FAAN	Dr. Schwedt has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Schwedt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Schwedt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Schwedt has received personal compensation in the range of $0-$499 for serving as a Consultant for Amgen. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scilex. Dr. Schwedt has stock in Aural Analytics. Dr. Schwedt has stock in Nocira. Dr. Schwedt has stock in Allevalux. The institution of Dr. Schwedt has received research support from National Institutes of Health. The institution of Dr. Schwedt has received research support from United States Department of Defense. The institution of Dr. Schwedt has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Schwedt has received research support from SPARK Neuro. The institution of Dr. Schwedt has received research support from Henry Jackson Foundation. The institution of Dr. Schwedt has received research support from Pfizer. The institution of Dr. Schwedt has received research support from National Headache Foundation. The institution of Dr. Schwedt has received research support from American Heart Association. Dr. Schwedt has received intellectual property interests from a discovery or technology relating to health care. Dr. Schwedt has received intellectual property interests from a discovery or technology relating to health care. Dr. Schwedt has received intellectual property interests from a discovery or technology relating to health care. Dr. Schwedt has received intellectual property interests from a discovery or technology relating to health care. Dr. Schwedt has received publishing royalties from a publication relating to health care.
Daniel J. Licht, MD	No disclosure on file
Bradford Dickerson, MD, FAAN	Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arkuda. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lantheus. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Dickerson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arkuda. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Dickerson has received publishing royalties from a publication relating to health care. Dr. Dickerson has received publishing royalties from a publication relating to health care.
Steven Galetta, MD, FAAN	Dr. Galetta has nothing to disclose.
Stewart J. Tepper, MD	Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aeon. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aruene. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atheneum. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Axsome Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Becker Pharmaceutical Consulting. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clearview Healhcare Partners. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CoolTech. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CRG. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Decision Resources. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Defined Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DRG. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ExpertConnect. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FCB Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fenix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Advances. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Science Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HMP Communications. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Impel. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InteractiveForums. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Keyquest. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Krog and Partners. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Magnolia Innovation. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJH Holdings. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurolief. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for P Value Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pain Insights Inc. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Palion Medical. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pulmatrix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Putnam Associates. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SAI MedPartners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Slingshot Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spherix Global Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Strategy Inc. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for System Analytic. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Taylor and Francis. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Trinity Partners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UnityHA. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for XOC. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Click Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Miravo. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurofront Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rehaler. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communications. Dr. Tepper has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Pfizer. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alphasights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Perfood. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Scilex. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communication. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tegus. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Catch Therapeutics. Dr. Tepper has received personal compensation in the range of $0-$499 for serving as a Consultant for DocDelta. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dr Reddy's. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FCB Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilmartin Capital. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Initiator Pharma. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Magellan Health. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Nocira. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Slingshot Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Third Bridge. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tonix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vial . Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DocDelta. The institution of Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bausch Health. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dr Reddy's. The institution of Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ClickTherapeutics. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CoolTech. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Miravo Healthcare. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pulmatrix. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Satsuma. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Tepper has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Pfizer. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Scilex. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Tonix. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Dr Reddy's. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Anneal. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Axsome. The institution of Dr. Tepper has received research support from Abbvie. The institution of Dr. Tepper has received research support from Aeon. The institution of Dr. Tepper has received research support from Amgen. The institution of Dr. Tepper has received research support from Annovis. The institution of Dr. Tepper has received research support from Axsome. The institution of Dr. Tepper has received research support from Cassava. The institution of Dr. Tepper has received research support from Cognition. The institution of Dr. Tepper has received research support from Eli Lilly. The institution of Dr. Tepper has received research support from Inibikase. The institution of Dr. Tepper has received research support from Ipsen. The institution of Dr. Tepper has received research support from Lundbeck. The institution of Dr. Tepper has received research support from Merz. The institution of Dr. Tepper has received research support from Pfizer. The institution of Dr. Tepper has received research support from PrecisionMed. The institution of Dr. Tepper has received research support from Revance. The institution of Dr. Tepper has received research support from Suven. The institution of Dr. Tepper has received research support from UCB. The institution of Dr. Tepper has received research support from Biohaven. The institution of Dr. Tepper has received research support from Johnson and Johnson/Intracellular. The institution of Dr. Tepper has received research support from Karuna. The institution of Dr. Tepper has received research support from Neurocrine. Dr. Tepper has received publishing royalties from a publication relating to health care. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a CME Speaker with Diamond Headache Clinic. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical Learning Institute Peerview. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical ��ɫ�� Speakers Network. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a CME Speaker with Miller Medical Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Physicians' ��ɫ�� Resource. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a CME Speaker with WebMD/Medscape. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with American Headache Society. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with Vindico Medical ��ɫ��. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with HMP Global. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CMe speaker with Medical Learning Institute Peerview. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with Consortium for Research ��ɫ�� Social Awareness and Training In Neurosciences.
Koto Ishida, MD, FAAN	Dr. Ishida has received publishing royalties from a publication relating to health care.
Ludwig Kappos, MD, FAAN	Dr. Kappos has nothing to disclose.
Michael Karras, MD	No disclosure on file
Asri Yuliati, MD	No disclosure on file
Eliot A. Licht, MD	No disclosure on file
Gene Y. Sung, MD, MPH	The institution of Dr. Sung has received research support from NIH.
Brin Freund, MD	Dr. Freund has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Freund has received research support from Mayo Clinic.
Malcolm Horne	No disclosure on file
Cindy Tsui	No disclosure on file
Marie Wencel, CCRP	Ms. Wencel has nothing to disclose.
Alexandra Gewirtz, MD	No disclosure on file
Enrique Alvarez, MD, PhD	Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Alvarez has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene/BMS. The institution of an immediate family member of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon.
Christopher Carosella, MD	Dr. Carosella has nothing to disclose.
Emma Matthews, MD	Dr. Matthews has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lupin Pharmaceuticals. The institution of Dr. Matthews has received research support from Myotonic Dystrophy Foundation.
Ilaria Cani, MD	No disclosure on file
Sarah Woidill	Sarah Woidill has nothing to disclose.
Lokesh Saini, DM	Dr. Saini has nothing to disclose.
William D. Gaillard, MD	The institution of Dr. Gaillard has received research support from all federal or foundation grants, NINDS, NIDCD, NICHD, NSF ,PERF.
Edlin Gonzales, MA	Ms. Gonzales has nothing to disclose.
John M. Stern, MD, FAAN	Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Science. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharma. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for LivaNova. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences. Dr. Stern has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Stern has stock in DEARhealth. Dr. Stern has stock in Ceribell. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care.
Lynne Verselis	No disclosure on file
Elanagan Nagarajan, MD	Dr. Nagarajan has nothing to disclose.
Divya S. Khurana, MD	No disclosure on file
Juan J. Vilchez Padilla, MD	Dr. Vilchez Padilla has nothing to disclose.
J. David Avila, MD, FAAN	Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Avila has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alnylam Pharmaceuticals. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for argenx. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda.
Florian Kurth	No disclosure on file
Andreas U. Monsch, PhD	No disclosure on file
Arastoo Vossough, MD	Dr. Vossough has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Syneos Health. Dr. Vossough has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for DeepSight. Dr. Vossough has received publishing royalties from a publication relating to health care.
Eric Jackowiak, MD	No disclosure on file
Umar A. Shuaib, MBBS	Dr. Shuaib has nothing to disclose.
Hui Yang, PhD	No disclosure on file
Arthur Toga	No disclosure on file
Lucy Tan	No disclosure on file
Jeffrey W. Britton, MD, FAAN	Dr. Britton has received personal compensation in the range of $0-$499 for serving as a Online course with American Clinical Neurophysiology Society.
Ellen M. Mowry, MD, FAAN	Dr. Mowry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octave. Dr. Mowry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SetPoint. The institution of Dr. Mowry has received research support from Genentech/Roche. The institution of Dr. Mowry has received research support from Biogen. Dr. Mowry has received publishing royalties from a publication relating to health care.
Filip Bergquist	The institution of Filip Bergquist has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Filip Bergquist has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Arvid Carlsson Research AB. The institution of Filip Bergquist has received research support from Swedish Government. The institution of Filip Bergquist has received research support from Parkinsonfonden. The institution of Filip Bergquist has received research support from Neuro Sweden. The institution of Filip Bergquist has received research support from Swedish Research Council. Filip Bergquist has received publishing royalties from a publication relating to health care. Filip Bergquist has received publishing royalties from a publication relating to health care. Filip Bergquist has a non-compensated relationship as a Advisor with Sense4Care that is relevant to AAN interests or activities.
Danielle Brushaber	No disclosure on file
David W. Dodick, MD, FAAN	Dr. Dodick has received personal compensation for serving as an employee of Mayo Clinic. Dr. Dodick has received personal compensation for serving as an employee of Atria Health. Dr. Dodick has received personal compensation for serving as an employee of Thomas Jefferson University . Dr. Dodick has received personal compensation for serving as an employee of Norwegian University of Science and Technology. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Allergan. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biopharm Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inside Practice Australia. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical ��ɫ�� Alliance. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of the Pacific . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medica Communications. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJ Healthcare. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nocira. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vector Psychometrics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Ayya Biosciences. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Theranica. Dr. Dodick has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Atria. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for WebMD. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Thomas Jefferson University. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medforce. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision HEOR. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Canadian Headache Society. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of New England. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen Japan. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for KingDevick Technologies. Dr. Dodick has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Precon Health. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Ontologics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Matterhorn. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Axon Therapeutics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Cephalgia Group. Dr. Dodick has stock in Healint. Dr. Dodick has stock in Theranica. Dr. Dodick has stock in Aural Analytics . Dr. Dodick has stock in Epien. Dr. Dodick has stock in Matterhorn. Dr. Dodick has stock in Ontologics. Dr. Dodick has stock in Precon Health. Dr. Dodick has stock in King Devick Technologies. Dr. Dodick has stock in Nocira. Dr. Dodick has stock in Exsano. Dr. Dodick has stock in Palion. Dr. Dodick has stock in AYYA Biosciences. Dr. Dodick has stock in Perfood. Dr. Dodick has stock in Cephalgia Group. Dr. Dodick has stock in Atria Health. Dr. Dodick has stock in Man and Science. Dr. Dodick has stock in Eigenlyfe. An immediate family member of Dr. Dodick has stock in ScotiaLyfe. Dr. Dodick has stock in Axon Therapeutics. The institution of Dr. Dodick has received research support from Department of Defense. The institution of Dr. Dodick has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Dodick has received research support from Henry Jackson Foundation. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has a non-compensated relationship as a Chair with American Brain Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Committee member/Course Director with ��ɫ�� that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair/Immediate Past Chair with American Migraine Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair Global Patient Advocacy Coalition with International Headache Society that is relevant to AAN interests or activities.
Larry B. Goldstein, MD, FAHA, FAAN	The institution of Dr. Goldstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. Dr. Goldstein has received intellectual property interests from a discovery or technology relating to health care. Dr. Goldstein has received publishing royalties from a publication relating to health care.
Alejandro A. Rabinstein, MD, FAAN	Dr. Rabinstein has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shionogi . Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceribell. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurocritical care/NCS-Springer. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters/UptoDate. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for EBSCO/DynaMed. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care.
Bradley F. Boeve, MD, FAAN	Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
Maria Laura Stromillo, PhD	Maria Laura Stromillo, PhD has nothing to disclose.
Valeria I. Naranjo, MD	No disclosure on file
Kaushik Gowthaman, Jr., MD	No disclosure on file
Jillian Alderson, MD	No disclosure on file
Tanya Simuni, MD, FAAN	Dr. Simuni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for cadia, AcureX, Adamas, AskBio, Amneal, Blue Rock Therapeutics, Caraway Therapeutics, Critical Path for Parkinson's Consortium (CPP), Denali, Michael J Fox Foundation, Neuroderm, Sanofi, Sinopia, Roche, Takeda and Vanqua Bio. Dr. Simuni has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for of Koneksa, Neuroderm, Sanofi, UCB, AcureX, Adamas, AskBio, Biohaven, Denali, GAIN, Neuron23 and Roche. Dr. Simuni has received research support from Amneal, Biogen, Neuroderm, Prevail, Roche, and UCB and an investigator for NINDS, MJFF, Parkinson's Foundation.
Marie F. Grill, MD	Dr. Grill has nothing to disclose.
Thais Armangue, MD	Dr. Armangue has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Armangue has received research support from ISCIII(Spanish institute of health) -PI21/00316, Marato TV3, La Caixa Research Foundadion, Pablove Foundation (689368), Torrons Vicens Foundation (PFNR0144), 2021 Invest AEP.
Bianca Weinstock-Guttman, MD	Dr. Weinstock-Guttman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme &Sanofi. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH.
Fernando Cendes, MD, PhD, FAAN	Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Biopharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for United Medical – Brazil. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zodiac Pharma . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eurofarma – Brazil . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology - Epilepsy. The institution of Dr. Cendes has received research support from São Paulo Research Foundation - FAPESP. The institution of Dr. Cendes has received research support from Conselho Nacional de Desenvolvimento Científico e Tecnológico - Brazil . The institution of Dr. Cendes has received research support from NIH.
Katherine P. Rankin, PhD	The institution of Dr. Rankin has received research support from Marcus Foundation.
Michael M. Gezalian, MD	Dr. Gezalian has nothing to disclose.
Angela Parsons, DO	Dr. Parsons has nothing to disclose.
Jodi Mueller-Hussein	Jodi Mueller-Hussein has nothing to disclose.
Alejandro Thomson, MD	Dr. Thomson has nothing to disclose.
Geeta Verma, MD	No disclosure on file
Yun Jik Park, MD	No disclosure on file
Shruthi N M, DM	No disclosure on file
Stuart D. Cook, MD, FAAN	No disclosure on file
Kathryn Kvam, MD	Dr. Kvam has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN / Neurology Clinical Practice.
Sitara Koneru, MD	Dr. Koneru has nothing to disclose.
Jean-Benoit Epiney, MD	No disclosure on file
Omar Sherbini	No disclosure on file
Igor Teslya	No disclosure on file
Jonathan Graff-Radford, MD, FAAN	Dr. Graff-Radford has received personal compensation for serving as an employee of Mayo Clinic. Dr. Graff-Radford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/NIH. Dr. Graff-Radford has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Open evidence . The institution of Dr. Graff-Radford has received research support from NIH. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Cognition therapeutics. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as a Faculty Member with IMPACT AD .
Sara E. Hocker, MD, FAAN	The institution of Dr. Hocker has received research support from Yale University. Dr. Hocker has received publishing royalties from a publication relating to health care.
Manoj K. Pandey, PhD	No disclosure on file
Kenneth M. Heilman, MD, FAAN	Dr. Heilman has received publishing royalties from a publication relating to health care.
Thomas G. Brott, MD, FAAN	Dr. Brott has nothing to disclose.
Ka-wai G. Ho, MD	No disclosure on file
Alyssa Bautista, MD	Dr. Bautista has or had stock in Gravity Medical Technology.
Ryan Chae	No disclosure on file
Tasneem F. Hasan, MD	Dr. Hasan has nothing to disclose.
Daniel M. Oh, MD	Dr. Oh has nothing to disclose.
Eva-Laudon Meyer	No disclosure on file
David B. Parker	No disclosure on file
Robert D. Brown, Jr., MD, MPH, FAAN	Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Craig H Neilsen Foundation. The institution of Dr. Brown has received research support from National Institutes of Health/NINDS. Dr. Brown has received publishing royalties from a publication relating to health care.
Guy Schwartz, MD	Dr. Schwartz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Schwartz has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Aaronson Rappaport Feinstein & Deutsch, LLP.
Nathalie Derache	Nathalie Derache has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MERCK. Nathalie Derache has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MERCK. Nathalie Derache has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS.
Shaneela Malik, MD	Dr. Malik has nothing to disclose.
Don Cleveland, PhD	No disclosure on file
Guillermo Izquierdo Ayuso, MD	Dr. Izquierdo Ayuso has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer, Biogen Idec, Novartis, Sanofi, Merck Serono, Roche, Actelion and Celgene. Dr. Izquierdo Ayuso has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme, Novartis, Sanofi Aventis, Alexion.
Sebina Bulic, MD	Dr. Bulic has nothing to disclose.
Ajaz Sheikh, MD	Dr. Sheikh has nothing to disclose.
Aravind Ganesh, MD	Dr. Ganesh has received personal compensation in the range of $0-$499 for serving as a Consultant for Figure 1. Dr. Ganesh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier Canada. Dr. Ganesh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Ganesh has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli-Lilly. Dr. Ganesh has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Let's Get Proof (Collavidence Inc). Dr. Ganesh has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ�� (journals Neurology and Neurology: Clinical Practice). Dr. Ganesh has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association (journal: Stroke). Dr. Ganesh has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers (for Frontiers in Neurology). Dr. Ganesh has or had stock in SnapDx.Dr. Ganesh has or had stock in Collavidence Inc.Dr. Ganesh has or had stock in DataSimpl. The institution of Dr. Ganesh has received research support from Canadian Institutes of Health Research . The institution of Dr. Ganesh has received research support from Alberta Innovates. The institution of Dr. Ganesh has received research support from University of Calgary Centre for Clinical Research. The institution of Dr. Ganesh has received research support from Innovation 4 Health. The institution of Dr. Ganesh has received research support from Government of Canada INOVAIT. The institution of Dr. Ganesh has received research support from Campus Alberta Neuroscience. The institution of Dr. Ganesh has received research support from Alzheimer Society of Canada. The institution of Dr. Ganesh has received research support from Heart and Stroke Foundation of Canada. The institution of Dr. Ganesh has received research support from New Frontiers in Research Fund. The institution of Dr. Ganesh has received research support from Panmure House. The institution of Dr. Ganesh has received research support from Brain Canada. The institution of Dr. Ganesh has received research support from MSI Foundation. The institution of Dr. Ganesh has received research support from France Canada Research Fund. Dr. Ganesh has received intellectual property interests from a discovery or technology relating to health care.
Christian Enzinger	Christian Enzinger has nothing to disclose.
Pedro Renato D. Brandao, MD	No disclosure on file
A. M. Barrett, MD, FAAN	The institution of Dr. Barrett has received research support from Veterans Health Association. The institution of Dr. Barrett has received research support from National Institutes of Health. The institution of Dr. Barrett has received research support from Mabel H Flory Trust. Dr. Barrett has received personal compensation in the range of $0-$499 for serving as a author, chapter with WebMD. Dr. Barrett has received personal compensation in the range of $10,000-$49,999 for serving as a scientific advisor with Winifred Masterson Burke Foundation.
Sanjeev V. Kothare, MD, FAAN	Dr. Kothare has nothing to disclose.
Murray Grossman, MD, FAAN	Dr. Grossman has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Grossman has received research support from NIH.
Aaron L. Nelson, MD, FAAN	Dr. Nelson has nothing to disclose.
David S. Knopman, MD, FAAN	Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH.
Gil D. Rabinovici, MD, FAAN	Dr. Rabinovici has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Dr. Rabinovici has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Norodisk. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for C2N. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Joihnson. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Peerview. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medscape. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA. The institution of Dr. Rabinovici has received research support from NIH. The institution of Dr. Rabinovici has received research support from American College of Radiology. The institution of Dr. Rabinovici has received research support from Alzheimer's Association. The institution of Dr. Rabinovici has received research support from Rainwater Charitable Foundation. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Topic Chair, Course Director and teacher with AAN. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with NIH. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Invited speaker with ANA.
Stephen G. Reich, MD, FAAN	Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Best Doctors. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UpToDate. Dr. Reich has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. Dr. Reich has received publishing royalties from a publication relating to health care. Dr. Reich has received publishing royalties from a publication relating to health care.
Frederik Barkhof, MD, PhD	Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Frederik Barkhof has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Combinostics. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IXICO. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EISAI.
Reem M. Alhammad, MD	No disclosure on file
Adeel Zubair, MD	Dr. Zubair has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The MedNet.
Muhammad A. Iqbal, MD	No disclosure on file
John Betjemann, MD	No disclosure on file
Temitayo Oyegbile-Chidi, MD, PhD, FAAN	Dr. Oyegbile-Chidi has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Spectrum/The Transmitter. The institution of Dr. Oyegbile-Chidi has received research support from NIH.
James R. Couch, Jr., MD, PhD, FAAN	No disclosure on file
Zachary Cross	No disclosure on file
Kyan Younes, MD	Dr. Younes has nothing to disclose.
Edlira Shemsi, MD	Dr. Shemsi has nothing to disclose.
Omar M. Al-Janabi, MD, PhD, MSc	Dr. Al-Janabi has nothing to disclose.
Dawn C. Buse, PhD	Dr. Buse has received personal compensation for serving as an employee of Vector Psychometric Group. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranicsa. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Buse has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Pain and Headache Reports. The institution of Dr. Buse has received research support from Amgen. The institution of Dr. Buse has received research support from FDA. The institution of Dr. Buse has received research support from National Headache Foundation.
Ted A. Weissfeld, MD	No disclosure on file
Matthew P. Wicklund, MD, FAAN	Dr. Wicklund has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus Therapeutics. Dr. Wicklund has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. Dr. Wicklund has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta Therapeutics. Dr. Wicklund has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Spark Therapeutics. Dr. Wicklund has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ultragenyx. Dr. Wicklund has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex Pharmaceuticals. The institution of Dr. Wicklund has received research support from Orphazyme. The institution of Dr. Wicklund has received research support from Muscular Dystrophy Association. The institution of Dr. Wicklund has received research support from Coalition to Cure Calpain 3. The institution of Dr. Wicklund has received research support from Sarepta Therapeutics. The institution of Dr. Wicklund has received research support from ML Bio. The institution of Dr. Wicklund has received research support from Alexion. The institution of Dr. Wicklund has received research support from Acceleron. The institution of Dr. Wicklund has received research support from Edgewise. The institution of Dr. Wicklund has received research support from Fulcrum. The institution of Dr. Wicklund has received research support from Roche-Genentech. The institution of Dr. Wicklund has received research support from Avidity. Dr. Wicklund has received research support from Harmony Bioscience.
Neelum T. Aggarwal, MD	Dr. Aggarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant with AtWHealth . Dr. Aggarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker with VCU Health.
Howard J. Rosen, MD	Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly . Dr. Rosen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alector. The institution of Dr. Rosen has received research support from NIH. The institution of Dr. Rosen has received research support from State of CA. Dr. Rosen has a non-compensated relationship as a Consultant with Prevail Therapeutics that is relevant to AAN interests or activities. Dr. Rosen has a non-compensated relationship as a consultant with Alchemab that is relevant to AAN interests or activities.
Michael G. Dwyer III, MD, PhD	Dr. Dwyer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Keystone Heart, Ltd. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Dwyer has received research support from Novartis. The institution of Dr. Dwyer has received research support from Keystone Heart, Ltd. The institution of Dr. Dwyer has received research support from Bristol Myers Squibb. The institution of Dr. Dwyer has received research support from Roche.
Guillermo Parilla Reverter	No disclosure on file
Eric Morse	No disclosure on file
Megan Brosious	No disclosure on file
Noha A. Mhjob, MD	No disclosure on file
Olwen Murphy, MD	Dr. Murphy has nothing to disclose.
Yu-Wei Lin, MD	No disclosure on file
Nicole Ziliotto	No disclosure on file
Cesar Ochoa-Lubinoff	Cesar Ochoa-Lubinoff has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ovid Therapeutics Inc.
Nikesh Bajaj, DO	Dr. Bajaj has received personal compensation for serving as an employee of Barrow Neurologal Institute Fellowship .
Cina Sasannejad, MD	No disclosure on file
Mario F. Mendez, MD, PhD, FAAN	Dr. Mendez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medical ��ɫ�� Speakers' Bureau. Dr. Mendez has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. The institution of Dr. Mendez has received research support from NIH. Dr. Mendez has received publishing royalties from a publication relating to health care.
Michael K. Racke, MD	Dr. Racke has received personal compensation for serving as an employee of Quest Diagnostics. Dr. Racke has or had stock in Quest Diagnostics.Dr. Racke has received intellectual property interests from a discovery or technology relating to health care.
Nikolaus McFarland, MD, PhD, FAAN	Dr. McFarland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sutter Health. Dr. McFarland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ONO Pharmaceuticals. Dr. McFarland has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Ferrer. The institution of Dr. McFarland has received research support from NIH, Michael J. Fox Foundation, Huntington Disease Society for America, CurePSP, and Mission MSA.. Dr. McFarland has received publishing royalties from a publication relating to health care.
Edward Fox, MD, PhD, FAAN	Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW Pharmaceuticals. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Fox has received research support from Biogen. The institution of Dr. Fox has received research support from Genentech. The institution of Dr. Fox has received research support from Celgene - BMS. The institution of Dr. Fox has received research support from Chugai. The institution of Dr. Fox has received research support from Novartis. The institution of Dr. Fox has received research support from EMD-Serono. The institution of Dr. Fox has received research support from TG Therapeutics. The institution of Dr. Fox has received research support from AbbVie. The institution of Dr. Fox has received research support from Sanofi Genzyme. The institution of Dr. Fox has received research support from AbbVie.
Koby Mok, PhD	Dr. Mok has received personal compensation for serving as an employee of TG Therapeutics. Dr. Mok has received stock or an ownership interest from TG Therapeutics.
Fen Bao	Fen Bao has nothing to disclose.
John T. Kissel, MD, FAAN	Dr. Kissel has nothing to disclose.
Adam L. Boxer, MD, PhD	An immediate family member of Dr. Boxer has received personal compensation for serving as an employee of Kaiser Permanente. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono. Dr. Boxer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Oscotec. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arrowhead. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine Biosciences. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Switch. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arvinas. Dr. Boxer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alector. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Transposon. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Boxer has stock in Alector. Dr. Boxer has stock in Arvinas. Dr. Boxer has stock in Neurovanda. The institution of Dr. Boxer has received research support from Biogen. The institution of Dr. Boxer has received research support from Eisai. The institution of Dr. Boxer has received research support from Regeneron. The institution of Dr. Boxer has received research support from NIH. The institution of Dr. Boxer has received research support from Bluefield Project-5. Dr. Boxer has received research support from Rainwater Charitable Foundation. Dr. Boxer has received research support from GHR Foundation. Dr. Boxer has received intellectual property interests from a discovery or technology relating to health care.
Edward Labin, MD	Dr. Labin has nothing to disclose.
Lubna E. El Sheikh, Jr., MBBS	Dr. El Sheikh has nothing to disclose.
Elise Wiersma, NP	No disclosure on file
Eric Klawiter, MD, FAAN	Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Galen/Atlantica. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Banner Life Sciences. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Greenwich Biosciences. Dr. Klawiter has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for OM1. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Klawiter has received research support from Biogen. The institution of Dr. Klawiter has received research support from Abbvie. The institution of Dr. Klawiter has received research support from Genentech.
Beau M. Ances, MD, PhD, MS, FAAN	Dr. Ances has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH.
Mazen M. Dimachkie, MD, FAAN	Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Octapharma. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ArgenX. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Catalyst. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Takeda. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medlink. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Astellas. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dianthus. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for TACT / Treat NMD. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Neurological Society of America, Inc . Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Ig Society, Inc. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abcuro. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon/Immunovant. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ��ɫ�� (AAN). Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM). Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Annexon Biosciences. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Candid Therapeutics. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Creyon Bio, Inc.. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig Therapeutics. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB Biopharma. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharmaceuticals. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fortrea. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kriya Therapeutics. The institution of Dr. Dimachkie has received research support from NIH. The institution of Dr. Dimachkie has received research support from The Myositis Association. The institution of Dr. Dimachkie has received research support from Biosensics. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care.
Joseph C. Masdeu, MD, PhD, FAAN	Dr. Masdeu has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lilly . The institution of Dr. Masdeu has received research support from NIH. The institution of Dr. Masdeu has received research support from Houston Methodist Foundation. The institution of Dr. Masdeu has received research support from Alector. The institution of Dr. Masdeu has received research support from Aviado-Bio. Dr. Masdeu has received publishing royalties from a publication relating to health care. Dr. Masdeu has received publishing royalties from a publication relating to health care. Dr. Masdeu has received personal compensation in the range of $100,000-$499,999 for serving as a Director, Nantz Nal Alzheimer Center with HOUSTON METHODIST NEUROLOGICAL INSTITUTE.
Jordan J. Elm	The institution of Dr. Elm has received research support from NIH.
Kelly Baldwin, MD	Dr. Baldwin has nothing to disclose.
Mark Rich, MD	No disclosure on file
Sanjeev Taneja, MD	No disclosure on file
Durdane Aksoy, MD	No disclosure on file
Sumiko Weir	No disclosure on file
MICHAIL KOSMIDIS	No disclosure on file
Ferid I. Domi, Jr., MD	Dr. Domi has nothing to disclose.
Sania Atta, MBBS	No disclosure on file
Faddi G. Saleh Velez, MD	Dr. Saleh Velez has nothing to disclose.
Umar Shariff, MD	No disclosure on file
M. Judith Peterschmitt, MD	No disclosure on file
Emily J. Gilmore, MD	Dr. Gilmore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for carpl.ai. Dr. Gilmore has received personal compensation in the range of $0-$499 for serving as a Consultant for AAN. Dr. Gilmore has received research support from NIH.
Helena C. Chui, MD	The institution of Dr. Chui has received research support from National Institute on Aging .
Paul E. Schulz, MD	Dr. Schulz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisa .
Joel Kramer, PhD	The institution of Dr. Kramer has received research support from tau consortium. Dr. Kramer has received publishing royalties from a publication relating to health care.
Lin Zhang, FRACP	No disclosure on file
Alejandro Gonzalez Aquines, Sr.	Mr. Gonzalez Aquines has nothing to disclose.
Musab Ali, MD	Dr. Ali has nothing to disclose.
Hassan Alhussein, MD	Dr. Alhussein has nothing to disclose.
Margi B. Patel, MD	No disclosure on file
Aaron Hadley	Aaron Hadley has received personal compensation for serving as an employee of Great Lakes NeuroTechnologies.
Hosein Nouri	No disclosure on file
Aimee A. Sato, MD	Dr. Sato has nothing to disclose.
Fredric J. Cohen, MD	No disclosure on file
Jacob Yomtoob, MD	Dr. Yomtoob has nothing to disclose.
Selim R. Benbadis, MD, FAAN	Dr. Benbadis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Stratus. Dr. Benbadis has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for SK Lifesciences. Dr. Benbadis has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Jazz. Dr. Benbadis has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Catalyst. Dr. Benbadis has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Neurelis. Dr. Benbadis has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Benbadis has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Livanova. Dr. Benbadis has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for UCB.
Stephen Krieger, MD, FAAN	Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Krieger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Krieger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Krieger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cycle. The institution of Dr. Krieger has received research support from Novartis. The institution of Dr. Krieger has received research support from Bristol Myers Squibb. The institution of Dr. Krieger has received research support from Biogen. The institution of Dr. Krieger has received research support from Sanofi.
Anthony Noto, MD	Dr. Noto has nothing to disclose.
Badal G. Jain, MD	No disclosure on file
Mamatha Pasnoor, MD, FAAN	Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx BVBA. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceutical. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amgen.
Rahul D. Abhyankar, MD	No disclosure on file
Yunsung Kim, PhD	Yunsung Kim has nothing to disclose.
Miles Cobia, MD	No disclosure on file
Enrique Urrea-Mendoza, MD	Dr. Urrea-Mendoza has nothing to disclose.
Andres F. Deik Acosta Madiedo, MD, FAAN	Dr. Deik Acosta Madiedo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal Pharmaceuticals. Dr. Deik Acosta Madiedo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for SPARK-NS. Dr. Deik Acosta Madiedo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Manifold Bio. Dr. Deik Acosta Madiedo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genus Lifesciences. Dr. Deik Acosta Madiedo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus Therapeutics. Dr. Deik Acosta Madiedo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal. The institution of Dr. Deik Acosta Madiedo has received research support from Teva Pharmaceuticals. The institution of Dr. Deik Acosta Madiedo has received research support from Cerevel Therapeutics. The institution of Dr. Deik Acosta Madiedo has received research support from Prevail Therapeutics. The institution of Dr. Deik Acosta Madiedo has received research support from Lundbeck Therapeutics. The institution of Dr. Deik Acosta Madiedo has received research support from AskBio. The institution of Dr. Deik Acosta Madiedo has received research support from Annovis Bio. The institution of Dr. Deik Acosta Madiedo has received research support from Ono pharmaceuticals. The institution of Dr. Deik Acosta Madiedo has received research support from Amylyx therapeutics. The institution of Dr. Deik Acosta Madiedo has received research support from Dystonia Coalition/Dystonia Medical Research Foundation. Dr. Deik Acosta Madiedo has received publishing royalties from a publication relating to health care. Dr. Deik Acosta Madiedo has received publishing royalties from a publication relating to health care. Dr. Deik Acosta Madiedo has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with PeerView CME.
Atlantic Dsouza, MD	No disclosure on file
Andrew Russo	Andrew Russo has nothing to disclose.
Reem Deeb, MD	No disclosure on file
Alexander Kolevzon	Alexander Kolevzon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ovid Therapeutics. Alexander Kolevzon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Alexander Kolevzon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ovid Therapeutics. Alexander Kolevzon has received stock or an ownership interest from Ovid Therapeutics. The institution of Alexander Kolevzon has received research support from AMO Pharma. Alexander Kolevzon has received publishing royalties from a publication relating to health care.
Fiona E. Costello, MD	Dr. Costello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Accure Therapeutics. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for the Sumaira Foundation.
Nerses Sanossian, MD, FAAN	Dr. Sanossian has received personal compensation for serving as an employee of Univeristy of Southern California. Dr. Sanossian has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Sanossian has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Sanossian has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Portola. The institution of Dr. Sanossian has received research support from Diffusion Pharma.
Andrew C. Schomer, MD	No disclosure on file
Giulia Frasca Polara, MD	No disclosure on file
Peter Lynch	No disclosure on file
Elizabeth McCuaig	No disclosure on file
Celia McIntosh, NP	Dr. McIntosh has received personal compensation for serving as an employee of Rochester Regional Health . Dr. McIntosh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Rochester Regional Coalition Against Human Trafficking .
Michel T. Torbey, MD, MPH, FAAN	Dr. Torbey has nothing to disclose.
Frederic Assal, MD	Dr. Assal has nothing to disclose.
Tatiana Foroud, PhD	The institution of Dr. Foroud has received research support from NIH. The institution of Dr. Foroud has received research support from Michael J. Fox Foundation. The institution of Dr. Foroud has received research support from Parkinson Foundation. Dr. Foroud has received personal compensation in the range of $500-$4,999 for serving as a Member of an Advisory Committee with Mayo Clinic, University of Pennsylvania, Allen Institute, Mt. Sinai, Van Andel Institute.
Christian Czech, PhD	No disclosure on file
Anteneh M. Feyissa, MD, MSc, FAAN	Dr. Feyissa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis.
S. A. Josephson, MD, FAAN	Dr. Josephson has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Josephson has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for McGraw Hill---Harrison's Principles of Internal Medicine. Dr. Josephson has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various legal firms. The institution of Dr. Josephson has received research support from NINDS. Dr. Josephson has received publishing royalties from a publication relating to health care. Dr. Josephson has received publishing royalties from a publication relating to health care.
Robert A. Bermel, MD, FAAN	Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Bermel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Bermel has received research support from Biogen. The institution of Dr. Bermel has received research support from Roche. The institution of Dr. Bermel has received research support from Novartis. Dr. Bermel has received intellectual property interests from a discovery or technology relating to health care.
Haya Glick-Shames, PhD	No disclosure on file
Todd D. Rozen, MD, FAAN	No disclosure on file
Andrea L. Gropman, MD, FAAN	Dr. Gropman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Baylor Mirica. Dr. Gropman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Immedica. Dr. Gropman has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various legal firms. The institution of Dr. Gropman has received research support from National Institutes of Health.
Laura A. Adang, MD	Dr. Adang has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Orchard Therapeutics.
Roman M. Kassa, MD	Dr. Kassa has nothing to disclose.
Pritikanta Paul, MD	The institution of Dr. Paul has received research support from ZS Associates.
Robyn Weijma, MD	No disclosure on file
Elizabeth Donley, JD, MBA, MS	No disclosure on file
Anne C. Roc, PhD	No disclosure on file
Annette M. Langer-Gould, MD, PhD	An immediate family member of Dr. Langer-Gould has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of American Thoracic Society. The institution of Dr. Langer-Gould has received research support from PCORI. The institution of an immediate family member of Dr. Langer-Gould has received research support from PCORI, ARQ, NIH. Dr. Langer-Gould has a non-compensated relationship as a Voting Member with ICER CTAF Panel that is relevant to AAN interests or activities.
Leo H. Wang, MD, PhD, FAAN	Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AskBio. Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Fulcrum Therapeutics. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Wang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Wang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Avidity. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lupin. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. The institution of Dr. Wang has received research support from National Institute of Health. Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with US Government.
Tanja Hojs Fabjan, MD	No disclosure on file
Vaibhav Goswami, MD	Dr. Goswami has nothing to disclose.
Jessica L. Coleman	No disclosure on file
Kwang I. Yang, MD	No disclosure on file
James V. Lee, MD	No disclosure on file
Kasun I. Navarathna, MD	Dr. Navarathna has nothing to disclose.
Korhan Buyukturkoglu, PhD	Dr. Buyukturkoglu has nothing to disclose.
Robin Bansal, DM	No disclosure on file
Fatma Gokcem Yildiz	No disclosure on file
Haitham Hussein, MD, FAAN	Dr. Hussein has nothing to disclose.
Jamie K. Capal, MD	Dr. Capal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CTI Clinical Trials. Dr. Capal has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Intellectual Disability Research. The institution of Dr. Capal has received research support from NIH. The institution of Dr. Capal has received research support from Roche . The institution of Dr. Capal has received research support from Ionis.
Afra Janarious, MD	Dr. Janarious has nothing to disclose.
Mark A. Ross, MD, FAAN	No disclosure on file
Paul Mattis	Paul Mattis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Meiragtx.
Alessandro d'Ambrosio	Alessandro d'Ambrosio has nothing to disclose.
Cosette M. Burian, PA	No disclosure on file
Christopher Tarolli, MD, FAAN	Dr. Tarolli has received personal compensation for serving as an employee of University of Rochester. The institution of Dr. Tarolli has received research support from National Institutes of Health. The institution of Dr. Tarolli has received research support from Biogen. The institution of Dr. Tarolli has received research support from Neuron23. Dr. Tarolli has received personal compensation in the range of $500-$4,999 for serving as a Speaker, Committee Member with ��ɫ��. Dr. Tarolli has received personal compensation in the range of $500-$4,999 for serving as a Committee member with National Board of Medical Examiners. Dr. Tarolli has a non-compensated relationship as a Committee Member with ��ɫ�� that is relevant to AAN interests or activities.
Marcos C. Lange, MD	No disclosure on file
Darshan Pandya, MD	Dr. Pandya has nothing to disclose.
Shauna Cheung, MD	Dr. Cheung has nothing to disclose.
Zachery Rohm, MD	Dr. Rohm has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Rohm has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Rohm has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for City of Chicago.
Hanim Kwon, MD	No disclosure on file
Matheus K. Pedro, MD	Dr. Pedro has nothing to disclose.
Bryan E. Tsao, MD, FAAN	Dr. Tsao has received publishing royalties from a publication relating to health care.
Bruce Hermann, PhD	Bruce Hermann, PhD has nothing to disclose.
Viviane H. Zetola, MD	Dr. Zetola has nothing to disclose.
Nuria Muelas	Nuria Muelas has nothing to disclose.
Harold J. Weinberg, MD	Dr. Weinberg has nothing to disclose.
Brett Skolnick, PhD	No disclosure on file
George C. Newman, MD, PhD	Dr. Newman has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Clyde Bergstresser, LLC. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Maria Rubio LLC. The institution of Dr. Newman has received research support from Albert Einstein Society.
Jayantee Kalita, MD	No disclosure on file
Fabien Scalzo, PhD	Prof. Scalzo has nothing to disclose.
Peter Brunner	No disclosure on file
Daniel Miller, MD	Dr. Miller has nothing to disclose.
Patrick Hautecoeur	No disclosure on file
Teerin Liewluck, MD, FAAN	Dr. Liewluck has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta Therapeutics. Dr. Liewluck has received publishing royalties from a publication relating to health care.
Alexandra Urban, MD, FAAN	Dr. Urban has received personal compensation in the range of $0-$499 for serving as a Consultant for Neuropace. Dr. Urban has received personal compensation in the range of $0-$499 for serving as a Consultant for LivaNova.
Fumihiro Yanagimura	No disclosure on file
Meghan D. Caulfield, PhD	No disclosure on file
May A. Kim-Tenser, MD, MHA, FAHA	Dr. Kim-Tenser has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chiesi.
Meral Tubi	No disclosure on file
Kristine Woodward, MD	No disclosure on file
Donna M. Wilcock, PhD	Dr. Wilcock has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AC Immune. Dr. Wilcock has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alector. Dr. Wilcock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AvroBio. Dr. Wilcock has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neuroscience.
Noemi Piramide, MSc	Noemi Piramide has nothing to disclose.
Florian Lipsmeier	No disclosure on file
Matthew Tenser, MD	No disclosure on file
Julia O'Mahony	Ms. O'Mahony has nothing to disclose.
Sigal Melamed-Gal	No disclosure on file
Siddharth Gupta, MD	No disclosure on file
Jamila Godil	No disclosure on file
Serena Soleimani, DO	Dr. Soleimani has nothing to disclose.
Eelco F. Wijdicks, MD, FAAN	Dr. Wijdicks has received publishing royalties from a publication relating to health care.
Carmela Tartaglia, MD	Dr. Tartaglia has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Tartaglia has received research support from NIH. The institution of Dr. Tartaglia has received research support from University of Toronto.
Meredith N. Braskie	No disclosure on file
Hitha Amin, MD, MBBS	No disclosure on file
Dagny N. Holle, MD	Dr. Holle has nothing to disclose.
Benjamin Emanuel, DO	Dr. Emanuel has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Reback McAndrews Blessey.
Marcus Cimino, MD	No disclosure on file
Jan A. Koper	No disclosure on file
Jerzy P. Szaflarski, MD, PhD, FAAN	Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova Inc. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Gidley, Sarli & Marusak, LLP. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firm. Dr. Szaflarski has stock in AdCel Biopharma, LLC. Dr. Szaflarski has stock in iFovea.
Emma Ciafaloni, MD, FAAN	Dr. Ciafaloni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx, Alexion, Sarepta, UCB, Hoffman-LaRoche, Biogen. Dr. Ciafaloni has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis, AnnJi Pharmaceutical, ML-BIO, Avidity. The institution of Dr. Ciafaloni has received research support from CDC, CureSMA, FDA, Orphazyme, Sarepta, PCORI, Neurogene. Dr. Ciafaloni has received publishing royalties from a publication relating to health care.
Sandra M. Cushner Weinstein	No disclosure on file
Christine Smith	The institution of Dr. Smith has received research support from B.J. and Eve Wilder Excellence in Epilepsy Research Fund. The institution of Dr. Smith has received research support from National Institutes of Health. Dr. Smith has received personal compensation in the range of $100,000-$499,999 for serving as a Staff Physician with Department of Veterans Affairs.
Danielle Takacs, MD	Dr. Takacs has received publishing royalties from a publication relating to health care.
Kledisa Shemsi	Dr. Shemsi has nothing to disclose.
Marcel Severe, MD	No disclosure on file
Guillaume Brion	No disclosure on file
Hae-young Hawong, DO, PhD	Dr. Hawong has nothing to disclose.
Shreya Agarwal	No disclosure on file
Min Kyung Chu, MD, PhD	No disclosure on file
Pippa S. Loupe, PhD	No disclosure on file
Boyd M. Koffman, MD, PhD	Dr. Koffman has nothing to disclose.
Roberto Araujo	No disclosure on file
Ashwin Sakhare	No disclosure on file
John Ney, MD, MPH, FAAN	Dr. Ney has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell. Dr. Ney has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Clinical Practice.
Jun Goto, MD, PhD	No disclosure on file
Maria V. Diaz Rojas, MD	Dr. Diaz Rojas has nothing to disclose.
Alexandria E. Matic, MD	No disclosure on file
Vicki Shanker, MD, FAAN	Dr. Shanker has received personal compensation in the range of $0-$499 for serving as a Consultant for The Insighters.
Allison L. Weathers, MD, FAAN	Dr. Weathers has received personal compensation in the range of $500-$4,999 for serving as a CME question writer, interviewer, presenter with ��ɫ��. Dr. Weathers has a non-compensated relationship as a Chair, Neurology Adult Steering Board with Epic that is relevant to AAN interests or activities. Dr. Weathers has a non-compensated relationship as a Member, Quality Informatics Subcommittee with ��ɫ�� that is relevant to AAN interests or activities. Dr. Weathers has a non-compensated relationship as a Member of the NCP Editorial Board with ��ɫ�� that is relevant to AAN interests or activities.
Spyridon Papapetropoulos, MD, PhD	Dr. Papapetropoulos has received personal compensation for serving as an employee of Vigil Neuroscience . Dr. Papapetropoulos has received personal compensation for serving as an employee of Bionomics Ltd. Dr. Papapetropoulos has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Lipocine Inc. Dr. Papapetropoulos has stock in Vigil Neuroscience. Dr. Papapetropoulos has stock in Lipocine. Dr. Papapetropoulos has stock in Bionomics Ltd.
Eric Mariuma, MD	Dr. Mariuma has nothing to disclose.
Maria Gaughan, MBBS	Dr. Gaughan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Gaughan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Gaughan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Gaughan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck.
Colm Elliott	Colm Elliott has received personal compensation for serving as an employee of NeuroRx Research.
Stephan Eisenschenk, MD	Dr. Eisenschenk has nothing to disclose.
Aftab Alam	No disclosure on file
Ryan T. Brennan, DO	Dr. Brennan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie.
Cynthia Correll, MD	Dr. Correll has nothing to disclose.
Faisal Rashid	No disclosure on file
Sophia I. Thomopoulos	No disclosure on file
Rebecca Bernheimer	No disclosure on file
Chae Won Shin, MD	No disclosure on file
John-Michael Li, MD	No disclosure on file
Muhammad Taimur A. Malik, MD	Dr. Malik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genetech . Dr. Malik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jansen . Dr. Malik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD serono. The institution of Dr. Malik has received research support from National MS Society .
Latanya Agurs, MD	Dr. Agurs has nothing to disclose.
Adam B. Lewis, MD	Dr. Lewis has received personal compensation in the range of $100,000-$499,999 for serving as a Brain Health Research Coordinator with U.S. Army.
Eric S. Lee	No disclosure on file
Alex Baeta	Alex Baeta has nothing to disclose.
Robert Beach, MD, PhD, FAAN	The institution of Dr. Beach has received research support from Neurona.
Michael Grundman, MD, MPH	Dr. Grundman has received personal compensation for serving as an employee of Global R&D Partners.
Martin Koller, MD, MPH	No disclosure on file
Paul T. Twydell, DO, FAAN	Dr. Twydell has received publishing royalties from a publication relating to health care.
Lenore J. Launer, PhD	No disclosure on file
Etsuji Saji, MD, PhD	No disclosure on file
Krishnamoorthy Kuppusamy, Jr., MD	No disclosure on file
Brinder Vij, MD	Dr. Vij has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie/Allergan. Dr. Vij has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven .
Bruce A. Cree, MD, PhD, MAS, FAAN	The institution of Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuron23. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal/Sandoz. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. The institution of Dr. Cree has received research support from Genentech. The institution of Dr. Cree has received research support from Kyverna. Dr. Cree has received publishing royalties from a publication relating to health care.
Jennifer S. Kriegler, MD	Dr. Kriegler has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for DynaMed. The institution of Dr. Kriegler has received research support from Teva.
Bradley Jacobs, MD, MS, FAAN	Dr. Jacobs has nothing to disclose.
Lawrence Steinman, MD, FAAN	Dr. Steinman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for 180 Life Sciences. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for BioAtla. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Pasithea. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Atreca. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Wilmer Hale Cutler Pickering. Dr. Steinman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Steinman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Steinman has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for National Academy of Sciences. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Gibson Dunn. The institution of Dr. Steinman has received research support from Roche. The institution of Dr. Steinman has received research support from Novartis. Dr. Steinman has received intellectual property interests from a discovery or technology relating to health care.
Martin Weygandt, PhD	No disclosure on file
Jan Krasensky, MD	No disclosure on file
Arielle M. Kurzweil, MD, FAAN	Dr. Kurzweil has nothing to disclose.
Sankar P. Gorthi, MD, FAAN	Dr. Gorthi has nothing to disclose.
Zachary M. Newcomer, DO	Dr. Newcomer has nothing to disclose.
Laurianne R. Garabed	No disclosure on file
Scott Woolf, DO	No disclosure on file
Jose E. Cavazos, MD, PhD	Dr. Cavazos has received stock or an ownership interest from Brain Sentinel . The institution of Dr. Cavazos has received research support from NIH.
Shoji Tsuji, MD, PhD	The institution of Dr. Tsuji has received research support from Novelpharma Co. Ltd..
Maria Hella, MD	Dr. Hella has nothing to disclose.
Vijay K. Ramanan, MD, PhD	The institution of Dr. Ramanan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Daridorexant trial for AD prevention (funded by Weston Family Foundation). The institution of Dr. Ramanan has received research support from the National Institutes of Health. The institution of Dr. Ramanan has received research support from the Mangurian Foundation for Lewy Body Disease Research. The institution of Dr. Ramanan has received research support from as part of clinical trials sponsored by the Alzheimer's Association, Eisai, the Alzheimer's Treatment and Research Institute at USC, and Transposon Therapeutics, Inc.. The institution of Dr. Ramanan has received research support from Medscape. The institution of Dr. Ramanan has received research support from Expert Perspectives in Medicine. The institution of Dr. Ramanan has received research support from Roche/ADLM. The institution of Dr. Ramanan has received research support from American College of Radiology. Dr. Ramanan has received personal compensation in the range of $500-$4,999 for serving as a Conference Speaker/Organizer (Honoraria) with AANI. Dr. Ramanan has received personal compensation in the range of $500-$4,999 for serving as a Speaker/CME Content with Clinical Care Options.
Sireesha Chinthaparthi, MD	No disclosure on file
Kristen Malloy	No disclosure on file
Eric Waldron	No disclosure on file
Michelle L. Mauermann, MD, FAAN	The institution of Dr. Mauermann has received research support from Intellia. Dr. Mauermann has received publishing royalties from a publication relating to health care.
Joanna S. Fong-Isariyawongse, MD, FAAN	Dr. Fong-Isariyawongse has nothing to disclose.
Chelsea S. Chen	Ms. Chen has nothing to disclose.
Julia Rybkina	No disclosure on file
André Luiz Guimarães de Queiroz	André Luiz Guimarães de Queiroz has nothing to disclose.
Princy Malhi	No disclosure on file
Charles D. Smith, MD, FAAN	No disclosure on file
Joseph M. Savitt, MD, PhD	The institution of Dr. Savitt has received research support from Bial. The institution of Dr. Savitt has received research support from UCB.
Lisa Wolfe, MD	No disclosure on file
Kristie Chu, MD	No disclosure on file
Ana C. Albuja, MD	No disclosure on file
Jonathan D. Thomas, MD	No disclosure on file
Jessica P. Ng, MD	Dr. Ng has nothing to disclose.
Alexander Kalin	Alexander Kalin has received personal compensation for serving as an employee of Mitsubishi Tanabe Pharma America, Inc..
Nilesh Desai	The institution of Nilesh Desai has received research support from NIH.
Soo-Jin Cho, MD	No disclosure on file
Huned S. Patwa, MD, FAAN	No disclosure on file
Kevin M. Barrett, MD, FAAN	Dr. Barrett has nothing to disclose.
Doris A. Trauner, MD	No disclosure on file
Ursula Bellugi	No disclosure on file
Talyta Grippe, MD	Dr. Grippe has nothing to disclose.
Harish Jayakumar, MD MRCP DM DNB FRCP FEBN PDF, FAAN	No disclosure on file
Rhonda Voskuhl, MD	Dr. Voskuhl has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for CleopatraRX. Dr. Voskuhl has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for CleopatraRX. Dr. Voskuhl has or had stock in CleopatraRX. The institution of Dr. Voskuhl has received research support from NIH. The institution of Dr. Voskuhl has received research support from Conrad N Hilton Foundation. Dr. Voskuhl has received intellectual property interests from a discovery or technology relating to health care.
Juha-Pekka Eralinna, MD, PhD	No disclosure on file
Ji Y. Yun, MD	Dr. Yun has nothing to disclose.
Francesca Sangalli	No disclosure on file
H. C. Diener, MD, FAAN	Dr. Diener has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme. The institution of Dr. Diener has received research support from German Research Council.
Kimiko Domoto-Reilly, MD	Dr. Domoto-Reilly has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MedBridge. The institution of Dr. Domoto-Reilly has received research support from Lawson Health Research Institute. The institution of Dr. Domoto-Reilly has received research support from NIH. The institution of Dr. Domoto-Reilly has received research support from Biogen. The institution of Dr. Domoto-Reilly has received research support from Lewy Body Dementia Association. The institution of Dr. Domoto-Reilly has received research support from Garvey Institute for Brain Health Solutions. The institution of Dr. Domoto-Reilly has received research support from Cognition Therapeutics. The institution of Dr. Domoto-Reilly has received research support from Takayama Family.
Elisabeth B. Marsh, MD, FAAN	Dr. Marsh has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ��ɫ��. Dr. Marsh has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Neurological Association. Dr. Marsh has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke. Dr. Marsh has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ACTN. The institution of Dr. Marsh has received research support from American Heart Association. The institution of Dr. Marsh has received research support from National Institutes of Health. The institution of Dr. Marsh has received research support from National Institutes of Health.
Adrienne M. Keener, MD	Dr. Keener has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie.
Phi N. Luong	No disclosure on file
Akatsuki Kubota	No disclosure on file
Rahul H. Rahangdale, MD	Dr. Rahangdale has nothing to disclose.
S. Pablo Sardi, PhD	Dr. Sardi has received personal compensation for serving as an employee of Sanofi. The institution of Dr. Sardi has received research support from MJFF.
Jared Sweeney	No disclosure on file
Diego Torres-Russotto, MD, FAAN	Dr. Torres-Russotto has received personal compensation for serving as an employee of Movement Disorders Consulting, Inc. The institution of Dr. Torres-Russotto has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acorda. The institution of Dr. Torres-Russotto has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. The institution of Dr. Torres-Russotto has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. The institution of Dr. Torres-Russotto has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Revance. The institution of Dr. Torres-Russotto has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Anneal. Dr. Torres-Russotto has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acorda. Dr. Torres-Russotto has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for IPSEN. Dr. Torres-Russotto has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Torres-Russotto has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie. The institution of Dr. Torres-Russotto has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine. Dr. Torres-Russotto has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Your Nest Asset Solutions, LLC. Dr. Torres-Russotto has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Bright Future Asset Solutions, LLC.
Lawrence J. Hirsch, MD, FAAN	Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ceribell. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for marinus. The institution of Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Natus. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rapport Therapeutics. Dr. Hirsch has received publishing royalties from a publication relating to health care. Dr. Hirsch has received publishing royalties from a publication relating to health care. Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker; Faculty for Fellows' training course with Neuropace. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Natus.
Jayawant N. Mandrekar, PhD	Dr. Mandrekar has nothing to disclose.
Paul Fu, MD	No disclosure on file
Aristides Hadjinicolaou, MD	Dr. Hadjinicolaou has nothing to disclose.
Irina Sharinova	No disclosure on file
Danny Bega, MD	Dr. Bega has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GE Healthcare. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WebMD. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva Pharmaceuticals. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Acorda Therapeutics. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine Biosciences. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus Pharmaceuticals. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ACTN / ANA. The institution of Dr. Bega has received research support from Huntington Disease Society of America. The institution of Dr. Bega has received research support from Parkinson Foundation.
Saima Chaudhry, MD	Dr. Chaudhry has nothing to disclose.
Melody Gilroy, BS	Ms. Gilroy has nothing to disclose.
Valentina Garibotto	No disclosure on file
Jeannie Visootsak	No disclosure on file
Peter R. Bergethon, MD, FAAN	No disclosure on file
John C. Morris, MD, FAAN	Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CBR International Advisory Board. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cure Alzheimers Fund. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LEADS Steering Commitee. The institution of Dr. Morris has received research support from NIH grants. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care.
Jose M. Trejo, MD	No disclosure on file
Christina L. Szperka, MD, FAAN	The institution of Dr. Szperka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. The institution of Dr. Szperka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. The institution of Dr. Szperka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Szperka has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Szperka has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Upsher Smith. The institution of Dr. Szperka has received research support from PCORI. Dr. Szperka has a non-compensated relationship as a Cochair Scientific Committee with American Headache Society that is relevant to AAN interests or activities.
Brandon Francis, MD	Dr. Francis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovian. Dr. Francis has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Montgomery and Associates.
Karen S. Marder, MD, MPH, FAAN	Dr. Marder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Marder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Marder has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Parkinson's Foundation . Dr. Marder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CHDI. Dr. Marder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC therapeutics. Dr. Marder has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer LTD. The institution of Dr. Marder has received research support from Vaccinex. The institution of Dr. Marder has received research support from Genentech. The institution of Dr. Marder has received research support from Triplet Therapeutics. The institution of Dr. Marder has received research support from Prilenia.
Aashit K. Shah, MD, FAAN	Dr. Shah has stock in Abbot, Abbivie, Gilead, Johnson and Johnson, Pfizer. The institution of Dr. Shah has received research support from Xenon Pharma.
Maria A. Rocca	Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Murali Ramanathan, PhD	The institution of Dr. Ramanathan has received research support from DoD. Dr. Ramanathan has received publishing royalties from a publication relating to health care.
Elif Bayraktar	No disclosure on file
Joseph G. Nugent, MHS, CRT-I	No disclosure on file
Calixto Machado, MD, PhD, FAAN	Dr. Machado has nothing to disclose.
Boulenouar Mesraoua, MD, FAAN	Dr. Mesraoua has nothing to disclose.
Ellen Carl, MS	No disclosure on file
Michelle Bell, MD	Dr. Bell has nothing to disclose.
Natalya Shneyder, MD	Dr. Shneyder has nothing to disclose.
Marina K. Alvim	Dr. Alvim has nothing to disclose.
Ali Mahta, MD	Dr. Mahta has received research support from Brown University Health.
Brian Mac Grory, MB BCh BAO	An immediate family member of Dr. Mac Grory has received personal compensation for serving as an employee of Sanofi. Dr. Mac Grory has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke. The institution of Dr. Mac Grory has received research support from National Institutes of Health. The institution of Dr. Mac Grory has received research support from American Heart Association.
Shipra Dubey	Shipra Dubey has nothing to disclose.
Kenneth Hayashida	Kenneth Hayashida has nothing to disclose.
Bernardo C. De Almeida Teixeira, MD	No disclosure on file
Rahul Guha, MD	Dr. Guha has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Experienced Neurology Consulting.
Anam Syed, DO	Dr. Syed has nothing to disclose.
Neil R. Holland, MBBS, FAAN	Dr. Holland has nothing to disclose.
James Connor, PhD	No disclosure on file
Marcia E. Morita-Sherman, MD	An immediate family member of Dr. Morita-Sherman has received personal compensation for serving as an employee of Forrester Research. Dr. Morita-Sherman has received personal compensation for serving as an employee of Eisai Inc.. An immediate family member of Dr. Morita-Sherman has stock in Forrester Research. The institution of Dr. Morita-Sherman has received research support from Cleveland Clinic.
David Callen, MD	No disclosure on file
Peter A. Calabresi, MD, FAAN	Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. An immediate family member of Dr. Calabresi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MyMD. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Myelin Repair Foundation. The institution of Dr. Calabresi has received research support from Genentech. Dr. Calabresi has received publishing royalties from a publication relating to health care. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Grant reveiwer with Myelin Repair Foundation. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker for CME with NYAS. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Academic CME.
Jelena M. Pavlovic, MD, PhD	Dr. Pavlovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven.
Amrinder Singh, MD	No disclosure on file
Jong-Ling Fuh, MD, FAAN	Dr. Fuh has nothing to disclose.
Dirk T. Deleu, MD, PhD, FRCP, FAAN	Dr. Deleu has nothing to disclose.
Kathleen Poston, MD, FAAN	Dr. Poston has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Curasen Therapeutics, INC. Dr. Poston has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Amprion, INC. Dr. Poston has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Poston has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders Journal. Dr. Poston has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. Dr. Poston has stock in Curasen Therapeutics, INC. Dr. Poston has stock in Amprion, INC. The institution of Dr. Poston has received research support from NIH. The institution of Dr. Poston has received research support from Michael J Fox Foundation. The institution of Dr. Poston has received research support from Alzheimer's Drug Discovery Foundation . The institution of Dr. Poston has received research support from Lewy Body Dementia Association. Dr. Poston has received intellectual property interests from a discovery or technology relating to health care.
David Hojnacki, MD, FAAN	Dr. Hojnacki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Hojnacki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Hojnacki has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Federica Agosta	Federica Agosta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philips. Federica Agosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier INC.
Kiran S. Para	No disclosure on file
Veena Mathew	No disclosure on file
Jeffrey Bakal	Jeffrey Bakal has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association.
Robert J. Fox, MD, FAAN	Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria Biologica. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InnoCare Pharma. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Fox has received research support from National Institutes of Health. The institution of Dr. Fox has received research support from National MS Society. Dr. Fox has received publishing royalties from a publication relating to health care.
Jessica K. Alexander, PhD	Jessica K. Alexander has received personal compensation for serving as an employee of Teva Pharmaceuticals. Jessica K. Alexander has received stock or an ownership interest from Teva Pharmaceuticals.
Luiz E. Betting	Dr. Betting has nothing to disclose.
Cary L. Twyman, MD, FAAN	No disclosure on file
Yi Wang, PhD	Prof. Wang has received intellectual property interests from a discovery or technology relating to health care.
Belen Pascual, PhD	The institution of Prof. Pascual has received research support from NIH. The institution of Prof. Pascual has received research support from NIH.
Bruce L. Miller, MD, FAAN	Dr. Miller has nothing to disclose.
Ricardo C. Reisin, MD	Dr. Reisin has nothing to disclose.
Spozhmy Panezai, MD	Dr. Panezai has nothing to disclose.
Ali H Mannaa	No disclosure on file
Francesco Gavazzi, MD, MD, PhD	The institution of Dr. Gavazzi has received research support from NIH. The institution of Dr. Gavazzi has received research support from NIH, NINDS. The institution of Dr. Gavazzi has received research support from IONIS Pharmaceuticals.
James J. Gugger, Jr., MD, PharmD	Dr. Gugger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ceribell. The institution of Dr. Gugger has received research support from American Epilepsy Society.
Linda D. Lewis, MD, FAAN	No disclosure on file
David Eidelberg, MD, FAAN	Dr. Eidelberg has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for MeiraGTx. Dr. Eidelberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TreeFrog Therapeutics. Dr. Eidelberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Blue Rock Therapeutics, Inc.. Dr. Eidelberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SANA Biotechnology, Inc. Dr. Eidelberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bio Vie, Inc.. Dr. Eidelberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for KenaiTx, Inc.. Dr. Eidelberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aspen Neuroscience. Dr. Eidelberg has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Oxford University Press. The institution of Dr. Eidelberg has received research support from The Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Eidelberg has received research support from Lupus Research Alliance. The institution of Dr. Eidelberg has received research support from National Institutes of Health. The institution of Dr. Eidelberg has received research support from Blue Rock Therapeutics. The institution of Dr. Eidelberg has received research support from National Institute of Neurological Disorders and Stroke. The institution of Dr. Eidelberg has received research support from The Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Eidelberg has received research support from National Institute of Allergy and Infectious Diseases. The institution of Dr. Eidelberg has received research support from Aspen Neurosciences, Inc. . The institution of Dr. Eidelberg has received research support from NIH. Dr. Eidelberg has received intellectual property interests from a discovery or technology relating to health care. Dr. Eidelberg has received intellectual property interests from a discovery or technology relating to health care.
James R. Williams III, PhD	Dr. Williams has received personal compensation for serving as an employee of Biogen. Dr. Williams has received stock or an ownership interest from Biogen.
Ryan D. Jacobson, MD	Dr. Jacobson has nothing to disclose.
Deborah Y. Bradshaw, MD, FAAN	The institution of Dr. Bradshaw has received research support from Cytokinetics. Dr. Bradshaw has received publishing royalties from a publication relating to health care.
Netta Levin, MD, PhD	Dr. Levin has nothing to disclose.
Alaleh Raji, MD	No disclosure on file
Rebecca Romero, MD, FAAN	Dr. Romero has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Romero has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics . Dr. Romero has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Romero has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon.
Dustin A. Heldman, PhD	Dr. Heldman has received personal compensation for serving as an employee of Great Lakes NeuroTechnologies Inc.. Dr. Heldman has stock in Great Lakes NeuroTechnologies. The institution of Dr. Heldman has received research support from NIH.
Laurel J. Cherian, MD, FAAN	The institution of Dr. Cherian has received research support from NIH.
Khalid S. Alqadi, MD	No disclosure on file
Joel C. Morgenlander, MD, FAAN	Dr. Morgenlander has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Duke University.
Michael G. Harrington, MD	No disclosure on file
Michael T. Pulley, MD, PhD, FAAN	Dr. Pulley has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Pulley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MT Pharma. Dr. Pulley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amylyx. Dr. Pulley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Pulley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for csl/behring. Dr. Pulley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cabaletta. Dr. Pulley has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Multiple law firms.
Dimos Dimitrios D. Mitsikostas, MD, PhD	The institution of Dr. Mitsikostas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. The institution of Dr. Mitsikostas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Mitsikostas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. The institution of Dr. Mitsikostas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Leli Lilly. The institution of Dr. Mitsikostas has received research support from Eli Lilly. Dr. Mitsikostas has a non-compensated relationship as a Co-Chair of Headache Panel with EAN that is relevant to AAN interests or activities. Dr. Mitsikostas has a non-compensated relationship as a President with Hellenic Headache Society that is relevant to AAN interests or activities. Dr. Mitsikostas has a non-compensated relationship as a Associate Editor with J Headache Pain that is relevant to AAN interests or activities. Dr. Mitsikostas has a non-compensated relationship as a Associate Editor with Frontier Neurology that is relevant to AAN interests or activities.
Kyle B. Womack, MD	The institution of Dr. Womack has received research support from NIH. The institution of Dr. Womack has received research support from Janssen.
Tadeu Fantaneanu, MD	Dr. Fantaneanu has nothing to disclose.
Ilia Itin, MD	No disclosure on file
Hassan Jassim Al Hail, MD, FAAN	Dr. Al Hail has nothing to disclose.
Lon Schneider, MD	Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AC Immue. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biovie. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Athira. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alpha-cognition. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Corium. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cortexyme. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurim Ltd. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Otsuka. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. The institution of Dr. Schneider has received research support from NIH. The institution of Dr. Schneider has received research support from Eli Lilly. The institution of Dr. Schneider has received research support from Biogen. The institution of Dr. Schneider has received research support from Biohaven.
Chin-Sang Chung, MD, PhD	No disclosure on file
Arsalan Ahmad, MD	Dr. Ahmad has received stock or an ownership interest from Shifa International Hospitals Limited (Current employer).
Nicholas B. Galifianakis, MD	Dr. Galifianakis has nothing to disclose.
Mi-Ji Lee, MD	Dr. Lee has nothing to disclose.
Nicolas Gaspard, MD, PhD	The institution of Prof. Gaspard has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bioserenity. The institution of Prof. Gaspard has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Angelini. The institution of Prof. Gaspard has received research support from Fonds pour la Recherche Scientifique.
Karen L. Furie, MD	The institution of Dr. Furie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen/BMS. Dr. Furie has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMJ/JNNP. The institution of Dr. Furie has received research support from NINDS.
Bryan M. Spann, DO, PhD	No disclosure on file
Timothy K. Vartanian, MD, PhD	Dr. Vartanian has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Vartanian has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Vartanian has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Vartanian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tisch MS Center. Dr. Vartanian has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen.
Massimo Filippi, MD, FAAN	Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Mya C. Schiess, MD, FAAN	Dr. Schiess has nothing to disclose.
David M. Ermak, DO	Dr. Ermak has nothing to disclose.
Michael E. Goldberg, MD	No disclosure on file
Ken Ikeda, MD, PhD	No disclosure on file
Omar M. Wazzan, MD	No disclosure on file
Genevieve Bernard, MD	Dr. Bernard has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Calico. Dr. Bernard has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Orchard Therapeutics. Dr. Bernard has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for N/A. The institution of Dr. Bernard has received research support from Canadian Institutes of Health Research. The institution of Dr. Bernard has received research support from Montreal Children's Foundation. The institution of Dr. Bernard has received research support from Yaya Foundation for 4H Leukodystrophy. The institution of Dr. Bernard has received research support from Fondation Les Amis d'Elliot. The institution of Dr. Bernard has received research support from Ionis. Dr. Bernard has a non-compensated relationship as a Member of the Scientific Advisory Board with Pelizaeus-Merzbacher Foundation that is relevant to AAN interests or activities. Dr. Bernard has a non-compensated relationship as a Member of the Medical and Scientific Advisory Board with United Leukodystrophy Foundation that is relevant to AAN interests or activities. Dr. Bernard has a non-compensated relationship as a Chair of the Medical and Scientific Advisory Board with United Leukodystrophy Foundation that is relevant to AAN interests or activities. Dr. Bernard has a non-compensated relationship as a Member of the Scientific and Clinical advisory Council with Yaya Foundation that is relevant to AAN interests or activities.
William H. Roth, MD	No disclosure on file
Nicholas D. Osteraas, MD	Dr. Osteraas has nothing to disclose.
Maria Julieta Russo, MD	Dr. Russo has nothing to disclose.
Noriko T. Anderson, MD	Dr. Anderson has nothing to disclose.
Grace A. Zimmerman, MPH	The institution of Ms. Zimmerman has received research support from National Institutes of Health. The institution of Ms. Zimmerman has received research support from Batten Disease Support and Research Association. The institution of Ms. Zimmerman has received research support from Greater Rochester Health Foundation.
Guido D. Vazquez II, PhD	Dr. Vazquez has nothing to disclose.
Fang Ba, MD	Dr. Ba has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. The institution of Dr. Ba has received research support from Social Sciences and Humanities Research Council.
Christina M. Ulane, MD, PhD	Dr. Ulane has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian Therapeutics. The institution of Dr. Ulane has received research support from Cabaletta Bio. The institution of Dr. Ulane has received research support from Arcellx. The institution of Dr. Ulane has received research support from Sanofi.
Frances E. Chow, MD	Dr. Chow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Chow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Chow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Chow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Servier.
Kelly Andrzejewski, DO, PhD	No disclosure on file
Chris Tang, MD	No disclosure on file
David Q. Beversdorf, MD, FAAN	Dr. Beversdorf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Yamo pharmaceuticals. Dr. Beversdorf has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Autism Research Institute. Dr. Beversdorf has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier (Research in Autism Spectrum Disorders). The institution of Dr. Beversdorf has received research support from Autism Research Institute. Dr. Beversdorf has received personal compensation in the range of $5,000-$9,999 for serving as a Case Consultant with Best Doctors.
David C. Reutens, MD	The institution of Dr. Reutens has received research support from Australian Research Council. The institution of Dr. Reutens has received research support from Siemens Health Care. The institution of Dr. Reutens has received research support from Vivazone Pty Ltd. Dr. Reutens has received intellectual property interests from a discovery or technology relating to health care.
Catherine Legault, MD	No disclosure on file
Kalea L. Colletta, DO	Dr. Colletta has nothing to disclose.
Emanuele Ghione, MD	No disclosure on file
Jau-Shin Lou, MD, PhD, FAAN	Dr. Lou has nothing to disclose.
Yasushi Kisanuki, MD, FAAN	Dr. Kisanuki has nothing to disclose.
Matilde Inglese, MD, PhD	Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI GENZYME. Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVARTIS. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK-SERONO. Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MS Journal.
Andrew D. Hershey, MD, PhD, FAAN, FAHS, FAAN	The institution of Dr. Hershey has received personal compensation in the range of $0-$499 for serving as a Consultant for Amgen. The institution of Dr. Hershey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. The institution of Dr. Hershey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. The institution of Dr. Hershey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Upsher-Smith. The institution of Dr. Hershey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. The institution of Dr. Hershey has received research support from Amgen. The institution of Dr. Hershey has received research support from NIH, NINDS. The institution of Dr. Hershey has received research support from Bioahaven. The institution of Dr. Hershey has received research support from Upsher-Smith. Dr. Hershey has received publishing royalties from a publication relating to health care.
Brent P. Goodman, MD	Dr. Goodman has nothing to disclose.
Jun Shimizu, MD, PhD	No disclosure on file
Matthew A. McCoyd, MD	Dr. McCoyd has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. McCoyd has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono.
Ameer Hassan, DO	Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Stryker. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Penumbra. Dr. Hassan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cerenovus. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Viz.ai. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Hassan has received research support from GE Healthcare.
Monica Falautano	Monica Falautano has nothing to disclose.
Rodolfo Savica, MD, PhD, FAAN	The institution of Dr. Savica has received research support from ACADIA Pharmaceuticals, Inc.
Blake E. Senay, DO	No disclosure on file
Christopher A. Brown, MD, PhD	The institution of Dr. Brown has received research support from National Institute of Health.
Diego Silva, MD, PhD	No disclosure on file
Padmaja Sudhakar, MD	Dr. Sudhakar has nothing to disclose.
Laura Donovan, MD	Dr. Donovan has nothing to disclose.
Julie A. Fields, PhD	The institution of Dr. Fields has received research support from National Institutes of Health. The institution of Dr. Fields has received research support from Patient-Centered Outcomes Research Institute.
Dejan Jakimovski, MD, PhD	Dr. Jakimovski has nothing to disclose.
Nouf S. Al-Faidi, MD	Dr. Al-Faidi has nothing to disclose.
Tijil Agarwal, MD	Dr. Agarwal has nothing to disclose.
Ivan Cuesta Isabel, MD	No disclosure on file
Rima Dafer, MD	Dr. Dafer has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Dafer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Dafer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Anderson, Rasor, and partners.
Nupur Ghoshal, MD, PhD	No disclosure on file
MaryKay A. Pavol, PhD	Dr. Pavol has nothing to disclose.
Daniel M. Togasaki, MD, PhD	No disclosure on file
Alexis D. Boro, MD	Dr. Boro has nothing to disclose.
Cheran Elangovan, MD	Dr. Elangovan has nothing to disclose.
Suhayl S. Dhib-Jalbut, MD, FAAN	No disclosure on file
Alfredo Thomson, MD	Dr. Thomson has nothing to disclose.
Laura Nist, MD, FAAN	Dr. Nist has nothing to disclose.
Kiyokazu Kawabe, MD	No disclosure on file
Jeremy K. Cutsforth-Gregory, MD, FAAN	Dr. Cutsforth-Gregory has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Cutsforth-Gregory has received publishing royalties from a publication relating to health care.
Deena Nasr, DO	Dr. Nasr has nothing to disclose.
Jorge Campos, MD	No disclosure on file
Yash Jalundhwala, PhD	Dr. Jalundhwala has received personal compensation for serving as an employee of AbbVie . An immediate family member of Dr. Jalundhwala has received personal compensation for serving as an employee of AbbVie . Dr. Jalundhwala has received stock or an ownership interest from AbbVie.
Judy Pa, PhD	No disclosure on file
Lamya Shihabuddin, PhD	No disclosure on file
Lamar Davis, MD	Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen MA Inc.
Michael J. Schneck, MD, FAAN	An immediate family member of Dr. Schneck has received personal compensation for serving as an employee of Cellcarta. Dr. Schneck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for HLT Medical. Dr. Schneck has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Miscellaneous legal firms. Dr. Schneck has stock in Baxter Labs. The institution of Dr. Schneck has received research support from NIH.
Hamza I. Maqsood, MD	Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Jong W. Lee, MD, PhD	The institution of Dr. Lee has received research support from NIH. The institution of Dr. Lee has received research support from NIH. The institution of Dr. Lee has received research support from UCB. Dr. Lee has received personal compensation in the range of $10,000-$49,999 for serving as a Contract work with Teladoc.
Pariwat Thaisetthawatkul, MD, FAAN	Dr. Thaisetthawatkul has nothing to disclose.
Clotilde Balucani, MD, PhD	Dr. Balucani has nothing to disclose.
Peter T. Nelson	Peter T. Nelson has nothing to disclose.
Carla E. Santiago-Martinez	Ms. Santiago-Martinez has nothing to disclose.
Calli L. Cook, DNP, FNP-C, DAAN, FAAN	Dr. Cook has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Cook has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Dr. Cook has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer . Dr. Cook has a non-compensated relationship as a Board Member with Alliance for Patient Access that is relevant to AAN interests or activities.
Yasmeen Rauf, MBBS	Dr. Rauf has nothing to disclose.
Annalena Venneri, PhD	No disclosure on file
Joseph Grieco, PhD	No disclosure on file
Hao Zhang, PhD	No disclosure on file
Alfred Fonteh	No disclosure on file
Michael M. Dowling, MD, PhD, FAAN	Dr. Dowling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. Dr. Dowling has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NHLBI. The institution of Dr. Dowling has received research support from NIH.
David Sulzer, PhD	No disclosure on file
Ryan M. Smith, DO, FAAN	Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie.
Timothy Lynch, MD	Dr. Lynch has nothing to disclose.
Shuu-Jiun Wang, MD	Dr. Wang has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli-Lilly. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Norvatis. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie. Dr. Wang has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Pfizer, Taiwan. The institution of Dr. Wang has received research support from Eli-Lilly. The institution of Dr. Wang has received research support from Norvatis.
Esther Cubo Delgado, MD, PhD, FAAN	Dr. Cubo Delgado has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Cubo Delgado has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Zambon. Dr. Cubo Delgado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Cubo Delgado has received research support from Spanish health ministry. The institution of Dr. Cubo Delgado has received research support from European union grant.
Roland G. Henry, PhD	Dr. Henry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MEDDAY. Dr. Henry has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Henry has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Henry has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi/Genzyme.
Ronald L. Thibert, DO	Dr. Thibert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ovid Pharmaceuticals.
Robert J. Molinari, PhD	No disclosure on file
David S. Atkins, PA	No disclosure on file
Brian Hom	No disclosure on file
Ifat Vigiser	Ifat Vigiser has nothing to disclose.
Stefano Bastianello	No disclosure on file
Shih-Pin Chen, MD	No disclosure on file
Sibyl E. Wray, MD	Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb/Celgene. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche/Genentech. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi/Genzyme. The institution of Dr. Wray has received research support from Biogen. The institution of Dr. Wray has received research support from Atara Biotherapeutics. The institution of Dr. Wray has received research support from Bristol Myers Squibb/Celgene. The institution of Dr. Wray has received research support from Novartis. The institution of Dr. Wray has received research support from Roche/Genentech. The institution of Dr. Wray has received research support from Sanofi/Genzyme. The institution of Dr. Wray has received research support from TG Therapeutics. The institution of Dr. Wray has received research support from EMD Serono. The institution of Dr. Wray has received research support from Pharmaceuticals Corp..
Mauricio F. Farez, MD	Dr. Farez has received personal compensation for serving as an employee of Entelai. Dr. Farez has stock in Entelai. The institution of Dr. Farez has received research support from Fundación Sadosky.
Philip Defina, PhD	No disclosure on file
Robert I. Thompson-Stone, MD, FAAN	Dr. Thompson-Stone has received personal compensation in the range of $500-$4,999 for serving as a Krabbe Disease expert with Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC). Dr. Thompson-Stone has a non-compensated relationship as a Editorial Board Member with Neurology: ��ɫ�� Journal that is relevant to AAN interests or activities.
Charles S. DeCarli, MD, FAAN	Dr. DeCarli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. The institution of Dr. DeCarli has received research support from NIH.
Rohit Bakshi, MD, FAAN	Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Bakshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. The institution of Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neuroimaging. The institution of Dr. Bakshi has received research support from Bristol Myers Squibb. The institution of Dr. Bakshi has received research support from EMD Serono. The institution of Dr. Bakshi has received research support from Novartis.
Nir Giladi, MD, FAAN	Dr. Giladi has received personal compensation in the range of $0-$499 for serving as a Consultant for Sionara. Dr. Giladi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NeuroDerm. Dr. Giladi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pharma2B. Dr. Giladi has stock in Vibrant. Dr. Giladi has stock in Lysosomal Therapeutics . The institution of Dr. Giladi has received research support from The Michael J Fox Foundation. The institution of Dr. Giladi has received research support from The National Parkinson Foundation. The institution of Dr. Giladi has received research support from The European Union . The institution of Dr. Giladi has received research support from The Israel Science Foundation. The institution of Dr. Giladi has received research support from Biogen . The institution of Dr. Giladi has received research support from Ionis. The institution of Dr. Giladi has received research support from Sieratzki Family Foundation . The institution of Dr. Giladi has received research support from The Aufzien Academic Center in Tel-Aviv University.
Vittorio Martinelli	Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis, Biogen, Sanofi Genzyme, TEVA and Merck. Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck .
Bruno Colombo	Bruno Colombo has nothing to disclose.
Imran I. Ali, MD, FAAN	Dr. Ali has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for ABPN.
Vincent Truong, MD	Dr. Truong has nothing to disclose.
Sonja Potrebic, MD, PhD, FAAN	Dr. Potrebic has nothing to disclose.
Sarah Song, MD, MPH, FAAN	Dr. Song has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN.
Sheffali Gulati, MD, FAMS, FIAP, FNASc, FIANs	Prof. Gulati has nothing to disclose.
Sarah Zubkov, MD	No disclosure on file
Gabriela Cohen, MD	No disclosure on file
Scott Grossman, MD	Dr. Grossman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acuta Pharmaceuticals.
Margaret Sutherland	No disclosure on file
Shivika Chandra, MD, FAAN	The institution of Dr. Chandra has received research support from American Board of Psychiatry and Neurology Faculty Innovation in ��ɫ�� Award. The institution of Dr. Chandra has received research support from Michael J Fox Foundation.
Lauren B. Krupp, MD, FAAN	Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EBIX. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman LaRoche. Dr. krupp has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for MMMK. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Patrick, Dolan, and Kaufman. Dr. krupp has received intellectual property interests from a discovery or technology relating to health care.
Neil Masangkay, MD, FAAN	Dr. Masangkay has nothing to disclose.
Alejandro Vargas, MD, MS, FAAN	Dr. Vargas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer U.S. LLC Pharmaceuticals.
Ismael Calandri, MD	Dr. Calandri has nothing to disclose.
Sneha Pandya	No disclosure on file
Jennifer Haynes, MD	Dr. Haynes has nothing to disclose.
Saman Zafar, MD	Dr. Zafar has nothing to disclose.
Gea Drost, MD, PhD	No disclosure on file
Cen Zhang, MD	Dr. Zhang has nothing to disclose.
David Turkel-Parrella, MD	No disclosure on file
Ashley M. Roque, MD	No disclosure on file
Jessika Suescun, MD	Dr. Suescun has nothing to disclose.
Anelyssa Cysne Frota D' Abreu, MD, PhD, MPH, FAAN	The institution of Dr. Cysne Frota D' Abreu has received research support from U.S. NIH Institute on Aging. The institution of Dr. Cysne Frota D' Abreu has received research support from Biogen. The institution of Dr. Cysne Frota D' Abreu has received research support from American College Of Radiology. The institution of Dr. Cysne Frota D' Abreu has received research support from COGNITION THERAPEUTICS, INC.. The institution of Dr. Cysne Frota D' Abreu has received research support from Eli Lilly. The institution of Dr. Cysne Frota D' Abreu has received research support from Jansen. Dr. Cysne Frota D' Abreu has received personal compensation in the range of $10,000-$49,999 for serving as a Lecturer with Pri_med.
Neill R. Graff-Radford, MD, FAAN	The institution of Dr. Graff-Radford has received research support from Biogen. The institution of Dr. Graff-Radford has received research support from Lilly. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Biogen. Dr. Graff-Radford has received publishing royalties from a publication relating to health care.
Giovanni Castelnovo	No disclosure on file
Amy T. Waldman, MD	Dr. Waldman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SwanBio. An immediate family member of Dr. Waldman has or had stock in Pfizer. The institution of Dr. Waldman has received research support from Ionis Pharmaceuticals. The institution of Dr. Waldman has received research support from Roche/Genentech. The institution of Dr. Waldman has received research support from Ionis Pharmaceuticals. The institution of Dr. Waldman has received research support from Calico. Dr. Waldman has received publishing royalties from a publication relating to health care. Dr. Waldman has received publishing royalties from a publication relating to health care.
Suzanne Powell, MD	Dr. Powell has nothing to disclose.
John Kornak	No disclosure on file
Aurelie Ruet	The institution of Aurelie Ruet has received research support from BIOGEN. The institution of Aurelie Ruet has received research support from ROCHE. The institution of Aurelie Ruet has received research support from SANOFI GENZYME. The institution of Aurelie Ruet has received research support from BMS. Aurelie Ruet has received personal compensation in the range of $0-$499 for serving as a Board member with Horizon therapeutic. Aurelie Ruet has received personal compensation in the range of $0-$499 for serving as a Board member with Alexion. Aurelie Ruet has received personal compensation in the range of $0-$499 for serving as a Speaker meeting with BIOGEN. Aurelie Ruet has received personal compensation in the range of $500-$4,999 for serving as a Speaker meeting with MERCK. Aurelie Ruet has received personal compensation in the range of $0-$499 for serving as a Speaker meeting with Sanofi Genzyme.
Thomas J. Shoemaker, MD	Dr. Shoemaker has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Shoemaker has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AMGEN. Dr. Shoemaker has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono.
Michelle L. Sudyn	No disclosure on file
Jozef Magdic, MD	No disclosure on file
Christopher P. Eckstein, MD	The institution of Dr. Eckstein has received research support from Biogen. The institution of Dr. Eckstein has received research support from Genzyme.
Arun R. Antony, MD	Dr. Antony has nothing to disclose.
James J. Reese, Jr., MD, MPH, MA, FAAN	Dr. Reese has a non-compensated relationship as a member with Child Neurology Society that is relevant to AAN interests or activities.
Iris Katharina Penner, PhD	The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Penner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. The institution of Dr. Penner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Penner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Penner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene . Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Pratik D. Bhattacharya, MD, MPH	Dr. Bhattacharya has a non-compensated relationship as a Research Advisor with Defeat MSA Alliance 501 (c) (3) that is relevant to AAN interests or activities.
Christian Cornelissen	No disclosure on file
Hussam Shaker, MD	Dr. Shaker has nothing to disclose.
Jeffrey B. Ratliff, MD, FAAN	Dr. Ratliff has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for the journal Neurology. The institution of Dr. Ratliff has received research support from Scion NeuroStim, LLC.
Ying Sun, MD	No disclosure on file
Maha Daimee, MD	Dr. Khan has nothing to disclose.
Barbara Nuesslein-Hildesheim, PhD	Dr. Nuesslein-Hildesheim has received personal compensation for serving as an employee of Novartis Pharma AG. Dr. Nuesslein-Hildesheim has stock in Novartis Pharma AG.
Karthikeyan M. Arcot, MD	No disclosure on file
Karen A. Schwab	No disclosure on file
Amy Kuceyeski, PhD	An immediate family member of Dr. Kuceyeski has received personal compensation for serving as an employee of Heyer Physical Therapy. The institution of Dr. Kuceyeski has received research support from National Institutes of Health. Dr. Kuceyeski has received personal compensation in the range of $500-$4,999 for serving as a Grant Panel Member with Department of Defense.
Joon Mo Koo, MD	No disclosure on file
Diana Greene-Chandos, MD, FAAN	Dr. Greene-Chandos has nothing to disclose.
Ralitza H. Gavrilova, MD	Dr. Gavrilova has nothing to disclose.
Mercedes P. Jacobson, MD	The institution of Dr. Jacobson has received research support from Engage. The institution of Dr. Jacobson has received research support from XENON. The institution of Dr. Jacobson has received research support from SK Life Sciences.
Richard A. Rudick, MD, FAAN	Dr. Rudick has received personal compensation for serving as an employee of Biogen. Dr. Rudick has received stock or an ownership interest from Biogen. Dr. Rudick has received publishing royalties from a publication relating to health care.
Susan W. Law, DO	Dr. Law has nothing to disclose.
Ulrike Kaunzner, MD	Dr. Kaunzner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Kaunzner has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medlearning.
Crystal J. Yeo, MD, PhD	Dr. Yeo has nothing to disclose.
Neeraj Singh, MD	Dr. Singh has nothing to disclose.
Adrian Budhram, MD	Dr. Budhram has nothing to disclose.
Roy A. Poblete, MD	No disclosure on file
Lakshmi Leishangthem, MD, MBBS	Dr. Leishangthem has nothing to disclose.
Wayne Martin, MD	No disclosure on file
Andrew C. Taylor, MD	No disclosure on file
Brij M. Ahluwalia-Singh, MD, FAAN	No disclosure on file
Ricardo F. Allegri, MD, PhD, FAAN	Dr. Allegri has nothing to disclose.
Baziel G. van Engelen, MD, PhD, MA	The institution of Dr. van Engelen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum . The institution of Dr. van Engelen has received research support from Stichting Spieren voor Spieren. The institution of Dr. van Engelen has received research support from Prinses Beatrix Fonds. The institution of Dr. van Engelen has received research support from Dutch FSHD society. Dr. van Engelen has received intellectual property interests from a discovery or technology relating to health care.
Jill S. Goldman, MS MPhil CGC	No disclosure on file
Paula C. Azevedo, MD	Dr. Azevedo has nothing to disclose.
Patricio Chrem Mendez, MD	Dr. Chrem Mendez has nothing to disclose.
Thanh Nguyen	No disclosure on file
Christiaan Saris, MD, PhD	Dr. Saris has nothing to disclose.
Margaret Adler, MD	Dr. Adler has nothing to disclose.
Vineet Punia, MD	Dr. Punia has nothing to disclose.
Maria Petracca, PhD	Dr. Petracca has nothing to disclose.
Jerry S. Wolinsky, MD, FAAN	Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainstorm Cell Therapeutics. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cleveland Clinic Foundation. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inmagene. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis/Sandoz. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Alabama Birmingham. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care.
Giuseppe Magnani	Giuseppe Magnani has nothing to disclose.
Raed Alroughani, MD, FAAN	Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, AstraZeneca, Novartis, Merck, Roche, Sanofi. Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AstraZeneca, Biogen, Novartis, Merck, Roche, Sanofi.
Sarah I. Sheikh, BM Bch, MSc, MRCP, FAAN	Dr. Sheikh has received personal compensation for serving as an employee of Takeda.
Leah Harburg	No disclosure on file
Samar F. Ahmed, MD	Dr. Ahmed has nothing to disclose.
Carol Darbonne, CCRC	No disclosure on file
Advait Mahulikar, MD	No disclosure on file
Achillefs Ntranos, MD	No disclosure on file
Phillip Ye	No disclosure on file
Irena Dujmovic Basuroski, MD, PhD	The institution of Dr. Dujmovic Basuroski has received research support from Alexion Pharmaceuticals, Inc. The institution of Dr. Dujmovic Basuroski has received research support from Biogen MA Inc. The institution of Dr. Dujmovic Basuroski has received research support from EMD Serono Research and Development Institute, Inc . The institution of Dr. Dujmovic Basuroski has received research support from Celgene Corporation/Bristol-Myers Squibb. The institution of Dr. Dujmovic Basuroski has received research support from The Bodford Family Transverse Myelitis Center Fund. The institution of Dr. Dujmovic Basuroski has received research support from CorEvitas, LLC. The institution of Dr. Dujmovic Basuroski has received research support from Novartis. The institution of Dr. Dujmovic Basuroski has received research support from Ad Scientiam. Dr. Dujmovic Basuroski has received personal compensation in the range of $0-$499 for serving as a Travel -related expenses to attend clinical trial investigator meeting with Novartis. Dr. Dujmovic Basuroski has received personal compensation in the range of $500-$4,999 for serving as a International Clinical Consortium Member, Travel -related expenses to attend the meeting with The Guthy-Jackson Charitable Foundation.
Robert Staudinger, MD, FAAN	Dr. Staudinger has nothing to disclose.
James L. Frey, MD, FAAN	No disclosure on file
Amit Bar-Or, MD, FRCPC	Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merk/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for cabaletta. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. The institution of Dr. Bar-Or has received research support from Novartis. The institution of Dr. Bar-Or has received research support from Biogen. The institution of Dr. Bar-Or has received research support from Roche/Genentech.
Yan Zhang, MD, PhD	Dr. Zhang has nothing to disclose.
Flavia B. Consens, MD	Dr. Consens has received personal compensation in the range of $500-$4,999 for serving as a Presenter at TNS meeting with Texas Neurological Society.
Amy E. Lovett Racke, PhD	No disclosure on file
Jelena Drulovic	Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck . Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hemofarm. Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PharmaSwiss. Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck . Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Actavis TEVA. Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Hemofarm. Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medis. Jelena Drulovic has received research support from Ministry of Science, Technological Development and Innovations of the Republic of Serbia.
Aline Herlopian, MD	Dr. Herlopian has nothing to disclose.
Margherita Milone, MD, FAAN	Dr. Milone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian Therapeutics. Dr. Milone has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics, AAN. The institution of Dr. Milone has received research support from Mayo Clinic, CCaTS-CBD. The institution of Dr. Milone has received research support from Mayo Clinic, SGP Award. The institution of Dr. Milone has received research support from MDA for Care Center grant. The institution of Dr. Milone has received research support from Regenerative medicine Minnesota.
Leslie Leahy, PhD	Dr. Leahy has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Vigil Neuroscience. Dr. Leahy has stock in Ovid Therapeutics.
Stephen J. Marks, MD	No disclosure on file
Boris A. Kallmann, MD	No disclosure on file
Mefkure Eraksoy, MD	Dr. Eraksoy has nothing to disclose.
Tanya Harlow, MD, FAAN	Dr. Harlow has nothing to disclose.
Stephen W. Yeung, DO	Dr. Yeung has received personal compensation for serving as an employee of Novartis.
Richard D. Dortch, PhD	Dr. Dortch has nothing to disclose.
Sara Razmjou-Schwarz, MD	No disclosure on file
Bing Zhu, MD	No disclosure on file
Zafer Keser, MD	Dr. Keser has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier Practice Update.
Stasia Rouse, MD	Dr. Rouse has nothing to disclose.
Samuel Lichtman-Mikol, BA	Mr. Lichtman-Mikol has nothing to disclose.
Matthew T. McAdams, MD	No disclosure on file
Rachit Patil, MD	Dr. Patil has nothing to disclose.
Melissa Schorn, ARNP, DNP	No disclosure on file
Ariel M. Lyons-Warren, MD, PhD	Dr. Lyons-Warren has received personal compensation in the range of $0-$499 for serving as a Consultant for Guidepoint. Dr. Lyons-Warren has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology.
Natalia Murinova, MD, FAAN	Dr. Murinova has nothing to disclose.
Patricia Sacco, MPH	No disclosure on file
Naoir Zaher, MD	No disclosure on file
Tanya Fischer, MD, PhD	No disclosure on file
Riddhi Patira, MD	Dr. Patira has nothing to disclose.
Marinos C. Dalakas, MD, FAAN	Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols, . Dr. Dalakas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dysimmune Diseases Foundation. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ARGENX. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Therapeutic Advances in Neurology (TAND). Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink.
Raju Kapoor, MD	No disclosure on file
Michael L. Reed, PhD	The institution of Dr. Reed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. The institution of Dr. Reed has received research support from Allergan. The institution of Dr. Reed has received research support from Dr Reddy's Labs/Promius. The institution of Dr. Reed has received research support from Allay Lamp. Dr. Reed has a non-compensated relationship as a Research Analyst with National Headache Foundation that is relevant to AAN interests or activities.
Carmen Castrillo-Viguera	Dr. Castrillo-Viguera has received personal compensation for serving as an employee of Biogen. Dr. Castrillo-Viguera has received stock or an ownership interest from Biogen.
Elka Stefanova	No disclosure on file
Iva Stankovic	Iva Stankovic has nothing to disclose.
Simy K. Parikh, MD	Dr. Parikh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Parikh has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Pain and Headache Reports. Dr. Parikh has received personal compensation in the range of $500-$4,999 for serving as a Author with Medlink. Dr. Parikh has received personal compensation in the range of $500-$4,999 for serving as a Faculty with Touch Independent Medical ��ɫ�� (touchIME) . Dr. Parikh has a non-compensated relationship as a Medical Advisory Board Member with Spinal CSF Leak Foundation that is relevant to AAN interests or activities.
Elisabetta Sarasso	Elisabetta Sarasso has nothing to disclose.
Corrado Bernasconi	Corrado Bernasconi has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Roche. Corrado Bernasconi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GeNeuro. Corrado Bernasconi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Santhera.
Carlos Santiago Claverie, MD	No disclosure on file
Casey F. Jeffreys, MD	The institution of Dr. Jeffreys has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. The institution of Dr. Jeffreys has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. The institution of Dr. Jeffreys has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Jeffreys has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Clinical Neurological Society of America Inc.. Dr. Jeffreys has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Hall Booth Smith PC. The institution of Dr. Jeffreys has received research support from Novartis.
Drake D. Duane, MD, FAAN	No disclosure on file
Julie A. Khoury, MD	Dr. Khoury has nothing to disclose.
Andrew M. Southerland, MD, FAAN	Dr. Southerland has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Plaintiffs and Defense Cases related to Stroke and Vascular Neurology.. The institution of Dr. Southerland has received research support from American Heart Association. The institution of Dr. Southerland has received research support from NIH. The institution of Dr. Southerland has received research support from Abbvie Pharmaceuticals, Inc.. Dr. Southerland has received intellectual property interests from a discovery or technology relating to health care. Dr. Southerland has received intellectual property interests from a discovery or technology relating to health care.
Daniel G. Healy, MD	No disclosure on file
Douglas L. Arnold, MD, FAAN	Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Frequency Therapeutics. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xfacto communications. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Find therapeutics. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiniksa. Dr. Arnold has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Clario.
Stephen L. Hauser, MD	Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NGM Bio. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BD. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pheno Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nurix Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilead. Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Accure. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hinge Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Neurona. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Roche that is relevant to AAN interests or activities. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Novartis that is relevant to AAN interests or activities.
Jorge D. Correale, MD	Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROche. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Correale has received research support from Merck. The institution of Dr. Correale has received research support from Biogen. The institution of Dr. Correale has received research support from Novartis .
Sean D. Ruland, MD	Dr. Ruland has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up to Date. Dr. Ruland has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Law Firms.
Francesca Bagnato, MD	Dr. Bagnato has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Bagnato has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyne. Dr. Bagnato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Bagnato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jenseen. Dr. Bagnato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merk-Serono.
Sachin Kedar, MD, FAAN	Dr. Kedar has nothing to disclose.
Kristina M. Fanning, PhD	The institution of Dr. Fanning has received research support from Abbvie. The institution of Dr. Fanning has received research support from NYC Langone Health . The institution of Dr. Fanning has received research support from Uiversity of SC - Irvine. The institution of Dr. Fanning has received research support from AESARA.
Jennifer Rasmussen-Winkler, MD	Dr. Rasmussen-Winkler has nothing to disclose.
Leonardo Almeida	No disclosure on file
Nishi Rampal, MD	Dr. Rampal has received personal compensation for serving as an employee of Amgen. Dr. Rampal has received personal compensation for serving as an employee of Horizon Therapeutics. Dr. Rampal has stock in Amgen. Dr. Rampal has stock in Horizon Therapeutics.
Willa D. Brenowitz, PhD, MPH	No disclosure on file
Jiyoung Kim	No disclosure on file
Allan J. MacKenzie-Graham, PhD, BS	No disclosure on file
Ignacio Valencia, MD	No disclosure on file
James F. Meschia, MD, FAAN	The institution of Dr. Meschia has received research support from NINDS. The institution of Dr. Meschia has received research support from NINDS.
Allison Kaup	No disclosure on file
Robert J. Baumann, MD, FAAN	Dr. Baumann has nothing to disclose.
Kelly E. Lyons, PhD	Dr. Lyons has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Lyons has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage. Dr. Lyons has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Parkinson's Foundation. Dr. Lyons has a non-compensated relationship as a President with International Essential Tremor Foundation that is relevant to AAN interests or activities.
Jan N. Lycke, MD	Dr. Lycke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Lycke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Lycke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Dr. Lycke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Lycke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Lycke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Lycke has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Lycke has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Lycke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GeNeuro. The institution of Dr. Lycke has received research support from Sanofi.
Maria S. Pacha	No disclosure on file
Colin Wilbur, MD	No disclosure on file
Gabriele Siciliano	Gabriele Siciliano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Gabriele Siciliano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Open Health. Gabriele Siciliano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Gabriele Siciliano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Gabriele Siciliano has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL Behring. Gabriele Siciliano has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Grifols. The institution of Gabriele Siciliano has received research support from Biogen.
Hiba A. Haider, MD	Dr. Haider has received publishing royalties from a publication relating to health care. Dr. Haider has received publishing royalties from a publication relating to health care.
Melissa L. Rayhill, MD, FAAN	Dr. Rayhill has received personal compensation in the range of $500-$4,999 for serving as a Presenter with Headache Cooperative of New England. Dr. Rayhill has received personal compensation in the range of $500-$4,999 for serving as a Presenter with Clusterbusters. Dr. Rayhill has received personal compensation in the range of $500-$4,999 for serving as a Presenter with ��ɫ��.
Kimberly R. McDonald, MD	Dr. McDonald has nothing to disclose.
Rachel Brandstadter, MD	Dr. Brandstadter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion.
Juliana VanderPluym, MD	Dr. VanderPluym has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Neurology and Neuroscience Reports. The institution of Dr. VanderPluym has received research support from Amgen.
Paolo Gallo, MD	Dr. Gallo has nothing to disclose.
M. B. Westover, MD, PhD	Dr. Westover has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Beacon Biosignals. Dr. Westover has stock in Beacon Biosignals. The institution of Dr. Westover has received research support from NIH. Dr. Westover has received publishing royalties from a publication relating to health care. Dr. Westover has a non-compensated relationship as a cofounder with Beacon Biosignals that is relevant to AAN interests or activities.
Kartik Raghupathi	No disclosure on file
Adriana S. Perilla, MD	No disclosure on file
Abdallah M. Hamdallah, MD	Dr. Hamdallah has nothing to disclose.
Valentina Poretto, MD	Dr. Poretto has nothing to disclose.
Milagros Hidalgo de la Cruz	Milagros Hidalgo de la Cruz has nothing to disclose.
Annie L. Hsieh, MD, PhD	An immediate family member of Dr. Hsieh has received personal compensation for serving as an employee of Pfizer.
Adam D. Wallace, MD	Dr. Wallace has nothing to disclose.
Seth A. Smith, PhD	Dr. Smith has nothing to disclose.
Evanthia Bernitsas, MD, FAAN	Dr. Bernitsas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Bernitsas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Vanda. The institution of Dr. Bernitsas has received research support from Roche/Genentech.
Murat Kurtuncu, MD	Dr. Kurtuncu has nothing to disclose.
Kim Yen Thi Vu, LMSW	No disclosure on file
Phillip Kucab, MD	Dr. Kucab has received personal compensation in the range of $500,000-$999,999 for serving as a Neurology Chief with US Department of Veteran Affairs.
Adil Iqbal, MD	No disclosure on file
Joseph F. Carrera, MD	Dr. Carrera has nothing to disclose.
T. Scott Diesing, MD	Dr. Diesing has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Union Pacific Railroad.
Hyman M. Schipper, MD, PhD, FAAN	No disclosure on file
Eric Molho, MD, FAAN	Dr. Molho has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Molho has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CNS Ratings. Dr. Molho has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine Biosciences.
Corrado Angelini, MD, FAAN	Dr. Angelini has nothing to disclose.
Steven Levine, MD, FAHA	Dr. Levine has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MEDLINK. Dr. Levine has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Law Firms. The institution of Dr. Levine has received research support from NIH.
Conor Corbin	No disclosure on file
Maryam Oskoui, MD, FAAN	Dr. Oskoui has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for the Association des Neurologues du Quebec. The institution of Dr. Oskoui has received research support from Hoffmann-La Roche Ltd. The institution of Dr. Oskoui has received research support from Muscular Dystrophy Canada. The institution of Dr. Oskoui has received research support from Canadian Institutes of Health Research. The institution of Dr. Oskoui has received research support from Santhera. The institution of Dr. Oskoui has received research support from Novartis. The institution of Dr. Oskoui has received research support from Fonds de Recherche du Québec. Dr. Oskoui has a non-compensated relationship as a Member of the Medical and Scientific Advisory Committee with Muscular Dystrophy Canada that is relevant to AAN interests or activities.
John A. Lincoln, MD, PhD	The institution of Dr. Lincoln has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. Dr. Lincoln has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Lincoln has received research support from Deaprtment of Defense. The institution of Dr. Lincoln has received research support from National Institutes of Health. The institution of Dr. Lincoln has received research support from EMD-Serono. Dr. Lincoln has received intellectual property interests from a discovery or technology relating to health care.
Achim Gass, MD	Dr. Gass has nothing to disclose.
Richard R. Murphy, MBChB, FAAN	Dr. Murphy has nothing to disclose.
Charlene R. Hoffman-Snyder, DNP	No disclosure on file
Manuela Vaneckova	Manuela Vaneckova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Manuela Vaneckova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Manuela Vaneckova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Manuela Vaneckova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Manuela Vaneckova has received research support from Czech Ministry of Health project—grants NU 22-04-00193 . Manuela Vaneckova has received research support from Czech Ministry of Health project - RVO VFN 64165 . Manuela Vaneckova has received personal compensation in the range of $500-$4,999 for serving as a principal investigator with Czech Ministry of Health project—grants NU 22-04-00193 .
Lakshmi Warrior, MD, FAAN	Dr. Warrior has nothing to disclose.
Pradeep C. Bollu, MD	Dr. Bollu has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie.
Jasem Y. Al-Hashel, MD	Dr. Al-Hashel has nothing to disclose.
Navid Seraji-Bozorgzad, MD	No disclosure on file
Vivek Rai, MD	Dr. Rai has nothing to disclose.
Andrea C. Wasilewski, MD	Dr. Wasilewski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novocure. Dr. Wasilewski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier Pharmaceuticals .
Daniel Krashin, MD	Dr. Krashin has nothing to disclose.
Jullie W. Pan, MD, PhD	No disclosure on file
Michael A. Kelly, MD, FAAN	No disclosure on file
Louise D. McCullough, MD, PhD	The institution of Dr. McCullough has received research support from NIH. The institution of Dr. McCullough has received research support from American Heart Association.
Andrew G. Engel, MD, FAAN	The institution of Dr. Engel has received research support from NIH.
Anto Bagic, MD, PhD	Dr. Bagic has nothing to disclose.
Anna Khanna, MD	Dr. Khanna has nothing to disclose.
Sarlota Mesaros	Sarlota Mesaros has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Sarlota Mesaros has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. Sarlota Mesaros has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Sarlota Mesaros has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Hemofarm. Sarlota Mesaros has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Thomas Finnegan, Jr., PhD	Dr. Finnegan has nothing to disclose.
Aaron Deykin, MD	No disclosure on file
Michael D. Perloff, MD, PhD	Dr. Perloff has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for several law firms/Universities.
Lawrence M. Samkoff, MD, FAAN	Dr. Samkoff has nothing to disclose.
Jonathan J. Halford, MD, FAAN	Dr. Halford has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Life Sciences. Dr. Halford has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Halford has received stock or an ownership interest from Corticare. The institution of Dr. Halford has received research support from Takeda. The institution of Dr. Halford has received research support from SK Life Sciences. The institution of Dr. Halford has received research support from Biogen.
Elie Naddaf, MD	Dr. Naddaf has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Expert Connect. Dr. Naddaf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Klick, Inc. Dr. Naddaf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WebMD. Dr. Naddaf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson and Johnson. Dr. Naddaf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arcellx. The institution of Dr. Naddaf has received research support from NIAMS. The institution of Dr. Naddaf has received research support from Fulcrum therapeutics. The institution of Dr. Naddaf has received research support from Abcuro. The institution of Dr. Naddaf has received research support from Cabaletta . The institution of Dr. Naddaf has received research support from Arcellx.
Stacey L. Hughes	No disclosure on file
Praveen Vemuri, MBBS	No disclosure on file
Gamaleldin M. Osman, MD	Dr. Osman has nothing to disclose.
Naomi Nevler, MD	No disclosure on file
Damon P. Cardenas, PhD	No disclosure on file
Mohammed Ismail, MD	Dr. Ismail has nothing to disclose.
Isin Unal-Cevik, MD, PhD	The institution of Prof. Unal-Cevik has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Viatris .
Gerwin Schalk, PhD	No disclosure on file
Rafael H. Llinas, MD, FAAN	Dr. Llinas has nothing to disclose.
Pushpa Narayanaswami, MD, MBBS, FAAN	Dr. Narayanaswami has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for UCB. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CVS. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Narayanaswami has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx USA. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Narayanaswami has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Narayanaswami has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NMD pharma. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD-Serono (Merck usa). Dr. Narayanaswami has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Immuneabs. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viridian. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cabaletta-Bio. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Narayanaswami has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vor Bio. Dr. Narayanaswami has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Muscle and Nerve, Wiley. Dr. Narayanaswami has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Narayanaswami has or had stock in Dr. Reddys laboratories.Dr. Narayanaswami has or had stock in Doximity. The institution of Dr. Narayanaswami has received research support from Alexion. The institution of Dr. Narayanaswami has received research support from NIH. The institution of Dr. Narayanaswami has received research support from Argenx. The institution of Dr. Narayanaswami has received research support from Cabaletta Bio. Dr. Narayanaswami has received publishing royalties from a publication relating to health care. Dr. Narayanaswami has a non-compensated relationship as a Member, Finance Committee with AANEM that is relevant to AAN interests or activities.
Ashish V. Kapoor, MD, FAAN	Dr. Kapoor has nothing to disclose.
Manjamalai Sivaraman, MD	Dr. Sivaraman has nothing to disclose.
Rowena Ng	No disclosure on file
Dorthea Juul, PhD	Dr. Juul has received personal compensation for serving as an employee of American Board of Psychiatry and Neurology.
Beomseok Jeon, MD	Dr. Jeon has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Jeon has received research support from peptron. The institution of Dr. Jeon has received research support from zemvax & kael. Dr. Jeon has received personal compensation in the range of $500-$4,999 for serving as a expert panel with Aspen Neuroscience.
Rajesh Pahwa, MD, FAAN	Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ACADIA. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Insightec. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jaaz. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fasikl. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Photopharmics. The institution of Dr. Pahwa has received research support from Abbott. The institution of Dr. Pahwa has received research support from Abbvie. The institution of Dr. Pahwa has received research support from Biogen. The institution of Dr. Pahwa has received research support from Parkinson Foundation. The institution of Dr. Pahwa has received research support from Roche. The institution of Dr. Pahwa has received research support from Sage. The institution of Dr. Pahwa has received research support from Sun Pharma. The institution of Dr. Pahwa has received research support from Theravance. The institution of Dr. Pahwa has received research support from Neuroderm. The institution of Dr. Pahwa has received research support from Ask Bio. The institution of Dr. Pahwa has received research support from Blue Rock. The institution of Dr. Pahwa has received research support from Cerevance. The institution of Dr. Pahwa has received research support from Fasikl. The institution of Dr. Pahwa has received research support from Scion. The institution of Dr. Pahwa has received research support from UCB. The institution of Dr. Pahwa has received research support from Ono. The institution of Dr. Pahwa has received research support from Intra-cellular Therapies. The institution of Dr. Pahwa has received research support from Ask Bio. The institution of Dr. Pahwa has received research support from Michael J Fox Foundation . The institution of Dr. Pahwa has received research support from Neuron 23. The institution of Dr. Pahwa has received research support from Roche.
Allan G. Kermode, MD, MBBS, FRACP	Dr. Kermode has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Kermode has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche.
Lucia Moiola, MD, PhD	Dr. Moiola has nothing to disclose.
Jean C. Ouallet	Jean C. Ouallet has nothing to disclose.
Jean Pelletier, MD, PhD	Dr. Pelletier has nothing to disclose.
Benjamin Zeskind	No disclosure on file
Patricia K. Coyle, MD, FAAN	Dr. Coyle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Accordant. Dr. Coyle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Coyle has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sanofi Genzyme. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GlaxoSmithKline. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon Therapeutics. The institution of Dr. Coyle has received research support from CorEvitas LLC. The institution of Dr. Coyle has received research support from Genentech/Roche. The institution of Dr. Coyle has received research support from NINDS. The institution of Dr. Coyle has received research support from Sanofi Genzyme. The institution of Dr. Coyle has received research support from Cleveland Clinic.
Lakshmi N. Ranganathan, MD, PhD, FAAN	Dr. Ranganathan has nothing to disclose.
Paul Frohna, MD, PhD, PharmD	No disclosure on file
Karl Krecke	Karl Krecke has nothing to disclose.
Bertrand Bourre	Bertrand Bourre has nothing to disclose.
Alessandro D'Ambrosio	No disclosure on file
William Mack	William Mack has received personal compensation for serving as an employee of NFL. William Mack has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Imperative Care. The institution of William Mack has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vanderbilt University (Stryker study) . William Mack has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMJ. William Mack has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Goza and Honnald LLC. William Mack has stock in egret therapeutics. William Mack has stock in Borvo. William Mack has stock in Radical Catheters. William Mack has stock in Vastrax. William Mack has stock in Q'Apel. William Mack has stock in Viseon. William Mack has stock in Stream Biomedical. William Mack has stock in Spartan Micro. William Mack has stock in Endostream. The institution of William Mack has received research support from National Institutes of Health.
Marzena Pedrini, PhD	Dr. Pedrini has nothing to disclose.
Helen Carlson	No disclosure on file
Sharjeel Panjwani, MD	No disclosure on file
Suraj Rajan, MD	No disclosure on file
Si Baek Lee	Si Baek Lee, 1512 has nothing to disclose.
Lil-Antonia Meyer-Arndt, MD, PhD	No disclosure on file
Pablo Bonardo, MD	Dr. Bonardo has nothing to disclose.
Ann Gruber-Baldini	No disclosure on file
Galeno Rojas, MD	No disclosure on file
Vishal Shah, MBBS	Dr. Shah has nothing to disclose.
Marcela Uribe Roca	The institution of Marcela Uribe Roca has received research support from Roche.
Mohammad J. Humayun, MD	Dr. Humayun has nothing to disclose.
Carlos Lopez Gomez, PhD	No disclosure on file
Ana G. Cristancho, MD, PhD	Dr. Cristancho has nothing to disclose.
Osamu Onodera, MD	Dr. Onodera has nothing to disclose.
Friedemann Paul	Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hoffmann-La Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol-Myers Squibb GmbH & Co. KGaA (BMS. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics GmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Paul has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for F&U Confirm. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb GesmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MICE Service. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for VINDICO medical education. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Beijing Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sandoz Internation GmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Thailand. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche . Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology, Neuroimmunology&Neuroinflammation.
Gerhard Winkler, MD	No disclosure on file
Frederic Sedel	No disclosure on file
Patricia Linortner, PhD	No disclosure on file
Benjamin Turner, MD, MBBS	No disclosure on file
Vann Chau, MD, FRCPC	No disclosure on file
Anastasie M. Dunn-Pirio, MD	Dr. Dunn-Pirio has nothing to disclose.
Emmanouil Dermitzakis	No disclosure on file
Lixin Zhou	Lixin Zhou has nothing to disclose.
Rabia Jamy, MD	Dr. Jamy has nothing to disclose.
Tina M. Burton, MD	Dr. Burton has nothing to disclose.
Michael A. Farrell, MB	No disclosure on file
Vladimir S. Kostic, MD, PhD	Dr. Kostic has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. An immediate family member of Dr. Kostic has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Alkaloid. The institution of Dr. Kostic has received research support from Ministry of ��ɫ��, Science and Technological Development of Serbia.
Flavia Nelson, MD	Dr. Nelson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Brystol Meyer Squib. Dr. Nelson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Nelson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Nelson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genetech. The institution of Dr. Nelson has received research support from NIH. Dr. Nelson has received research support from Novartis.
Dana Horakova	Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Chiseko Ikenaga, MD, PhD	Dr. Ikenaga has nothing to disclose.
Tomas Uher	Tomas Uher has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Tomas Uher has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol myers. Tomas Uher has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Tomas Uher has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Tomas Uher has received research support from Novartis.
Tuncay Gunduz, MD	The institution of Dr. Gunduz has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Pharmaceuticals. Dr. Gunduz has received research support from Turkish Neuroimmunology Society.
Silvia Basaia	Silvia Basaia has nothing to disclose.
Richard A. Shubin, MD	No disclosure on file
Sai Sripada R. Koneru, Sr., MD	No disclosure on file
Joseph J. Melvin, DO	Dr. Melvin has received personal compensation in the range of $100,000-$499,999 for serving as a Physican with Tower health.
Agustin Legido, MD, PhD, MBA	No disclosure on file
Jeffrey M. Kornitzer, MD, FAAN	Dr. Kornitzer has nothing to disclose.
Rohit A. Marawar, MD, FAAN	Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Pharma. Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon. Dr. Marawar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis.
Giulia Longoni, MD	Dr. Longoni has nothing to disclose.
Steffen Naegel, MD	No disclosure on file
Alexander Pantelyat, MD, FAAN	Dr. Pantelyat has received personal compensation for serving as an employee of MedRhythms, Inc.. Dr. Pantelyat has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MedRhythms, Inc.. Dr. Pantelyat has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Kelly & Ignoffo Law Group. The institution of Dr. Pantelyat has received research support from NIH/NIA.
Corlier Fabian, PHD STUDENT	No disclosure on file
Catherine Norise, MD	Dr. Norise has nothing to disclose.
Magdy H. Selim, MD, PhD	Dr. Selim has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. The institution of Dr. Selim has received research support from NIH/NINDS. Dr. Selim has received publishing royalties from a publication relating to health care.
Catarina Quinzii Hirano, MD	No disclosure on file
Agessandro Abrahao, Jr., MD	Dr. Abrahao has nothing to disclose.
Yury Seliverstov, MD, PhD	No disclosure on file
Lorne H. Zinman, MD	Dr. Zinman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, MTP, AB Science, Cytokinetics, Amylyx. Dr. Zinman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx.
Scott McGinnis, MD	Dr. McGinnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai.
Thomas Beach	Thomas Beach has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vivid Genomics. Thomas Beach has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Diagnostics. The institution of Thomas Beach has received research support from National Institutes of Health. The institution of Thomas Beach has received research support from Michael J Fox Foundation . The institution of Thomas Beach has received research support from State of Arizona.
Norbert Schuff	No disclosure on file
Sara K. Rostanski, MD	Dr. Rostanski has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Individual law firms.
David Brassat, MD, PhD	No disclosure on file
Jalyoung Joe, MD	Dr. Joe has nothing to disclose.
Lucrecia Bandeo	Lucrecia Bandeo has nothing to disclose.
Jee Young Kim, MD	No disclosure on file
Mark S. Freedman, MD, FAAN	Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion(Janssen/J&J). Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BiogenIdec. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS/Celgene. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Inc. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion (Janssen/J&J). Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atara Biotherapeutics. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer Healthcare. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BiogenIdec. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Clene Nanomedicine. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GRI Bio. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Magenta Therapeutics. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Freedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Freedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. The institution of Dr. Freedman has received research support from Sanofi Genzyme.
Gioacchino Tedeschi, MD	Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Clifford R. Jack, Jr., MD	The institution of Dr. Jack has received research support from NIH. The institution of Dr. Jack has received research support from Alexander Family Alzheimer's Disease Research Professorship of the Mayo Clinic.
Olivier Simon	No disclosure on file
Mark Obermann, MD, FAAN	No disclosure on file
Lonni Schultz, PhD	Dr. Schultz has nothing to disclose.
Judith Bellmann-Strobl, MD	Judith Bellmann-Strobl, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Judith Bellmann-Strobl, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Judith Bellmann-Strobl, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Judith Bellmann-Strobl, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Judith Bellmann-Strobl, MD has received research support from Bayer. The institution of Judith Bellmann-Strobl, MD has received research support from NEMOS.
Alexander U. Brandt, MD	No disclosure on file
Gloria Dalla Costa	No disclosure on file
Fatima Pantiu	No disclosure on file
Richard A. Lewis, MD	No disclosure on file
Katrina T. Schrader, MA, CCRP	No disclosure on file
Arjumond Khan	No disclosure on file
Olga Ciccarelli, MD, PhD, FRCP	Prof. Ciccarelli has received personal compensation in the range of $0-$499 for serving as a Consultant for Lundebeck. Prof. Ciccarelli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Ciccarelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Prof. Ciccarelli has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Prof. Ciccarelli has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEUROLOGY Journal.
Federica Esposito	Federica Esposito has received personal compensation in the range of $0-$499 for serving as a Consultant for Merck. Federica Esposito has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Federica Esposito has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Federica Esposito has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Federica Esposito has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. The institution of Federica Esposito has received research support from Italian MS Society. The institution of Federica Esposito has received research support from Italian Ministry of Health. The institution of Federica Esposito has received research support from ERA Net. The institution of Federica Esposito has received research support from European Commission. Federica Esposito has received intellectual property interests from a discovery or technology relating to health care.
Tigran Kesayan, MD	Dr. Kesayan has nothing to disclose.
Nina H. Kim, MD	Dr. Kim has nothing to disclose.
Stephanie Grover, MSc, CCRP	No disclosure on file
Michael Erb	No disclosure on file
Beth B. Hogans, MD, PhD	Dr. Hogans has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Academy of Pain Medicine. The institution of Dr. Hogans has received research support from VA Office of Research and Development. Dr. Hogans has received intellectual property interests from a discovery or technology relating to health care. Dr. Hogans has received publishing royalties from a publication relating to health care. Dr. Hogans has received publishing royalties from a publication relating to health care. Dr. Hogans has a non-compensated relationship as a Grant reviewer with Veterans Affairs Office of Research and Development that is relevant to AAN interests or activities. Dr. Hogans has a non-compensated relationship as a Grant reviewer with National Institutes of Health that is relevant to AAN interests or activities.
Janannaz Dastgir, DO	Dr. Dastgir has received personal compensation for serving as an employee of Regenxbio. Dr. Dastgir has a non-compensated relationship as a Scientific Advisory Board with Team Titin that is relevant to AAN interests or activities. Dr. Dastgir has a non-compensated relationship as a Scientific Advisory Board with Hannah's Hope Fund / Gengan Therapeutics that is relevant to AAN interests or activities.
Anil Neelakantan, MD, FAAN	Dr. Neelakantan has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Gould Medical Group.
Mariel Pullman, MD	The institution of Dr. Pullman has received research support from Empire Clinical Research Investigator Program.
Nico J. Diederich, MD	No disclosure on file
Zoltan Mari, MD, FAAN	Dr. Mari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Mari has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ACADIA. Dr. Mari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Mari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Parkinson Study Group. Dr. Mari has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie. Dr. Mari has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for ACADIA. Dr. Mari has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for US World Meds. Dr. Mari has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Mari has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Moore and Moore PLLC. Dr. Mari has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Francis Law Firm PLLC. Dr. Mari has stock in NeuroReserve. Dr. Mari has stock in Sensory Cloud. The institution of Dr. Mari has received research support from Cerevel. The institution of Dr. Mari has received research support from AbbVie. The institution of Dr. Mari has received research support from NIH. The institution of Dr. Mari has received research support from Parkinson's Foundation. The institution of Dr. Mari has received research support from Michael J Fox Foundation. The institution of Dr. Mari has received research support from LBDA. The institution of Dr. Mari has received research support from Eli Lilly.
Elisabetta Pagani	Elisabetta Pagani has nothing to disclose.
Matthew Smith	Matthew Smith has nothing to disclose.
Ramesh Madhavan, MD, FAAN	Dr. Madhavan has received stock or an ownership interest from TiaTech USA and TiaTech India. Dr. Madhavan has received intellectual property interests from a discovery or technology relating to health care.
Sharon Ash	No disclosure on file
Gilles Allali, MD, PhD	Dr. Allali has nothing to disclose.
Monica Margoni	Monica Margoni has received research support from MAGNIMS. Monica Margoni has received research support from Merck-Serono. Monica Margoni has received research support from Sanofi-Genzyme.
Ih Chang	Ih Chang has received personal compensation for serving as an employee of Cerevel. Ih Chang has received stock or an ownership interest from Cerevel Therapeutics.
Stephen Hantus, MD	Dr. Hantus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Hantus has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB.
Brian Callaghan, MD, MS, FAAN	Dr. Callaghan has received personal compensation for serving as an employee of University of Michigan. Dr. Callaghan has received personal compensation for serving as an employee of Ann Arbor Veterans Affairs. Dr. Callaghan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dynamed. Dr. Callaghan has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��. Dr. Callaghan has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Medico-legal work. Dr. Callaghan has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Vaccine Injury Compensation Program. The institution of Dr. Callaghan has received research support from ��ɫ��. The institution of Dr. Callaghan has received research support from JDRF. The institution of Dr. Callaghan has received research support from NIA. Dr. Callaghan has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with NIH.
Ambooj Tiwari, MD	Dr. Tiwari has nothing to disclose.
Shitiz K. Sriwastava, MBBS	Dr. Sriwastava has nothing to disclose.
Sweta Patel, NP	No disclosure on file
Luis A. Chui, MD	No disclosure on file
Thomas R. Henry, MD, FAAN	Dr. Henry has nothing to disclose.
Elisa Canu	The institution of Elisa Canu has received research support from Italian Ministry of Health .
Krzysztof W. Selmaj	Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Scott M. Le, DO	No disclosure on file
Nadege Gilles	Ms. Gilles has nothing to disclose.
Chandler Gill, MD	Dr. Gill has nothing to disclose.
Hae Young Baang, MD	Dr. Baang has nothing to disclose.
Fabian Model	No disclosure on file
Brian Gold	No disclosure on file
Michael I. Shevell, MD, FAAN	Dr. Shevell has nothing to disclose.
Babar Khokhar, MD, FAAN	Dr. Khokhar has nothing to disclose.
Cormac A. O'Donovan, MD	Dr. O'Donovan has nothing to disclose.
Benjamin Legros, MD	No disclosure on file
Hiroyuki Ishiura, MD	No disclosure on file
Amy Kao, MD	No disclosure on file
Kunal Bhatia, MD	Dr. Bhatia has nothing to disclose.
William J. Litchy, MD, FAAN	Dr. Litchy has nothing to disclose.
Anil Mendiratta, MD	Dr. Mendiratta has nothing to disclose.
Christopher Skidmore, MD	Dr. Skidmore has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for SALTZ MONGELUZZI BENDESKY LLC. The institution of Dr. Skidmore has received research support from Neuropace. The institution of Dr. Skidmore has received research support from Jazz Pharmaceuticals. The institution of Dr. Skidmore has received research support from Rapport Therapeutics.
Paola Valsasina	Paola Valsasina has nothing to disclose.
Aubrey Adams, PhD	Dr. Manack Adams has received personal compensation for serving as an employee of Abbvie. Dr. Manack Adams has stock in Abbvie.
Tirisham Gyang, MD	Dr. Gyang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono.
Ahmed A. Malik, MD	No disclosure on file
Matteo De Marco, PhD	No disclosure on file
Luke Whitmire, PhD	No disclosure on file
Lesley Kaye, MD	The institution of Dr. Kaye has received research support from NeuroPace. The institution of Dr. Kaye has received research support from LivaNova.
Kalyan Yarraguntla, MD	Dr. Yarraguntla has nothing to disclose.
Franchesca Fiorito Torres, MD	Dr. Fiorito Torres has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli-Lilly. Dr. Fiorito Torres has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Fiorito Torres has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli-Lilly. Dr. Fiorito Torres has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biohaven. Dr. Fiorito Torres has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Abbvie/Allergan. Dr. Fiorito Torres has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Fiorito Torres has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis.
Wendy Su, PhD	No disclosure on file
Danielle M. Stember, MD	Dr. Stember has nothing to disclose.
Bridget V. MacDonald	No disclosure on file
Prakashini K	No disclosure on file
Justine Moonen	No disclosure on file
Jens Schjodt-Eriksen	No disclosure on file
Cho Soo-Jin	Cho Soo-Jin has nothing to disclose.
Won-Joo Kim, MD	No disclosure on file
Izumi Kawachi, MD, PhD	Dr. Kawachi has received personal compensation in the range of $0-$499 for serving as a Consultant for Mochida Pharmaceutical CO., LTD.. Dr. Kawachi has received personal compensation in the range of $0-$499 for serving as a Consultant for Euroimmune. Dr. Kawachi has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai Pharmaceuticals. Dr. Kawachi has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi Tanabe Pharma. Dr. Kawachi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Chugai Pharmaceuticals. Dr. Kawachi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis Pharma. Dr. Kawachi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Kawachi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Dr. Kawachi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe Pharma. Dr. Kawachi has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Argenx. Dr. Kawachi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Kawachi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Daiichi-Sankyo. Dr. Kawachi has received research support from JSPS KAKENHI. Dr. Kawachi has received research support from MHLW Research Program on Rare and Intractable Diseases. Dr. Kawachi has received research support from Japan Kampo Medicine ��ɫ�� Foundation.
Michael Dobbs, MD	Dr. Dobbs has received publishing royalties from a publication relating to health care.
Jose R. Romero, MD	The institution of Dr. Romero has received research support from NIH/NIA.
Nadir A. Syed, MD	No disclosure on file
Jason D. Hinman, MD, PhD	Dr. Hinman has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Bertoldo, Baker, Carter & Smith. Dr. Hinman has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Koskoff, Koskoff & Bieder. Dr. Hinman has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Matthew Millea, PC. Dr. Hinman has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Popham Law Firm PC. Dr. Hinman has received stock or an ownership interest from Sage Cerebrovascular Diagnostics, Inc.. Dr. Hinman has received research support from NIH. Dr. Hinman has received research support from American Heart Association. Dr. Hinman has received research support from Reneuron. Dr. Hinman has received intellectual property interests from a discovery or technology relating to health care.
Linda C. Wendell, MD, FAAN	Dr. Wendell has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. An immediate family member of Dr. Wendell has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. Dr. Wendell has stock in Apple. An immediate family member of Dr. Wendell has stock in Apple.
Angela N. Hays Shapshak, MD	The institution of Dr. Hays Shapshak has received research support from NIH/NINDS. Dr. Hays Shapshak has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with US Department of Justice.
Nancy M. Nealon, MD	Dr. Nealon has nothing to disclose.
Robert Cowan, MD, FAAN	Dr. Cowan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Cowan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Cowan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for lundbeck. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biohavenn. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbviie. Dr. Cowan has stock in Percept. Dr. Cowan has received intellectual property interests from a discovery or technology relating to health care. Dr. Cowan has received intellectual property interests from a discovery or technology relating to health care. Dr. Cowan has received publishing royalties from a publication relating to health care.
Deborah Raymond	The institution of Ms. Raymond has received research support from NIH.
Juan F. Gongora Rivera, MD, MD, MSc, PhD	Dr. Gongora Rivera has nothing to disclose.
Anna Karydas	No disclosure on file
Tuhin Virmani, MD, PhD, FAAN	The institution of Dr. Virmani has received research support from Parkinson's Foundation.
William D. Arnold, MD	Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for La Hoffmann Roche. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cadent Therapeutics . Dr. Arnold has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Arnold has received research support from NIH. The institution of Dr. Arnold has received research support from NMD Pharma. The institution of Dr. Arnold has received research support from Gilead Sciences. The institution of Dr. Arnold has received research support from CureSMA. Dr. Arnold has received intellectual property interests from a discovery or technology relating to health care.
Mark C. Stahl, MD, PhD	Dr. Stahl has received personal compensation for serving as an employee of Avidity Biosciences. Dr. Stahl has stock in Avidity Biosciences.
Sara Strauss, DO	Dr. Strauss has nothing to disclose.
Ester Carreon Guarnizo	Ester Carreon Guarnizo has nothing to disclose.
Noelia García Lax	No disclosure on file
Theodoros Constantinidis, MD, PhD	No disclosure on file
Ylec M. Cardenas Castillo, MD	Dr. Cardenas Castillo has nothing to disclose.
Quentin Funk	Quentin Funk has nothing to disclose.
Vesper F. Ramos, MD	Dr. Ramos has received personal compensation for serving as an employee of Pfizer. Dr. Ramos has or had stock in Pfizer.
Bing Yu Chen, MD	Dr. Chen has nothing to disclose.
Meixiang Yu	No disclosure on file
Clarissa L. Yasuda, MD, PhD	Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for LIBBS. Prof. Yasuda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBOTT. Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for LIBBS.
Shadi Yaghi, MD	Dr. Yaghi has nothing to disclose.
Manmeet Kaur, MBBS	Dr. Kaur has nothing to disclose.
Carlo Pozzilli	Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
Amanda B. Weber, DO	Dr. Weber has nothing to disclose.
Jean Philippe Ranjeva	No disclosure on file
Alvino Bisecco	Alvino Bisecco has nothing to disclose.
Ifrah Zawar, MD	The institution of Dr. Zawar has received research support from Alzheimer's association. The institution of Dr. Zawar has received research support from American epilepsy society . The institution of Dr. Zawar has received research support from NIH. The institution of Dr. Zawar has received research support from University of Virginia.
Jeremy Syrjanen	Jeremy Syrjanen has nothing to disclose.
Dannaly Reyes-Baerga, MD	No disclosure on file
Bhumika Balgobin, MD	No disclosure on file
David Baker	No disclosure on file
Inmaculada Tasset, MD	No disclosure on file
Joseph Giuffrida, PhD	No disclosure on file
Erik S. Musiek, MD, PhD	No disclosure on file
Cem Kucukali	No disclosure on file
Silvia Presas	Silvia Presas has nothing to disclose.
Lucas Alessandro, Sr., MD	Dr. Alessandro has nothing to disclose.
Zheng-Yu Jin	No disclosure on file
Ashish Kulhari, MD	No disclosure on file
Hisham Aldhukair, MBBS	Dr. Aldhukair has nothing to disclose.
Daniel Reich, MD, PhD	Dr. Reich has received research support from NIH. The institution of Dr. Reich has received research support from Adelson Medical Research Foundation. The institution of Dr. Reich has received research support from Sanofi. The institution of Dr. Reich has received research support from Abata Therapeutics. The institution of Dr. Reich has received research support from National Multiple Sclerosis Society. The institution of Dr. Reich has received research support from Cure Alzheimer's Fund. Dr. Reich has received intellectual property interests from a discovery or technology relating to health care. Dr. Reich has received personal compensation in the range of $5,000-$9,999 for serving as a CME Faculty with Integrity. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with Letters and Sciences. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with Academic CME. Dr. Reich has a non-compensated relationship as a Advisor with Sanofi that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Board of Directors with ACTRIMS that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Abata Therapeutics that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with University of Basel RC2NB that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Multiple Sclerosis Society of Canada that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Tuscan Doctorate in Neuroscience that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Editorial Board with Multiple Sclerosis Journal that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Hyperfine that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Imaginab that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Annexon that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Philips that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Siemens that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Calico Life Sciences that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Cognito Therapeutics that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Sudo that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Allumis that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with BioCentury that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Regeneron that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Eli Lilly that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with SetPoint that is relevant to AAN interests or activities.
Jinesh M. Shah, MBBS	No disclosure on file
Channa Kolb, MD	No disclosure on file
Gianna Carla Riccitelli	No disclosure on file
Mitra Afshari, MD	Dr. Afshari has received research support from Consolidated Anti-Aging Foundation . Dr. Afshari has received research support from Parkinson Study Group.
Pascal A. Atanga, MD	No disclosure on file
Anthony L. Ritaccio, MD, FAAN	The institution of Dr. Ritaccio has received research support from NIH. Dr. Ritaccio has received intellectual property interests from a discovery or technology relating to health care.
Christoph Kleinschnitz, MD	Dr. Kleinschnitz has nothing to disclose.
Janina Behrens	No disclosure on file
Thomas C. Pitts, MD	No disclosure on file
Daniel Hartung, PharmD, MPH	Mr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alkermes. Mr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Mr. Hartung has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Humana. Mr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for US DOJ. Mr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with NMSS.
Guru Ramaiah, MD	No disclosure on file
Linda S. Williams, MD, FAAN	The institution of Dr. Williams has received research support from VA HSR&D.
Jonathan H. McKinnon, MD	No disclosure on file
Muhammad Farooq, MD	Dr. Farooq has nothing to disclose.
Elan D. Louis, MD, MS, FAAN	Dr. Louis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer - Merritt's Textbook of Neurology. Dr. Louis has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Legal Firm. The institution of Dr. Louis has received research support from National Institutes of Health. Dr. Louis has received publishing royalties from a publication relating to health care. Dr. Louis has a non-compensated relationship as a Board of Directors with International Essential Tremor Foundation that is relevant to AAN interests or activities. Dr. Louis has a non-compensated relationship as a Medical Advisory Board with HopeNET that is relevant to AAN interests or activities.
Marlis Gonzalez-Fernandez, MD, PhD	No disclosure on file
Christof Karmonik, PhD	No disclosure on file
Aparna M. Prabhu, MD	Dr. Prabhu has nothing to disclose.
Susan Gauthier, DO	Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Gauthier has received research support from Genentech.
Pavan Bhargava, MD, FAAN	The institution of Dr. Bhargava has received research support from EMD Serono. The institution of Dr. Bhargava has received research support from Amylyx pharmaceuticals. The institution of Dr. Bhargava has received research support from Genentech. The institution of Dr. Bhargava has received research support from GSK.
Gayane R. Melikyan, MD, FAAN	Dr. Melikyan has nothing to disclose.
Michael Reznik, MD	Dr. Reznik has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Morrison Mahoney. The institution of Dr. Reznik has received research support from NIDUS.
Howard L. Weiner, MD	Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiziana Life Sciences. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for vTv Therapeutics. Dr. Weiner has stock in vTv Therapeutics. The institution of Dr. Weiner has received research support from National Institute of Health. The institution of Dr. Weiner has received research support from National MS Society. The institution of Dr. Weiner has received research support from Genzyme Corp. The institution of Dr. Weiner has received research support from Genentech, Inc. . The institution of Dr. Weiner has received research support from Verily Life Sciences LLC. The institution of Dr. Weiner has received research support from EMD Serono, Inc..
Klaus Schmierer, MD, PhD	Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AXDEV. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MedScape. Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroDiem. Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurology Academy. Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck KGaA. Dr. Schmierer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Merck KGaA. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for F. Hoffmann-La Roche AG. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva.
Erdem Tuzun	Erdem Tuzun has nothing to disclose.
Melanie Glenn, MD	No disclosure on file
Jesper Hagemeier	No disclosure on file
Sarita Said-Said, MD, FAAN	Dr. Said-Said has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Gritman Medical Center.
Joy R. Esterlitz	No disclosure on file
Dana L. Vanino, DO	Dr. Vanino has nothing to disclose.
Suma Shah, MD	Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Shah has received research support from Biogen. The institution of Dr. Shah has received research support from National MS Society.
Eliezer Sternberg, MD	No disclosure on file
Camilo R. Gomez, MD, FAAN	Dr. Gomez has nothing to disclose.
Rushabh Modi	No disclosure on file
Daniela Perani	No disclosure on file
Patrick Hecht, PhD	Dr. Hecht has received personal compensation for serving as an employee of AbbVie. Dr. Hecht has stock in AbbVie.
Justine Shults	No disclosure on file
Michael Christiansen, MD	No disclosure on file
Paulo S. Santos, MD	No disclosure on file
Erik P. Pioro, MD, DPhil, FAAN	Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avanir Pharmaceutical, Inc.. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx Pharmaceuticals. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MT Pharma America, Inc.. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroTherapia, Inc.. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT Pharma America, Inc..
Yasuo Iwasaki, MD	No disclosure on file
Wengui Yu, MD, PhD	Dr. Yu has nothing to disclose.
Dorothea Altschul, MD	An immediate family member of Dr. Altschul has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Microvention and stryker . Dr. Altschul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens. The institution of Dr. Altschul has received research support from Max Kade .
Rosa Rademakers, PhD	Rosa Rademakers, PhD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mayo Clinic. Rosa Rademakers, PhD has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arkuda Therapeutics. Rosa Rademakers, PhD has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alzheimer Fondation. Rosa Rademakers, PhD has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Kisick Family Foundation (FTD grant program). The institution of Rosa Rademakers, PhD has received research support from NIH. The institution of Rosa Rademakers, PhD has received research support from DOD. The institution of Rosa Rademakers, PhD has received research support from Flanders Institute for Biotechnology (VIB). The institution of Rosa Rademakers, PhD has received research support from Flanders Funds for Scientific Research.
Edward Huey	No disclosure on file
Guy T. Helman	No disclosure on file
Marcus Sucksdorff, MD	Dr. Sucksdorff has nothing to disclose.
Guillermo A. Di Lorenzo, MD	No disclosure on file
Rae E. Bacharach, DO	Dr. Bacharach has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��.
Monique M. Montenegro, MD	Dr. Montenegro has nothing to disclose.
Igor Rybinnik, MD	Dr. Rybinnik has nothing to disclose.
Alexandra J. Sequeira, MD	Dr. Sequeira has nothing to disclose.
Stephen W. English, MD	Dr. English has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Brainomix.
Suyog U. Pol, PhD	Dr. Pol has nothing to disclose.
Carl DeMoor	Carl DeMoor has received personal compensation for serving as an employee of Biogen. Carl DeMoor has received stock or an ownership interest from Biogen. An immediate family member of Carl DeMoor has received personal compensation in the range of $100,000-$499,999 for serving as a Program Director with NIH.
Svetlana Eckert, MD	Dr. Eckert has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Eckert has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Eckert has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics.
Julie R. Korenberg, MD	No disclosure on file
Mark B. Skeen, MD, FAAN	Dr. Skeen has received personal compensation for serving as an employee of VeraSci. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD/Serono. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squib. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD/ Serono. The institution of Dr. Skeen has received research support from National MS Society. Dr. Skeen has received personal compensation in the range of $50,000-$99,999 for serving as a Retiree with US Navy.
Michael Vikelis, MD	No disclosure on file
Murat Gokden	No disclosure on file
Michelle Burack, MD, PhD	No disclosure on file
Miriam L. Freimer, MD, FAAN	Dr. Freimer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Freimer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for alexion. Dr. Freimer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for J and J. Dr. Freimer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Freimer has received research support from Alnylum. The institution of Dr. Freimer has received research support from UCB. The institution of Dr. Freimer has received research support from NIH. The institution of Dr. Freimer has received research support from Janssen. Dr. Freimer has received research support from Avidity. Dr. Freimer has received research support from Fulcrum. The institution of Dr. Freimer has received research support from Dept of defense. The institution of an immediate family member of Dr. Freimer has received research support from Abcurro. Dr. Freimer has received personal compensation in the range of $10,000-$49,999 for serving as a presentations/teaching with UCB.
Stephen D. Silberstein, MD, FAAN	Dr. Silberstein has received publishing royalties from a publication relating to health care.
Cristina M. Ramo, MD	Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALMIRALL . Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANDOZ. Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall. Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIOGEN. Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen . Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. The institution of Dr. Ramo has received research support from HORIZON-2020. The institution of Dr. Ramo has received research support from fis (SPANISH GOVERNMENT). The institution of Dr. Ramo has received research support from BIOGEN. The institution of Dr. Ramo has received research support from MERCK. The institution of Dr. Ramo has received research support from ALMIRALL. The institution of Dr. Ramo has received research support from NOVARTIS. The institution of Dr. Ramo has received research support from RICORS (Spanish Government). The institution of Dr. Ramo has received research support from ROCHE. Dr. Ramo has received publishing royalties from a publication relating to health care.
Bradford B. Thompson, MD	Dr. Thompson has nothing to disclose.
Ayse S. Tinaz, MD, PhD	The institution of Dr. Tinaz has received research support from NINDS/NIH.
Ali Saad, MD, FAAN	Dr. Saad has nothing to disclose.
Wazim Mohamed, MD	Dr. Mohamed has nothing to disclose.
Renxin Chu	Dr. Chu has nothing to disclose.
Varun Chauhan, MD	No disclosure on file
Adam Staffaroni	Adam Staffaroni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Adam Staffaroni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Aviado Bio. Adam Staffaroni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CervoMed. Adam Staffaroni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Prevail Therepeutics/Eli Lilly. Adam Staffaroni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. The institution of Adam Staffaroni has received research support from NIH. The institution of Adam Staffaroni has received research support from Bluefield Project To Cure FTD. The institution of Adam Staffaroni has received research support from AFTD/ALSA. Adam Staffaroni has received personal compensation in the range of $500-$4,999 for serving as a Scientific Advisory Board member with AADF.
Amanda Glickman	Ms. Glickman has nothing to disclose.
Fei-Fei Zhai	Fei-Fei Zhai has nothing to disclose.
Peter W. Kaplan, MBBS, FRCP, FAAN	Dr. Kaplan has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for DNP Epiwatch. Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for IFCN. Dr. Kaplan has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various law firms. Dr. Kaplan has received publishing royalties from a publication relating to health care.
Adeline Vanderver, MD, FAAN	An immediate family member of Dr. Vanderver has received personal compensation for serving as an employee of Maryland Physician Care. The institution of Dr. Vanderver has received research support from Takeda. The institution of Dr. Vanderver has received research support from Passage Bio. The institution of Dr. Vanderver has received research support from Homology. The institution of Dr. Vanderver has received research support from Eli Lilly. The institution of Dr. Vanderver has received research support from Myrtelle. The institution of Dr. Vanderver has received research support from SynaptixBio. The institution of Dr. Vanderver has received research support from PMD Foundation. The institution of Dr. Vanderver has received research support from Ionis. The institution of Dr. Vanderver has received research support from ISD . The institution of Dr. Vanderver has received research support from Boehringer-Ingelheim. The institution of Dr. Vanderver has received research support from Biogen. The institution of Dr. Vanderver has received research support from Sana. The institution of Dr. Vanderver has received research support from Affinia. The institution of Dr. Vanderver has received research support from BridgeBio. The institution of Dr. Vanderver has received research support from Orchard. The institution of Dr. Vanderver has received research support from Minoryx. The institution of Dr. Vanderver has received research support from Forge Biologics. The institution of Dr. Vanderver has received research support from Vigil. Dr. Vanderver has received intellectual property interests from a discovery or technology relating to health care. Dr. Vanderver has received intellectual property interests from a discovery or technology relating to health care.
Asha Singh, MD	Dr. Singh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharma.
Reza Seyedsadjadi, MD	Dr. Seyedsadjadi has received personal compensation for serving as an employee of American Neurological Association. Dr. Seyedsadjadi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SwanBio Therapeutics. Dr. Seyedsadjadi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Seyedsadjadi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. The institution of Dr. Seyedsadjadi has received research support from Cystinosis Research Foundation.
Kevin M. Biglan, MD	Dr. Biglan has received personal compensation for serving as an employee of Eli Lilly. Dr. Biglan has received stock or an ownership interest from Eli Lilly.
Osamu Kano, MD, PhD	Dr. Kano has nothing to disclose.
Giovanni Coppola, MD	Dr. Coppola has received personal compensation for serving as an employee of Regeneron. Dr. Coppola has received stock or an ownership interest from Regeneron.
E. Ray Dorsey, MD, MBA	Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Seelos Therapeutics. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eden McCallum, LLP. Dr. Dorsey has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven Pharmaceuticals. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WebMD. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BioSensics. Dr. Dorsey has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Mediflix. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevance. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kairos Cinema, LLC. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America Inc.. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HanAll. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Dorsey has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Advarra. Dr. Dorsey has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medrhythms. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ANA. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for HMP ��ɫ��, LLP. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ADIVO Associates France. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for University of Toronto. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philadelphia Neurological Society. Dr. Dorsey has stock in Included Health. Dr. Dorsey has stock in Mediflix. Dr. Dorsey has stock in SemCap. Dr. Dorsey has stock in Synapticure. The institution of Dr. Dorsey has received research support from NIH/NINDS. The institution of Dr. Dorsey has received research support from Burroughs Wellcome . The institution of Dr. Dorsey has received research support from Michael J. Fox Foundation - Fox Insight. The institution of Dr. Dorsey has received research support from Michael J. Fox Foundation - Emerald. The institution of Dr. Dorsey has received research support from B. Thomas Golisano Foundation. The institution of Dr. Dorsey has received research support from Emerald Innovations, Inc.. The institution of Dr. Dorsey has received research support from Photopharmics Inc.. The institution of Dr. Dorsey has received research support from Averitas Pharma Inc.. The institution of Dr. Dorsey has received research support from DOD/Army Medical Research Acquisition Activity. The institution of Dr. Dorsey has received research support from NIH/NINDS.
Sun Ju Chung, MD, PhD, FAAN	Dr. Chung has nothing to disclose.
Syed F. Zaidi, MD	Dr. Zaidi has nothing to disclose.
Yujie Wang, MD	Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Wang has received research support from Genentech. The institution of Dr. Wang has received research support from uniQure. The institution of Dr. Wang has received research support from NIH/NINDS.
Sandra Weintraub, PhD, FAAN	Dr. Weintraub has nothing to disclose.
William S. Baek, MD, FAAN	Dr. Baek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie.
James Conners, MD	The institution of Dr. Conners has received research support from nih.
Nirali Vora, MD	Dr. Vora has nothing to disclose.
Asako Takanohashi, PhD, DVM	Dr. Takanohashi has nothing to disclose.
Francisco Germiniani	No disclosure on file
Sarah Ingersoll, RN, PHN	Ms. Ingersoll has nothing to disclose.
Syed H. Shabbir, MD	Dr. Shabbir has nothing to disclose.
Konstantin E. Balashov, MD, PhD, FAAN	Dr. Balashov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech.
Ging-Yuek R. Hsiung, MD, FAAN	Dr. Hsiung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Hsiung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. The institution of Dr. Hsiung has received research support from CIHR. The institution of Dr. Hsiung has received research support from NIH. The institution of Dr. Hsiung has received research support from Eli Lilly. The institution of Dr. Hsiung has received research support from Biogen.
Manal A. Badawi, MD	Dr. Badawi has nothing to disclose.
Eero Rissanen, MD	Dr. Rissanen has received research support from Sigrid Juselius Foundation.
Jessica B. Smith, MPH	Ms. Smith has nothing to disclose.
Thomas Marshall, PharmD	No disclosure on file
Ann Scher, PhD, FAAN	No disclosure on file
David S. Roby, MD	No disclosure on file
Bruno Brochet, MD, FEAN	Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for celgene. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for jansen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for novartis. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for merck. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for celgene.
Ian R.A. Mackenzie, MD, FRCP	No disclosure on file
Anila Thomas, MD	Dr. Thomas has nothing to disclose.
Annette Wundes, MD, FAAN	The institution of Dr. Wundes has received research support from Benaroya Research Institute .
Chokri A. Mhiri, MD	Prof. Mhiri has received personal compensation for serving as an employee of Hikma. Prof. Mhiri has received personal compensation for serving as an employee of Sanofi Genzyme. Prof. Mhiri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Prof. Mhiri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche.
Luiza G. Piovesana, MD	No disclosure on file
Jason Chen	No disclosure on file
Christopher M. Filley, MD, FAAN	Dr. Filley has received personal compensation for serving as an employee of University of Colorado Press. Dr. Filley has received personal compensation for serving as an employee of Oxford University Press. Dr. Filley has received personal compensation for serving as an employee of Cambridge University Press . Dr. Filley has received personal compensation for serving as an employee of Elsevier, Inc.. Dr. Filley has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Wheeler Trigg O'Donnell LLP. Dr. Filley has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Evans Case LLP. The institution of Dr. Filley has received research support from Department of Defense. Dr. Filley has received publishing royalties from a publication relating to health care. Dr. Filley has received publishing royalties from a publication relating to health care. Dr. Filley has received publishing royalties from a publication relating to health care. Dr. Filley has received publishing royalties from a publication relating to health care.
Edward J. Cupler, MD, FAAN	Dr. Cupler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Fernando Dangond, MD, FAAN	Dr. Dangond has received personal compensation in the range of $1,000,000+ for serving as a Head, Global Clinical Development (employee for 12 years) with EMD Serono.
Thomas Leist, MD, PhD, FAAN	Dr. Leist has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Leist has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Leist has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Leist has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Seono. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Expert Wittness with DHHS HRSA.
Omar M. Hussein, MD	No disclosure on file
Kurt Marhardt	No disclosure on file
Christina M. Dheel	No disclosure on file
Kye Won Park, MD	Dr. Park has nothing to disclose.
Harmanpreet Tiwana, MD	No disclosure on file
Ferdinand Schweser, PhD	Dr. Schweser has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Elizabeth Fisher	Elizabeth Fisher has received personal compensation for serving as an employee of Biogen. Elizabeth Fisher has stock in Biogen. Elizabeth Fisher has received intellectual property interests from a discovery or technology relating to health care.
Joost Raaphorst, MD	Dr. Raaphorst has nothing to disclose.
Laura Airas, MD, PhD	Dr. Airas has nothing to disclose.
Rachel P. Guimaraes, PT	Ms. Guimaraes has nothing to disclose.
Benjamin J. Koo, MD	No disclosure on file
Marc Bigaud	Marc Bigaud has received personal compensation for serving as an employee of Novartis Pharma.
Sridhara S. Yaddanapudi, MD	Dr. Yaddanapudi has nothing to disclose.
Muhammad Niazi, MD	No disclosure on file
Youssef Al Said, MBBS	No disclosure on file
Ignacio Demey, MD, PhD	Ignacio Demey, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Laboratorio Bagó.
Dennis N. Bourdette, MD, FAAN	Dr. Bourdette has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Magellan Health Care. Dr. Bourdette has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Best Doctor's Inc. Dr. Bourdette has stock in Authobahn Therapeutics. Dr. Bourdette has received intellectual property interests from a discovery or technology relating to health care.
Senda Ajroud-Driss, MD, FAAN	Dr. Ajroud-Driss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Ajroud-Driss has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astrazeneca. Dr. Ajroud-Driss has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Ajroud-Driss has received research support from NIH. The institution of Dr. Ajroud-Driss has received research support from University of Minesota/FDA. The institution of Dr. Ajroud-Driss has received research support from Edgewise Therapeutics. The institution of Dr. Ajroud-Driss has received research support from Biogen. The institution of Dr. Ajroud-Driss has received research support from Woolsey Pharmaceuticals. The institution of Dr. Ajroud-Driss has received research support from Uniqure Biopharma. The institution of Dr. Ajroud-Driss has received research support from Coya Therapeutics. The institution of Dr. Ajroud-Driss has received research support from Novartis. The institution of Dr. Ajroud-Driss has received research support from Alnylam pharmaceuticals. The institution of Dr. Ajroud-Driss has received research support from Healey and AMG center for ALS . The institution of Dr. Ajroud-Driss has received research support from les Turner ALS Foundation. The institution of Dr. Ajroud-Driss has received research support from Hopewell. The institution of Dr. Ajroud-Driss has received research support from Peripheral neuropathy foundation. Dr. Ajroud-Driss has received publishing royalties from a publication relating to health care.
Francoise Durand Dubief	The institution of Francoise Durand Dubief has received research support from ARSEP.
Deepti Zutshi, MD, FAAN	Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon pharmaceuticals. An immediate family member of Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aucta Pharmaceuticals. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aucta.
Teshamae Monteith, MD, FAAN	Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Headache Society . Dr. Monteith has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Monteith has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merz. Dr. Monteith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva . Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN . Dr. Monteith has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Monteith has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN . Dr. Monteith has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Cephalalgia. Dr. Monteith has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for New England Journal of Medicine JW. The institution of Dr. Monteith has received research support from AbbVie. The institution of Dr. Monteith has received research support from lilly. The institution of Dr. Monteith has received research support from Ipsen. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a ��ɫ�� with Medscape. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a ��ɫ�� with Massachusetts Medical Society . Dr. Monteith has a non-compensated relationship as a President Elect with Florida Society of Neurology that is relevant to AAN interests or activities. Dr. Monteith has a non-compensated relationship as a Editorial Board /Board Member with American Migraine Foundation that is relevant to AAN interests or activities. Dr. Monteith has a non-compensated relationship as a Board Member with International Headache Society that is relevant to AAN interests or activities. Dr. Monteith has a non-compensated relationship as a author with Pfizer that is relevant to AAN interests or activities. Dr. Monteith has a non-compensated relationship as a author with Abbvie that is relevant to AAN interests or activities. Dr. Monteith has a non-compensated relationship as a author with Theranica that is relevant to AAN interests or activities.
Henrik Zetterberg	Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie, Acumen, Alector, Alzinova, ALZpath, Amylyx, Annexon, Apellis, Artery Therapeutics, AZTherapies, Cognito Therapeutics, CogRx, Denali, Eisai, LabCorp, Merry Life, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Quanterix, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave. Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alzecure, BioArctic, Biogen, Cellectricon, Fujirebio, Lilly, Novo Nordisk, Roche, and WebMD. Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley and Elsevier. Henrik Zetterberg has stock in Brain Biomarker Solutions.
Bertrand Audoin	No disclosure on file
Philip G. Eye, MD	No disclosure on file
Ugur Sener, MD	Dr. Sener has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier Pharmaceuticals. Dr. Sener has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Sener has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion.
Balakrishnan Shankar, Jr., MD	Dr. Shankar has nothing to disclose.
Perrin A. Pleninger, MD, FAAN	Dr. Pleninger has nothing to disclose.
Simona Bonavita	No disclosure on file
Adam Kirton, MD	Dr. Kirton has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Multiple. The institution of Dr. Kirton has received research support from Multiple.
Elliot Dimberg, MD, FAAN	Dr. Dimberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Academic CME.
Maysaa M. Basha, MD, FAAN	Dr. Basha has nothing to disclose.
Marta Radaelli	Marta Radaelli has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Marta Radaelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Marta Radaelli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Marta Radaelli has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi-Genzyme.
Victoria Leavitt, PhD, FAAN	Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Leavitt has received research support from National Institutes of Health. The institution of Dr. Leavitt has received research support from National Multiple Sclerosis Society. The institution of Dr. Leavitt has received research support from Department of Defense. Dr. Leavitt has received intellectual property interests from a discovery or technology relating to health care.
Nicholas L. Zalewski, MD	Dr. Zalewski has nothing to disclose.
Ashhar Ali, DO, FAAN	Dr. Ali has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Ali has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Ebsco.
Preeti M. Rao, MD	No disclosure on file
Katalina McInerney	Katalina McInerney has nothing to disclose.
Christine Belden	Christine Belden has nothing to disclose.
Claire Riley, MD, FAAN	Dr. Riley has received personal compensation for serving as an employee of AstraZeneca. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cabaletta Bio. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics.
Kaj Blennow	Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AC Immune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ALZPath. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AriBio. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Beckman-Coulter. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioArctic. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moleac Pte. Ltd. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurimmune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Pharma. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prothena. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quanterix. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Diagnostics. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens Healthineers. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AC Immune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALZPath. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AriBio. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Beckman-Coulter. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BioArctic. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Moleac Pte. Ltd. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurimmune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ono Pharma. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prothena. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Quanterix. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Diagnostics. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Siemens Healthineers. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Julius Clinical. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AC Immune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Celdara Medical. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Diagnostics. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Co-founder with Brain Biomarker Solutions.
Gabriel M. Napoli, MD	Dr. Napoli has nothing to disclose.
Lisa T. Emrick, MD	Dr. Emrick has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Arkema. The institution of Dr. Emrick has received research support from Lysogene. The institution of Dr. Emrick has received research support from PTC. The institution of Dr. Emrick has received research support from Roche. The institution of Dr. Emrick has received research support from NIH.
Katrina Peariso, MD, PhD	No disclosure on file
Marissa Kellogg, MD, MPH, FAAN	The institution of Dr. Kellogg has received research support from VA & DoD.
Danielle S. Shpiner, MD	An immediate family member of Dr. Shpiner has received personal compensation for serving as an employee of University of Miami. Dr. Shpiner has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Mission MSA. The institution of Dr. Shpiner has received research support from American Parkinson's Disease Association. The institution of Dr. Shpiner has received research support from CurePSP. The institution of Dr. Shpiner has received research support from Parkinson's Foundation. Dr. Shpiner has a non-compensated relationship as a COE Medical Director with Parkinson's Foundation that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Medtronic that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Boston Scientific that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Abbott that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Abbvie that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Ipsen that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Amneal that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Michael J. Fox Foundation that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a CoC Medical Director with CurePSP that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a COE Medical Director with Mission MSA that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Merz that is relevant to AAN interests or activities.
Jennifer M. Martinez-Thompson, MD, FAAN	Dr. Martinez-Thompson has nothing to disclose.
Sunita Venkateswaran, MD	Dr. Venkateswaran has nothing to disclose.
Norbert Bruggemann, MD	No disclosure on file
Maria Goicochea	No disclosure on file
Fredy J. Revilla, MD, FAAN	Dr. Revilla has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA . Dr. Revilla has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA .
Aravindhan Veerapandiyan, MD	Dr. Veerapandiyan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen, Novartis,Edgewise Therapeutics, Pfizer, PTC Therapeutics, Sarepta Therapeutics, Inc., UCB Pharma, Catalyst, Entrada, Lupin, Percheron, ITF. Dr. Veerapandiyan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Veerapandiyan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Muscle and Nerve. The institution of Dr. Veerapandiyan has received research support from AMO Pharma, Capricor Therapeutics, Edgewise Therapeutics, FibroGen, Muscular Dystrophy Association, Novartis, Parent Project Muscular Dystrophy, Pfizer, RegenxBio, SolodBio and Sarepta Therapeutics. Dr. Veerapandiyan has received personal compensation in the range of $5,000-$9,999 for serving as a MD with PPMD, MDA.
Alrabi Tawil, MD, FAAN	Dr. Tawil has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kate Therapeutics. Dr. Tawil has received personal compensation in the range of $500-$4,999 for serving as a Consultant for meRicule. The institution of Dr. Tawil has received research support from Friends of FSH Research. The institution of Dr. Tawil has received research support from FSH Society. The institution of Dr. Tawil has received research support from NIH. The institution of Dr. Tawil has received research support from Fulcrum. Dr. Tawil has received intellectual property interests from a discovery or technology relating to health care.
Jawad F. Kirmani, MD	Dr. Kirmani has nothing to disclose.
Paolo Preziosa	Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb . Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Samantha J. LoRusso, MD	Dr. LoRusso has nothing to disclose.
Anibal Chertcoff	Anibal Chertcoff has nothing to disclose.
Paolo Zanotti Fregonara	Paolo Zanotti Fregonara has nothing to disclose.
Alison I. Thaler, MD	Dr. Thaler has received publishing royalties from a publication relating to health care.
Jun Ni	Jun Ni has nothing to disclose.
Yen-Feng Wang, MD	No disclosure on file
Shahamat Tauhid, MD	Dr. Tauhid has nothing to disclose.
Siddhart K. Mehta, MD	Dr. Mehta has nothing to disclose.
Rasheda El-Nazer, MD	No disclosure on file
Maria J SANCHEZ-QUINTERO, PhD	No disclosure on file
Nicolas Collongues, MD	Nicolas Collongues, MD has nothing to disclose.
Shubir Dutt	Mr. Dutt has nothing to disclose.
Fahad F. Albassam, MD	No disclosure on file
Michael Oshinsky, PhD	No disclosure on file
Tammie Benzinger	Tammie Benzinger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Tammie Benzinger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Tammie Benzinger has received personal compensation in the range of $0-$499 for serving as a Consultant for Sora Neuroscience. Tammie Benzinger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Tammie Benzinger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Tammie Benzinger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Tammie Benzinger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Tammie Benzinger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol, Myers Squibb. Tammie Benzinger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for PeerView. Tammie Benzinger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medscape. The institution of Tammie Benzinger has received research support from Siemens. The institution of Tammie Benzinger has received research support from Hyperfine. Tammie Benzinger has a non-compensated relationship as a Consultant with Siemens that is relevant to AAN interests or activities. Tammie Benzinger has a non-compensated relationship as a Consultant with Eisai that is relevant to AAN interests or activities.
Paolo Zamboni, MD	No disclosure on file
Melissa Motta, MD, MPH, FAAN	Dr. Motta has nothing to disclose.
Sheng-Han Kuo, MD, FAAN	Dr. Kuo has nothing to disclose.
Yi-Cheng Zhu, MD, PhD	Dr. Zhu has nothing to disclose.
Michael J. Lyerly, MD, FAAN	Dr. Lyerly has nothing to disclose.
Shawna M. Cutting, MD, FAAN	The institution of Dr. Cutting has received research support from Genentech.
Omar Jawdat, MD	Dr. Jawdat has nothing to disclose.
Tarun Singhal, MD	Dr. Singhal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Singhal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech . Dr. Singhal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Singhal has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Singhal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme Sanofi. Dr. Singhal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiziana LifeSciences. The institution of Dr. Singhal has received research support from Novartis. The institution of Dr. Singhal has received research support from Department of Defense. The institution of Dr. Singhal has received research support from Foundation for Neurologic Diseases.
Sotiris G. Mitropanopoulos, MD	Dr. Mitropanopoulos has nothing to disclose.
Mahesh Jayaraman	No disclosure on file
Simona Treidler, MD	Dr. Treidler has nothing to disclose.
Gabriel A. Marx	No disclosure on file
Ning Su, MD	Dr. Su has nothing to disclose.
Eyad Almallouhi, MD	Dr. Almallouhi has nothing to disclose.
Malveeka Sharma, MD	Dr. Sharma has nothing to disclose.
Bakhtier Nurmukhamedov, MD	No disclosure on file
Walaa A Aldarwish, MBBS	No disclosure on file
David H. Dennison, MD, FAAN	No disclosure on file
Corneliu C. Luca, MD	Dr. Luca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific. Dr. Luca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Signant Health. Dr. Luca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott.
Jia Zhen Cheng, MD	No disclosure on file
Georgios Manousakis, MD, FAAN	Dr. Manousakis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stealth Biotherapeutics. Dr. Manousakis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Manousakis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Manousakis has received research support from Marzolf foundation.
Sherita Alai	No disclosure on file
Keith Carolus	No disclosure on file
Sarah Tanveer, PhD, MA	The institution of Miss Tanveer has received research support from Laura and Arnold Foundation. The institution of Miss Tanveer has received research support from Food and Drug Administration.
Elisabeth Golden, MD	Dr. Golden has nothing to disclose.
Urvish K. Patel	Mr. Patel has nothing to disclose.
Brian J. Hanrahan, MD	Dr. Hanrahan has received personal compensation for serving as an employee of Nowyouknow Neuro.
Reema Choudhry, MD	Dr. Butt has nothing to disclose.
Fanny M. Elahi, MD, PhD	Dr. Elahi has nothing to disclose.
Feng Tian	No disclosure on file
Aldanica Olano	Aldanica Olano has nothing to disclose.
Hyujin Jo	Hyujin Jo has nothing to disclose.
Nicholas Lannen, MD	Dr. Lannen has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Genentech. Dr. Lannen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for TG Therapeutics. Dr. Lannen has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Horizon Theraputics.
Balasubramanian Samivel, MD	Dr. Samivel has nothing to disclose.
Ilya Nasrallah, MD, PhD	Dr. Nasrallah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Nasrallah has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Nasrallah has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Nasrallah has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Cassiday Schade LLP. The institution of Dr. Nasrallah has received research support from NIH. The institution of Dr. Nasrallah has received research support from ASNR.
Tae-Jin Song, MD	Dr. Song has nothing to disclose.
Kristine Yaffe, MD	Dr. Yaffe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Yaffe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Quintiles. Dr. Yaffe has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Alector. The institution of Dr. Yaffe has received research support from NIH. The institution of Dr. Yaffe has received research support from DOD. The institution of Dr. Yaffe has received research support from Veterans Affairs.
Filippo Martinelli Boneschi	No disclosure on file
E. Ann Yeh, MD, MA, FRCPC	Dr. Yeh has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pipeline therapeutics. Dr. Yeh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Yeh has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for SCN. Dr. Yeh has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Yeh has received research support from CIHR. The institution of Dr. Yeh has received research support from National MS Society. The institution of Dr. Yeh has received research support from SickKids Foundation. The institution of Dr. Yeh has received research support from MSSC. The institution of Dr. Yeh has received research support from Garry Hurvitz Foundation. The institution of Dr. Yeh has received research support from Leong Centre. The institution of Dr. Yeh has received research support from OMSLife. The institution of Dr. Yeh has received research support from Canada's Drug Agency. Dr. Yeh has received personal compensation in the range of $0-$499 for serving as a Author with Medscape. Dr. Yeh has a non-compensated relationship as a Editorial Board with Neurology that is relevant to AAN interests or activities. Dr. Yeh has a non-compensated relationship as a Editorial Board with MSJ that is relevant to AAN interests or activities.
Zulfi Haneef, MD, MBBS, MRCP, FAAN	Dr. Haneef has received publishing royalties from a publication relating to health care.
Larry R. Faulkner, MD	Dr. Faulkner has received personal compensation for serving as an employee of ABPN.
Sharon Chiang, MD, PhD	Dr. Chiang has stock in EpilepsyAI. Dr. Chiang has received research support from UCSF Clinical and Translational Science Institute UL1 TR001872. The institution of Dr. Chiang has received research support from NIH R25 NS070680 .
Antonio Gallo	Antonio Gallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Antonio Gallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Antonio Gallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Antonio Gallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis.
Hennan S. Teixeira, MD	Dr. Teixeira has nothing to disclose.
Marian L. Dale, MD, FAAN	Dr. Dale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Dale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synergic Medical Technologies . Dr. Dale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognito Therapeutics. The institution of Dr. Dale has received research support from NIH . The institution of Dr. Dale has received research support from Collins Medical Trust.
Francesca Caso, MD	Dr. Caso has nothing to disclose.
Ajay Goenka, MD	Dr. Goenka has nothing to disclose.
Matthew N. Jaffa, DO	Dr. Jaffa has nothing to disclose.
Frederic Heerinckx, PharmD	No disclosure on file
Shu-Yang Zhang	No disclosure on file
Jeremy Moeller, MD, FAAN	Dr. Moeller has received publishing royalties from a publication relating to health care.
Laura E. Baldassari, MD, MHS	No disclosure on file
Francisco J. Varela, MD	Dr. Varela has nothing to disclose.
Carolyn Pizoli, MD, PhD	No disclosure on file
Julieta A. Quiroga, MD	No disclosure on file

��ɫ����

��ɫ����

��ɫ��

��ɫ��